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 Abstract 
The main technology currently used in diabetic care, monitors blood glucose and involves an 
invasive “fingerstick” step. However, low patient compliance and non-continuous glucose 
monitoring imply poor management of diabetes through this technology, which could lead to 
adverse and potentially life threatening conditions. In this context, non-invasive glucose 
sensing appears as an alternative that can bring a change in the prevention and management 
of the diabetic condition, promising to eliminate patient resistance towards more frequent 
monitoring and, hence, considerably improving diabetic’s control over glycaemia. However, 
no non-invasive technology has yet succeeded on the market over the long term. The research 
field is therefore open to innovative and performant non-invasive technologies.  
This thesis presents the development of a non-invasive biosensor which as a core principle 
accesses individual, privileged glucose pathways in the skin (such as hair follicles), allowing 
the extraction of glucose directly from the interstitial fluid, via reverse iontophoresis (RI). 
The transdermally extracted glucose is then electrochemically detected in a small size sensor 
with very high sensitivity. A fully developed technology based on this principle will not 
require fingerpricking and would thus eliminate users’ main barrier to glucose monitoring. 
The developed sensor is enzymatic (using glucose oxidase), which electrochemically detects 
the produced H2O2; while the electrode material is graphene produced by Chemical Vapour 
Deposition, a promising carbon nanomaterial platform for biofunctionalisation and 
biosensing. The sensor is a miniature one (typically of 9 mm
2
 area, containing 24 µL of gel 
encasing the enzyme), with demonstrated performance parameters that are highly competitive 




 and limit of detection down to 1 µM), with high specificity 
towards glucose. The combination of this sensor with glucose extraction by reverse 
iontophoresis was then validated (with proportionality between subdermal and extracted 
glucose concentrations demonstrated); as well as enhanced extraction through targeting of 
hair follicles with the miniature device. The electrochemical determination of glucose 
concentration was further confirmed by 
1
H quantitative-NMR detection of glucose. Finally, 
several such sensors were integrated in a multiplex configuration, and independent sensing, 
with no cross-talk was demonstrated. The steps demonstrated and implemented so far are 
proof-of-concept of a highly promising non-invasive, transdermal, future technology for 
diabetic care. 
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Chapter 1: Diabetes, glucose sensing 
and graphene 
1.1 Introduction 
Diabetes is a growing healthcare problem [1], which needs rapid and efficient addressing. 
The disease involves abnormal blood glycaemia which can lead to a series of adverse events 
if the patient doesn’t manage the condition adequately. A diabetic individual will therefore 
require regular blood glucose monitoring in order to assess the glycaemic status and react 
with the correct therapeutic response. The project aims to benefit individuals suffering from 
Type 1 and Type 2 diabetes. If the disease is not managed properly, severely damaging 
adverse effects are apparent. As a result, a number of glucose biosensors of different sorts 
have been developed that rely upon several detection techniques. The breakthrough 
achievement was the invention of the oxygen/glucose electrochemical sensor in 1962 [2], 
triggering an industry that was estimated to be worth billions of $ in the US by 2012 [3]. This 
included the development of self-monitoring blood glucose devices SMBG (especially 
fingerstick glucose biosensors [4, 5]) which contributed substantially to the success story [6]. 
With these simple systems, patients were and are still able to monitor their blood glucose 
levels with a single drop of blood as low as 0.3 µL [7], radically changing the management of 
the disease. However, despite this innovation patient self-monitoring shows poor adherence 
only 46% of patients with type 1 diabetes, and 39% of patients with type 2 diabetes, have 
been reported to follow their glucose monitoring and treatment carefully, and have fewer 
adverse effects [8]. This lack of compliance was due to several factors: (1) psychological 
issues (anxiety, stress, etc.), (2) pain related problems, (3) lack of motivation, (4) poor disease 
management (particularly difficult at a young age), (5) cost, (6) religious beliefs, and (7) 
access to medication and to monitoring devices [9].  
Consequently, new technologies emerged with the goal of better controlling the disease. 
Specifically, invasive devices (surgically implanted [10] or subdermal[11]) and non-invasive 
sensors (tear analysis /contact lenses [12], sweat [13], urine [14], and saliva sensors [15], 
2 
optical techniques (near infrared spectroscopy (NIR) [16], optical scattering; spatially-
resolved diffuse reflectance [17], Raman scattering [18]), polarimetry, photo acoustic 
spectroscopy, and transdermal reverse iontophoresis [19]). To date, however, only invasive 
sensors have achieved an ongoing market presence, while two non-invasive technologies 
were also commercialized, the GlucoWatch 
®
 Biographer (Cygnus, CA, USA) which 
received U.S. FDA approval and the PENDRA
®
 (Pendragon Medical Ltd., Zurich, 
Switzerland). Neither proved to be successful nor are any longer available. PENDRA
® 
is a 
non-invasive technology based on impedance spectroscopy. It was introduced in Europe 
(2004) and the detection relied on the measurement of skin impedance. The idea was that 





 in gradients [20, 21]. The device, although relatively inexpensive and 
user friendly had significant limitations including: its indirect detection method; its 
ineffectiveness in 1/3 of users; the need for a blood glucose calibration [22], and a 60 minutes 
equilibration before useful blood glucose levels would be determined [23]. The GlucoWatch 
®
 Biographer on the other hand relied on the application of a small direct current across two 
electrodes positioned on the skin surface to induce the electroosmotic extraction of a very 
small volume of interstitial fluid containing glucose. However, the innovation suffered 
several drawbacks, the main ones being: (1) high dilution of the tiny extracted interstitial 
volume into the large volume of the sensor (typically, 400 µL of gel [24]), resulting in very 
low (submicromolar) concentrations of glucose and therefore requiring the sensor to operate 
very close to its limit of detection [25]; (2) sensitivity and accuracy issues especially in 
hypoglycaemic situations; and (3) the device still required an invasive “finger-pricking” 
calibration due to variations in the glucose dilution factors between subjects, or for different 
skin sites on a single individual [26]. These major issues combined with other problems, such 
as long warm-up time, skipped readings and skin irritation resulted in the withdrawal of the 
device from the market. 
 
There is, however, potential for a radically revised non-invasive glucose technology based on 
the reverse iontophoresis extraction technique. The path of electroosmotic fluid flow across 
the skin under the influence of iontophoresis is privileged through skin appendages, 
specifically through hair follicles [27]. This fact gave birth to the idea that was followed in 
this work: to develop a glucose sensor that will specifically target the hair follicles extraction 
pathways. The glucose concentration at these targeted sites is envisaged to be significantly 
higher than over a non-follicular part of the dermis, and to approach the glucose 
3 
concentration in the interstitial fluid. The electrode/sensor we developed is therefore a 
miniaturized amperometric glucose oxidase (GOD) biosensor (containing 24 µL volume of 
gel as receptacle, and of 9 mm
2
 geometric area) that will target the preferential extraction. 
Several such detectors are then multiplexed with the purpose of achieving an improved skin 
coverage as well as greater accuracy. The work also aimed at improving the sensing 
technology. Hence, as opposed to the carbon paste/platinum electrochemical glucose sensor 
involved in the GlucoWatch 
®
 Biographer detection [28], the successful integration of 
chemical vapour deposited (CVD) graphene as the transducer in a glucose oxidase first 
generation (i.e. relying on oxygen) biosensor is demonstrated. The reasons behind the choice 
of CVD graphene as a transducer in the sensor development are in section 1.4. 
 
Using graphene as the base of the research, a visualisation of different enzymatic 
functionalization and study of the catalytic activity of such coated enzymes will be presented. 
Two detection platforms will then be investigated in the form of a FET or an amperometric 
sensor. In parallel amperometric configurations involving detection of glucose via H2O2 (first 
generation sensor) and redox mediators (second generation sensors) or platinum nanoparticles 
will be studied and the advantage of one technique over the other presented. The optimized 
sensor will in the end be a CVD graphene-based sensor, enhanced by platinum nanoparticles, 
and coupled to an agarose gel reservoir containing glucose oxidase. 
 
In order to achieve a non-invasive detection of glucose the developed sensor will then be 
integrated with reverse iontophoresis to allow both glucose extraction through porcine skin 
(the closest physiological model to the human skin), and subsequent electrochemical 
detection. Targeted extraction will also be studied on individual hair follicles in order to 
confirm privileged path extraction of glucose and subsequent detection. The targeted 
extraction results will be validated by an independent 
1
H quantitative NMR control 
experiment. An attempt will finally be made to integrate the sensors in a multiplex assay and 
to demonstrate separated and autonomous glucose sensing, without cross talking. 
  
4 
This thesis is structured as follows: 
 Chapter 1: (1) Introduction (2) Diabetes mellitus, (3) biosensing, (4) graphene, (5) 
Analytical and microscopic techniques and (6) aims and objective of the thesis 
 Chapter 2: Glucose oxidase functionalization on CVD graphene 
 Chapter 3: Biosensor design and detection principle 
 Chapter 4: Performance of the sensor 
 Chapter 5: Non-invasive glucose monitoring 
 Chapter 6: General conclusion and future work. 
1.2 Diabetes Mellitus 
1.2.1 Disease pathology 
Diabetes mellitus has been defined by the WHO as: “a metabolic disorder of multiple 
aetiology characterized by chronic hyperglycaemia with disturbance of carbohydrate, fat and 
protein metabolism resulting from defects in insulin secretion, insulin action or both” [29].  
The metabolism of any organism is the sum of biological processes that either produce or 
consume energy (catabolism and anabolism). The disruption of these mechanisms constitute a 
metabolic disorder and will cause indirect adverse effects from minor symptoms to life 
threatening conditions. In the case of diabetes, the disturbed assimilation of glucose by cells 
causes dysregulation of metabolism inducing hyperglycaemia (high levels of glucose in the 
bloodstream) [30] and ketoacidosis (caused by incomplete metabolism of fatty acids and 
accumulation of ketones in the body fluids) [31]. Two types of diabetes (1 and 2) can be 
distinguished. 
 
1.2.1.1 Type 1 diabetes 
Type 1 diabetes is caused by the destruction of pancreatic β cells. This leads to an impaired 
production of insulin up to the point where insulin injections are required for survival. Type 1 
diabetes can be separated into two categories: (1) Type 1A (“immune-mediated”) which is 
characterised by the early presence of antibodies against glutamic acid, islet cells or insulin, 
and (2) Type 1B (“idiopathic”) which is not immunological. In type 1A, the rate of pancreatic 
β cell destruction is variable and a function of the age of the individual; faster for children, 
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slower in adults, who can retain a small insulin secretion activiti (so called “latent 
autoimmune diabetes”). However, ultimately even these diabetes ultimately reach a point at 
which insulin injections become vital [32, 33]. 
 
1.2.1.2 Type 2 diabetes 
Type 2 diabetes is the most common form of the disease. It is characterised by impairment of 
either insulin secretion by the pancreas or insulin detection by receptors or, and most 
generally, both. Type 2 diabetes involves a progressive degeneration of the pancreatic β cells 
with time. At least initially, Type 2 diabetics do not require insulin injections. They can 
remain asymptomatic over a long period of time before the disease is diagnosed, rendering 
prevention particularly difficult. 90% of the incidence of diabetes can be related to an 
unhealthy (“western”) life-style [34], correlated mainly with obesity, but also with smoking 
and/or alcohol consumption. A sedentary lifestyle is also associated with the progression of 
the disease and induced insulin resistance. Other, obvious risk factors include: little or no 
physical activity, high fat /carbohydrate and low fibre diet, high blood pressure, stress, aging, 
etc. [35]. Nevertheless, Type 2 diabetes can be reversed through exercise, and a healthier diet 
and lifestyle, if treated early [36]. Finally, although it is widely agreed that the development 
of insulin resistance and Type 2 diabetes are mainly due to environmental (life style) factors, 
a genetic component has also been identified and while the latter account for defective insulin 
secretion, no clear genetic relationship has yet been established with insulin resistance.[37]. 
 
1.2.1.3 Gestational diabetes and other types of diabetes 
Gestational diabetes is a life threatening condition for the mother and the child predisposing 
both individuals and occurs in 7% of all pregnancies in the USA [34]. It manifests during the 
3
rd
 trimester of pregnancy and usually terminates with delivery. Women with this condition, 
however are more likely to develop Type 2 diabetes later in life [34]. Other types of diabetes 
are related to underlying disorders: (1) diseases of the exocrine pancreas, (2) acute and 




Diabetes mellitus is now a worldwide health problem that has dramatically increased in 
prevalence in the past 30 years (5.6 million against 20.9 million of diagnosed diabetics in the 
US between 1980 and 2011 [38, 39, 40]). This shows that the disease is a serious and 





Figure 1.1. Estimated number of diagnosed and undiagnosed cases of diabetes 
(shaded rings) worldwide in 2012 (reproduced from [1   ]).
 
Furthermore, while it would make sense from the description of diabetes as a lifestyle related 
condition that developed countries would present the highest numbers of diabetics due to 
their poor “western lifestyle”, surprisingly middle to low income countries such as China, 
India and the Middle-East present the largest cases numbers of cases. This observation has 
multiple explanations: (1) It has been demonstrated that non-Caucasian ethnic groups present 
a higher risk of developing Type 2 diabetes [41]. (2) The number of cases can be correlated to 
economic development. China and India are among the emergent economic powers where the 
population have gradually changed their lifestyle, becoming more westernised [42]. (3) In 
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lower income countries, there is less access to preventive treatments, less education, and less 
infrastructure for early detection of the disease and continuation of treatments. This could 
explain the high growth rate in Africa, for instance [43].  
1.2.3 Diabetes blood glucose levels  
1.2.3.1 Fasting plasma glucose, oral glucose tolerance test, HbA1c testing 
Three tests are commonly used to diagnose diabetes mellitus: 
 Fasting plasma glucose (FPG) involves an 8 hour fast and then measuring the blood 
glucose concentration. The test provides a measurements of the basal glucose level 
[44]. 
 The oral glucose tolerance test (OGTT) and a measure of blood glucose 2 hours 
later. The OGTT involves administration of the equivalent of 75 g anhydrous glucose 
dissolved in water and measurement of the glycaemia after 2 hours [45].  
 Thirdly, these two parts are also combined with an analysis of HbA1c, a by-product of 
glucose metabolism (i.e., glycated haemoglobin; the HbA1c complex). HbA1c is 
expressed as a fraction of total haemoglobin and is proportional (subject to certain 
individual limitations related to race, age, blood disease [46]) to blood glucose levels. 
The HbA1c is accepted by the WHO as a diagnosis test for diabetes (i.e., HbA1c ratio ≥ 
6.5 %) [47]. However, measurement of HbA1c is not a “spot check” on glucose levels; 
rather, it provides information on the patient’s glycaemic state over a period of 
approximately the preceding 2 months (see section 1.2.4.1)[48].  
 
1.2.3.2 Blood glucose levels and diabetes diagnosis 
 
1.2.3.2.1 Diabetes 
Hyperglycaemia in diabetes has been defined by the following blood glucose level ranges: 
“fasting plasma glucose ≥7.0 mM (126 mg/dL) or 2 hours plasma glucose (after meal) ≥11.1 
mM (200 mg/dL) [44]”. 
 
1.2.3.2.2 Pre-diabetes 
Prediabetes comprises two physiological states: impaired glucose tolerance (IGT) and 
impaired fasting glucose (IFG). These are respectively defined as: “fasting plasma glucose 
8 
<7.0 mM (126 mg/dL) or 2 hours plasma glucose between 7.8 mM and 11.1 mM (140 and 
200 mg/dL)” for IGT, and “fasting plasma glucose between 6.1 and 6.9 mM (110 and 125 
mg/dL) or 2 hours plasma glucose <7.8 mM (140 mg/dL)” for IFG [44]. This implies that a 
normal fasting glycaemia (as defined by WHO) will correspond to “fasting plasma glucose of 
<6.1 mM and a 2 hours plasma glucose of <7.8 mM” [29]. IGT and IFG are both considered 
as transition states (i.e., risk factors) leading ultimately to diabetes. An individual 
experiencing several IFG, IGT and diabetic phases will eventually show hyperglycaemic 
symptoms which are defined as: (1) polydipsia (excessive thirst), (2) polyuria (frequent 
urination), (3) blurred vision, and (4) extreme fatigue [49]. These are the acute symptoms of 
diabetes; however, they are insufficient to make a robust diagnosis, especially in the early 
stages of the disease when they may be barely perceptible.  
 
1.2.3.2.3 Recommended blood glucose levels in non-pregnant diabetics, as defined by 
the American Diabetes Association (ADA). 
The ADA recommendation for glycaemic measurements with an HbA1c < 7% are: (1) pre-
prandial (before a meal) capillary plasma glucose between 3.9 and 7.2 mM (70 and 130 
mg/dL), or (2) peak post-prandial (after a meal) capillary plasma glucose < 10 mM (180 
mg/dL). The postprandial attribute is defined as 1 or 2 h after the beginning of the meal. 
These targets have to be moderated according to the following factors [48]: duration of 
diabetes, age, comorbid conditions, cardiovascular and microvascular diseases, 
hypoglycaemia unawareness, and other factors 
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1.2.4 Diabetes management 
Today, HbA1c testing, glucose sensing and urine sensing are used to monitor diabetes 
mellitus. 
 
1.2.4.1 HbA1c testing 
Glycation of haemoglobin occurs during the 120 days lifespan of the red blood cell. HbA1c 
monitoring should therefore be performed on a ≤ 2 monthly regular basis for diabetes 
management. The measurement of HbA1c should be viewed as a complement to daily blood 
glucose monitoring and a long term indicator of the outcome of therapeutic interventions 
[50]. 
 
1.2.4.2 Glucose monitoring technologies: Brief historical background 
The first glucose meter relied on a colorimetric reaction on a strip (“dextrostics”) and on 
reflectance measurements (“Ames Reflectance Meter: ARM; Miles Laboratories, (Elkhart, 
IN, USA)”) [9]. This laboratory or hospital-based instrument weighed around 1.2 kg, was 
priced at nearly $500, required a very complicated sample preparation, and provided 
consistantly overestimated glucose measurements in the low glycaemic range. The first 
electrochemical biosensor for glucose was developed in 1962 [2]. Its principle of operation 
involved reaction of glucose with the enzyme glucose oxidase to generate H2O2 which was 
then oxidized electrochemically on an electrode, generating a measurable current 
proportional to the concentration of glucose present [7]. This led to the development of the 
widely used fingerstick glucose biosensor (Exactech, first developed by Medisense, 
(Cambridge, MA, USA) in 1991 [5]) based on a redox mediator (i.e., ferrocene). This 
development represented a significant improvement in disease management as patients were 
then able to monitor their own blood glucose. The fingerstick blood sensors became a major 
commercial success, comprising up to 85% of the market [51]. The American Diabetes 
Association advised a fingerpricking frequency of 6 to 8 times a day for Type 1 diabetics 






1.2.4.3 Urine glucose sensors, glycosuria monitoring 
Glycosuria is the presence of glucose in urine. Below a blood glucose value known as the 
renal threshold, no glucose is identified in the urine due to renal reabsorption. This threshold 
varies between individuals and also depends on disease state (long-standing diabetics may 
have a higher threshold) or physiological condition (young children and pregnant women 
have reduced thresholds [52]). It is therefore very difficult to correlate blood glucose levels 
with measurements of glycosuria. Other problems of urine glucose sensing include: (1) 
Single point measurements and dependence on the frequency of urination. (2) No information 
about blood glucose levels below the renal threshold. (3) Testing provides an average glucose 
concentration in urine, not a direct measurement of blood glucose. (4) A negative urine 
glucose sensing test does not distinguish between hypoglycaemia, euglycaemia and mild or 
moderate hyperglycaemia. (5) Drugs can affect glycosuria. (6) Fluid intake and urine output 
modify the glycosuria. (7) Most glucose sensing urine tests are either based on glucose 
oxidase: Chemstrip (Roche Diagnostics, USA), Clinistix (Bayer, Leverkusen, Germany), 
Diastix (Bayer, Leverkusen, Germany), and Uristix (Siemens, Munich, Germany)) or copper 
sulphate reduction: Clinitest, (Bayer, Leverkusen, Germany). The latter is not specific to 
glucose, however. (8) Several urine sensors are imprecise at low urinary glucose 
concentrations [52]. Practical issues affecting accuracy have also been identified [53]. 
Overall, glycosuria does not reliably reflect blood glucose levels and is now rarely used as a 
surrogate for blood glucose monitoring. In fact, urine analysis is only employed for limited 
specific cases: (1) Relatively stable type 2 diabetics can gain information from a glycosuria 
test in conjunction with blood glucose measurements [53]. (2) Glycosuria sensing is 
sometimes undertaken to assess glucose control and dietary compliance. (3) It is also used 
with patients for whom blood glucose monitoring is impossible or impractical.  
1.3 Biosensing 
1.3.1 Biosensing general concept, transducer/bioreceptor 
The International Union of Pure and Applied Chemistry (IUPAC) define biosensors (figure 
1.2) as a subset of chemical sensors: “A chemical sensor is a device that transforms chemical 
information, ranging from the concentration of a specific sample component to total 
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composition analysis, into an analytically useful signal. Chemical sensors usually contain two 
basic components connected in series: a chemical (molecular) recognition system (receptor) 
and a physicochemical transducer. Biosensors are chemical sensors in which the recognition 
system utilizes a biochemical mechanism” [54]. A more extended definition has also been 
proposed [55, 56]: “Biosensors are defined as analytical devices incorporating a biological 
material (e.g. tissue, microorganisms, organelles, cell receptors, enzymes, antibodies, nucleic 
acids, natural products etc.), a biologically derived material (e.g. recombinant antibodies, 
engineered proteins, aptamers etc.) or a bio-mimic (e.g. synthetic receptors, biomimetic 
catalysts, combinatorial ligands, imprinted polymers etc.) intimately associated with or 
integrated within a physicochemical transducer or transducing microsystem, which may be 





















 Two structural components are common to all Figure 1.2. Biosensor operation.















































































































1.3.2 Biological entity: Enzymes 
Enzymes are the most common element found in biosensors. Glucose oxidase, for instance, is 
present in almost all glucose biosensors. Enzymes have several advantages for integration 
into sensing devices: (1) they are relatively stable and retain their catalytic activity when 
immobilised on an electrode, (2) both the catalytic and substrate affinities of an enzyme can 
be modified, (3) enzymes are highly substrate specific and follow Michaelis-Menten kinetics 
[57]. 
 
 Glucose oxidase 
Glucose oxidase (GOD) is the most commonly used enzyme in glucose biosensing. This 
enzyme catalyses the oxidation of β-D-glucose to D-glucono-1,5-lactone and then gluconic 
acid in the presence of molecular oxygen producing hydrogen peroxide (H2O2). GOD is 
isolated and produced from many fungal sources (Aspergillus, Penicilium or Saccharomyces) 
among which Aspergillus Niger is the most common. GOD is a dimeric protein composed of 
two identical polypeptide chains that are linked by disulphide bonds (figure 1.3). Each of the 
chains contains a tightly bound but non-covalently attached flavin adenine (FAD) moiety at 
the active site of the enzyme. The catalysis of β-D-glucose involves the reduction of FAD to 
FADH2 and then the re-oxidation to FAD with molecular oxygen. The FAD cofactors sit 








 (reproduced from [58]). A: Figure 1.3. Glucose oxidase crystallographic structure
Overall structure of the GOD with one subunit in grey and the other coloured. B: 
Representation of the GOD active site and the amino acids involved in the reaction; the 





GOD has a molecular weight of around 160 kDa and is specific to the β anomer of D-
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 and halide ions are 
competitive inhibitors towards molecular oxygen [60, 61]. The enzymatic activity is strongly 
dependent upon the ionic state of the active site amino acid residues. The optimal pH range 
for GOD is between 3.5 and 6.5 [62]. However, the enzyme is stable enough at physiological 
pH [63, 64].  
1.3.3 Transducer: Electrochemical detection 
Electrochemical biosensors are very common, the best example of which is the fingerstick 
glucose biosensor. These sensors rely on the transformation of a biochemical signal to an 
electrical signal which is detected at the transducer. Electrochemical biosensors can be 
separated into catalytic biosensors (enzymes, whole cells, etc…) and affinity sensors (DNA, 
antibodies etc…). Detection methods are classified in four categories: 
voltammetry/amperometry, potentiometry, impedance, and conductometry. 
 
1.3.3.1 Voltammetry/amperometry 
In voltammetric or amperometric techniques, a potential is applied to a working electrode; 
WE against a reference electrode; RE (held at a stable potential) and a current is measured 
that is a function of the electrochemical reaction happening at the WE. Amperometric 
biosensors are by far the most commonly found electrochemical devices. In amperometry, the 
potential at the WE is stepped to a constant value with respect to the RE and the change of 
current (induced by redox reactions at the working electrode) is measured over time (between 
the WE and a third counter electrode; CE) [65]. 
 
1.3.3.2 Potentiometry 
A potentiometric sensor is a device that relies on the measurement of the potential of an 
electrochemical cell while a negligible current is being drawn. Common potentiometric 
sensors are pH sensors involving the use of two reference electrodes separated by a 
membrane sensitive to protons or ions in solution. [65]. A specific type of potentiometric 
devices are field effect transistors (FET), and more precisely ion sensitive field effect 
transistors (ISFET) and biological field effect transistors (BioFET). These are three electrode 
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systems comprising a source, a drain and a gate. The source and drain are separated by a 
semiconductor and the potential applied at the gate will create an electric field that will 
influence the current flow from source to the drain. Again, any induction of charge at the 
semiconductor interface will change the potential and generate a signal proportional to the 
concentration of the analyte of interest (e.g., protons produced during an enzymatic reaction).  
 
1.3.3.3 Impedance 
Electrochemical impedance spectroscopy (EIS) is a technique that measures the resistive and 
capacitive properties of a material when subject to small amplitude sinusoidal Alternating 
Current. The resistance and capacitance are then obtained [65]. EIS is typically used for 
affinity biosensors where any binding (DNA, antibody…) will induce a change of impedance 
on the electrode material. EIS has received much attention from the scientific community in 
the past few years because it does not require any mediator (as opposed to certain 
voltammetric/amperometric analysis) and is very sensitive to any biological attachment [66]. 
The downside of the technique however, is non-specific binding. 
 
1.3.3.4 Conductimetry 
Conductimetric experiments measure the change of conductance in solution, due to the 
migration of ions. While these are among the less described biosensors, they have several 
advantages including: no requirement for a reference electrode, insensitivity to light, and 
cheap integration and miniaturization. However, an important drawback is the necessity for 
the produced ion to induce a conductance change that will be detectable [67]. The most 
described conductometric biosensors relate to urea detection [68], but some others have been 
developed to detect bacteria (Mycobacterium avium) [69] or heavy metal ions [70].  
1.3.4 Reference technique: fingerstick glucose biosensor 
The reference technology and the more successful commercially available biosensor is the 
fingerstick glucose biosensor. As already introduced in section 1.3.2, the device work on the 
detection of glucose via enzymes such as glucose oxidase; GOD or glucose dehydrogenase; 
GDH integrated with redox mediators in so called second generation sensors. The first 
fingerstick device: Exactech developed by Medisense (Cambridge, MA, USA) in 1991 was 
based on a GDH/ pyrrole-quinolinequinone (PQQ) enzymatic reaction associated to ferrocene 
as a redox mediator. PQQ is a cofactor in the enzymatic reaction with glucose and GDH [7]. 
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The transducer was a screen printed carbon electrode [71]. Most of the commercial 
fingerstick biosensor still work on the same combination of enzyme and redox mediator and 
are produced via the screen printing process. Table 1.1 is a list of some of the fingerstick 
devices available commercially along with some of their characteristics such as the sample 
volumes, the duration of the tests and the assay glucose concentration range [7].  
For low blood glucose measurement the reference accepted method would still be the same 
enzymatic one (i.e. fingerstick biosensor). Of course there are ways to quantify low blood 
glucose (chromatography, HPLC, qNMR, etc.), see chapter 5 section 5.1.2.2, but these 
methods are only used punctually and in no way qualified as reference techniques, adapted to 
patient studies. 














Care, Alameda, CA, 
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GDH/PQQ 0.6 5 0.6 to 33.3 
OneTouch 
UltraLink 
(LifeScan part of 
Johnson & Johnson 
medical, Livingston, 
UK) 
GOD 1 5 1.1 to 33.3 
 
The technology became the “star” and the major technique for glucose monitoring in only 24 
years. Noticeably it is used as a reference for comparison with newly developed techniques 
such as the transdermal monitoring devices described in the next section [19]. It is also a 
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fundamental element of diabetes care for many patients around the world. However, this table 
also brings to light the fundamental problem of each of these devices: the need for a blood 
sample (the fingerpricking) which is the cause of much stress, discomfort and bad glycaemic 
control for the majority of patients. The research was therefore oriented towards “next 
generation devices” separated in two major classes: implanted and non-invasive technologies. 
1.3.5  Alternative glucose sensing to the fingerstick meters: 
implanted and non-invasive technologies 
1.3.5.1 Implanted, continuous glucose monitoring system (CGMS) 
The following section will give a description of implanted technologies in next generation 
glucose sensing. 
 
1.3.5.1.1 Intravenously implanted sensors 
Intravenously implanted glucose monitoring sensors are for patients who are critically ill and 
in need of intensive insulin therapy or are in intensive care. The latter experience rapid 
fluctuations in blood glucose levels, blood flow distribution and temperature. In such 
situations, traditional fingerstick glucose sensors are insufficient to ensure efficient constant 
glucose monitoring. The direct intravenous technologies developed include: (1) The 
Via
®
Blood (Via Medical Corporation, Austin, TX, USA) [72], OPTImus (IntelliDx 
Corporation, Santa Clara, CA, USA) [73], and the STG-22
TM
 (Nikkiso, Tokyo, Japan) [74] 
systems which draw small samples of blood (2 mL per hour) via a catheter [74] that are 
subsequently analysed with a glucose sensor. [73]. And (2), glucose monitoring devices 
coupled to central catheters: The GlucoClear™ (Edwards Lifesciences, Irvine, CA, USA) 
[75], which uses enzymatic (glucose oxidase) amperometric detection, and the GluCath
®
 
Intravascular CGM System (GluMetrics Inc., Irvine, CA, USA) [76] which relies on a 
fluorescent sensor, were developed for continuous intravenous measurements [77]. 
 
1.3.5.1.2 Subcutaneous sensors 
The other widely developed implanted CGMS are subcutaneous sensors. These are available 
to a broader patient audience, subcutaneous tissues being more accessible and the 
implantation of the sensor less prone to complications than the intravascular technologies. 




MiniMed Inc., Northridge, CA, USA) [78, 79]. The sensor device is positioned on a needle, 
inserted subcutaneously [80] to electrochemically detect (via glucose oxidase) subdermal 
interstitial fluid glucose. Several devices were then commercialized based on the 
subcutaneous insertion of a needle sensor: (1) The Guardian
®
 Real-Time also developed by 
Medtronic, MiniMed Inc., Northridge, CA, USA is a real time glycemic monitor unlike its’ 
Minimed
®
 predecessor. It is formed of a platinum electrode/ polyurethane poly urea polymer 
and also measures glucose amperometrically via GOD (First generation: detection of H2O2). 
It received FDA approval in 2006 [81]. (2) DexCom Inc. (San Diego, CA, USA) also 
received FDA approval the same year for their device: the DexCom STS
TM
-7. The 
technology consists of a platinum electrode coupled with a hydrophobic polyurethane and a 
hydrophilic polyurethane mixture on a 26 gauge insertion needle. The sensor is similarly to 
the Medtronic devices a GOD/ amperometric device [81]. (3) Finally, the FreeStyle 
Navigator (Abbott Diabetes Care, Alameda, CA, USA) uses Carbon/ osmium wired electrode 
to provide a real time monitoring of the glycemia. The needle sensor is an amperometric 
second generation sensor based on a combination of GOD and an osmium mediator (Os
2+/3
). 
It received FDA approval in 2008 [81]. The principal limitation to the use of subcutaneous 
sensors have been identified as: (1) Biocompatibility, which is often a major problem, since 
any local inflammatory response not only influences the plasma/interstitial glucose 
concentration ratio but is also deleterious to the patient. (2) Biofouling (disruption of the 
sensing platform) which is detrimental to the sensing itself and approaches to address this 
problem are being examined [82]. (3) And the lack of compliance from the patients: the 
methods involving the placement of a needle underneath the skin [83].  
 
Nevertheless, subcutaneous technologies are the only alternative and approved glucose 
monitoring approach to the fingerstick method for home use [26]. Advantages and 
disadvantages of each of the technologies cited are listed in table 1.3 and their performance 
compared to the developed device in chapter 4, table 4.4. 
 
1.3.5.1.3 Interstitial fluid glucose concentrations/ blood glucose concentration 
relationship 
The subcutaneous technologies presented so far measure interstitial fluid glucose 
concentrations, not those in the plasma. These two reservoirs can be considered as separated 
compartments that interact dynamically with each other, see figure 1.4. In the skin, glucose 
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passes from the capillary endothelium to the interstitial fluid by simple diffusion across a 










Figure 1.4. Glucose distribution between “plasma glucose” and “interstitial glucose”  
 
The glucose concentration in the interstitial compartment has a proportional relationship with 
the plasma glucose level [85], the ratio depends on several factors, such as insulin production, 
blood flow, capillary permeability, etc. There is therefore a lag time (the time required for 
glucose to diffuse from the capillary to the tissue) [26] before the plasma and interstitial 
glucose concentrations come into dynamic equilibrium [85]. The lag time varies as a function 
of glucose concentration, metabolic rate, and glucose uptake. To relate interstitial blood 
glucose concentration to that in the blood would require a complex algorithm, that may be 
very patient and situation specific. The question, however, as to whether this conversion is 
necessary or, indeed, whether the interstitial level is not, in fact, the most relevant clinically 
for a diabetic, remain open and is the subject of much debate since “there are relatively 
limited data on dermal interstitial fluid glucose levels” [84]: A study performed on type 1 
diabetics on the plasma and interstitial fluid glucose concentrations in pre- and postprandial 
situations showed that dermal interstitial fluid glucose was highly correlated with plasma 
glucose [86]. The lag time between the two compartments however varies from study to 
study depending on the technique used to measure the glucose, the different tested conditions 
and the model studied (animal or human, diabetic or not) [84]. It has also been suggested that 
interstitial fluid glucose may decrease before plasma glucose due to a phenomenon called the 
“push-pull” during which the glucose is pushed from the blood to the interstitial fluid at times 
of increased blood glucose, and later on glucose is pulled from the interstitial fluid to the 
surrounding cells during decreasing blood glucose levels. However, this phenomenon is also 
the matter of debate at the moment with other studies demonstrating a compensation of the 
Insulin-independent 













glucose uptake  
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increased passage of glucose in the interstitial fluid by increased delivery of glucose to the 
plasma as well as a decrease of the effect of glucose removal from the interstitial fluid [84, 
87]. 
 
1.3.5.2 Other invasive technologies 
 
1.3.5.2.1 Microdialysis  
The GlucoDay
®
 (A. Menarini Diagnostics, Florence, Italy), and its later version, the 
GlucoMenDay
®
 [88], are alternatives for continuous subcutaneous glucose monitoring that 
use a microdialysis setup. The devices have been commercialised in Europe but have not 
received FDA approval [89]. The technique requires implantation of a microdialysis probe in 
the periumbilical region, via which interstitial fluid is collected with a perfusion solution. The 
latter then passes into a biosensor cell on the abdomen of the patient, where a GOD 
amperometric biosensor measures the glucose.  
 
1.3.5.2.2 The “artificial pancreas” 
The main function of the pancreas is to control glycaemia through the release of insulin and 
the production of the glucagon. Both glucose biosensing and insulin delivery technologies 
exist. The design of an “artificial pancreas” is therefore (at least in theory) possible. The holy 
grail, of course, is “closing the loop” with sensing and delivery operated automatically via an 
algorithmic feedback system. Nowadays, implantable CGMS [90], and insulin pumps [91], 
together with closed looped algorithms [92] are available but the ultimate prize is yet to be 
achieved. The closest approach to date is the Medtronic 530G with Enlite technology system 
(Medtronic, Northridge, CA, USA) which received FDA approval in 2013 [93]. This system 
provides “a threshold suspend feature that automatically stops insulin delivery when a pre-set 
low blood glucose value is detected by the continuous glucose monitor” [94]. It is not 
however an artificial pancreas as presented in table 1.2, along with the issues that would be 
associated with the design of such an artificial pancreas. 
 
1.3.5.3 Advantages and disadvantages of implanted glucose sensor 
Table 1.2 describes the advantages and disadvantages of several implanted sensor and 
technologies. It is split into three categories: (1) intraveneously implanted devices, (2) 
subcutaneous devices and (3) other invasive technologies. 
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Table 1.2. Advantages and disadvantages of implanted glucose sensing devices 
Techniques Advantages Disadvantages References 
Intravenously implanted devices 
Via®Blood 
 (Via Medical Corporation, Austin, TX, 
USA) 
 Use in intensive care units (ICU) 
 Reduced workload for ICU staff 
 STG-22TM:  
 Minimal patient glucose 
variability: standard deviation of 
19.9 ± 10.9 mg/dl 
 Good detection and prevention of 
hypoglycaemia when integrated 
with an insulin/glucose delivery 
system 
 Blood sampling 
 Small negative pressure necessary to avoid 
blood vessels to collapse 
 Requirement to stop other intravenous 
infusions to be stopped periodically 
 Interruption of glycaemic control due to 
poor blood removal 
 Problems of cost and device preparation 
[73, 74] 
OPTImus  





 (Nikkiso, Tokyo, Japan) 
GlucoClear™  
(Edwards Lifesciences, Irvine, CA, USA) 
 Blood automatically drawn every five 
minutes and then returned to the patient  
 Real time graphical display 
 System self-calibration 
 Biofouling of the sensor surfaces, i.e., the 
formation and accumulation of proteins and 
biological elements on the sensor creating a 
“barrier” that impairs performance 
 Invasive, surgical monitoring only 
applicable to ICU 
[77, 95] 
GluCath® Intravascular CGM System 
(GluMetrics Inc., Irvine, CA, USA) 
 Optical measurements made every 10 
seconds 
 Use in post-cardiothoracic surgery patients 
in whom glycaemic control is indicated 
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(Medtronic, MiniMed Inc., Northridge, CA, 
USA) 
Specific  General Specific General 
[81, 96-99] 
 “Primitive 
device and gold 




 Fewer finger 
pricking sensing 
 Safe and easy to 
use system 
 Real time 
sensing coupled 
with an alarm to 
warn of out of 
range sensing 
















 Increased patient 
motivation 
 No real time 
glucose 
monitoring  
 Requires to 
download datas 
on a computer 
every 72 hours 










 Calibration: the 
systems are not 
yet accurate 
enough to replace 
finger-pricking, 
hence necessity 
to draw blood 
samples one to 




High false alarm 
rate 










(Medtronic, MiniMed Inc., Northridge, CA, 
USA) 
 Real time 
glucose monitor 
 Numerical and 
graphic 
depictions 
 Wireless: 6 feet 
















 7 days sensor 
 1 invasive 
calibration after 2 
hours of the 
sensor insertion 





(Abbott Diabetes Care 
Alameda, CA, USA) 
 The addition of 
the TRUstart 
algorithm 







from 60-300 to 
60-400 mg/dL 
 First generation 










device: 1 hour 
warm up period 
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 (A. Menarini Diagnostics, 
Florence, Italy) 
 Linear response up to 30 mM glucose 
 Continuous monitoring for up to 48 hours 
 Invasive technique: reduced patient 
compliance 
 Daily fingerprick blood glucose calibration 
 Significant inter-individual variability 
 Lag time of 10 to 12 minutes  
 Sensor prone to interference and biofouling 
 Expensive system 
 Not commercially available 
[88, 100, 101] 
“Artificial pancreas” 
 “Holy grail”: “closing the loop” with 
sensing and delivery operated 
automatically via an algorithmic feedback 
system. 
 Technologies available to achieve such a 
goal 
 The closest approach to date is the 
Medtronic 530G with Enlite technology 
system (Medtronic, Northridge, CA, USA) 
 The Medtronic 530G with Enlite technology 
system (Medtronic, Northridge, CA, USA) 
is not an artificial pancreas: it is not coupled 
with an automatic insulin delivery, and 
fingerstick testing and glucose self-
management are still required. 
 Type 2 diabetes isn’t treated via insulin 
treatment (except at a late stage of the 
disease) 
 Algorithm don’t take into account punctual 
events influencing the glycaemia such as 
(i.e., stress, physical activity, meals, 
intercurrent illness, etc.) and the lag time for 
the plasma and interstitial glucose 
concentrations to come into dynamic 
equilibrium. 
 Glucose biosensing devices still suffer from 
sensitivity problems or reproducibility 
issues 
 The cost and accessibility of the 





Following the observations listed in table 1.2, it appears that implanted technologies are 
favourable to provide a real time monitoring of the glycemia, with alerts systems in place 
when the levels of blood glucose fall out of the normal range. Most of the devices are 
relatively safe and easy to use. Moreover, the subcutaneous and intraveneous sensors are the 
only alternative technologies to the finger pricking meters that are commercially available 
[106]. However, they also involve invasive insertion of the sensor and hence poor patient 
compliance, multiple fingerstick calibration per day, overestimation of hypoglycaemia, false 
alerts, etc. Research has therefore focused in recent years on the development of a non-
invasive technology that will tackle some of the cited issues.  
 
1.3.5.4 Non-invasive glucose sensing: Transdermal technologies 
 
1.3.5.4.1 Minimally and non-invasive sensing 
With respect to transdermal glucose monitoring, two approaches have been taken:  
(1) First the “minimally invasive” extraction of interstitial fluid by reversibly compromising 
the integrity of the stratum corneum (the outmost skin layer) through the application of 
physical energy or mechanical force (e.g., sonophoresis, microporation) [107].  
(2) Second, “non-invasive” optical techniques (Raman spectroscopy, polarimetry, photo 
acoustic spectroscopy, and spatially-resolved diffuse reflectance and NIR spectroscopy) that 
do not involve physical perturbation of the skin or withdrawal of interstitial fluids.  
Reverse iontophoresis has been described by some as “minimally invasive” and other “non-
invasive” and there is much debate around the terminology [107].  
 
1.3.5.4.2 Reverse iontophoresis (RI) 
Iontophoresis imposes a small intensity current between two electrodes placed on the top of 
the skin surface leading to the delivery of charged and uncharged therapeutic molecules for 
example. The phenomenon has been developed and used for many years. Indeed, the notion 
of iontophoresis emerged in the 18
th
 century with the study of Galvani and Volta on electrical 
motion of metallic ions [108], and was applied to skin delivery of therapeutics through the 
work of Leduc who proposed a theory for the process in 1900 [109]. Iontophoresis is a 
symmetrical process which creates flux of ions inside and out the skin. There is potential 
therefore to extract charged and uncharged molecules in the so called reverse iontophoresis 
process. This would be a great diagnostic tool since “information” (such as glucose) could be 
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extracted from the skin without the need for a blood sample [110]. Any iontophoretic 
transdermal process includes three fundamental phenomena: electromigration, electroosmosis 
and passive diffusion.  
 
1.3.5.4.2.1 Electromigration (EM) 
Electromigration describes the direct effect of the applied electric field inducing the 
movement of ions through the skin. This induced flux will carry the imposed current while 
the electro-neutrality of the system is maintained. The electromigration process can be 




Where JEM is the electromigration flux expressed in mol/sec, F is the Faraday constant equal 
to 9.64 × 10
4
 C/mol, I is the iontophoretic current expressed in Amperes, while ti and zi are 
the transport numbers (fraction of the total current carried by a defined ion and charges of the 
ions involved in the process, respectively). The electromigration flux is highly dependent on 
the capacity of the ion of interest to carry the current [111].  
 
1.3.5.4.2.2 Electroosmosis (EO) 
At physiological pH the skin presents a net negative charge (isoelectric point ranging from 
3.5 to 4.8) and it therefore acts as a cation permselective membrane. The iontophoretic 
current hence induces a net convective solvent flow (H2O in majority) from anode to cathode 
which carries the uncharged and high molecular weight molecules with it [112]. Cations flow 
towards the cathode under the combined influence of electromigrations and electroosmosis. 
However, although electromigration dominates for low molecular weight cations [113], 
electroosmosis is the dominant phenomenon for the extraction of the uncharged molecules 









 and ca the concentration of a 
molecule “a” expressed in mol, to be extracted. The volume flow component Jv is function of 
the characteristics of the permselective membranes , such as pH, NaCl concentration [115].  
𝐽𝐸𝑂 =  𝐽𝑉  𝑐𝑎 
 
 







1.3.5.4.2.3 Passive diffusion 
The last notion to be introduced is the passive diffusion of analytes through the skin. Passive 
diffusion refers to the transport of molecules through the skin membrane without any external 
actions. It is described by equation 1.3 and is dependent on the diffusivity, Dj, and the 
gradient of concentration, ∆Cj, through the skin of thickness, h [116]: 
 
 
1.3.5.4.2.4 Total iontophoretic flux 
The total flux of any iontophoretic operation will thereafter be defined as the sum of the 
electromigration flux, JEM, the electroosmosis flux, JEO, and the passive diffusion, Jp. 
However, the electromigration can be ruled out in the case of glucose, the interest being 
focused on the extraction of an uncharged molecule at the cathode. Moreover, the extraction 
of glucose is much faster by electroosmosis than by passive diffusion [117]. Passive diffusion 
is therefore considered as negligible compared to electroosmosis during RI of glucose [118]. 
The RI flux is therefore approximated as JEO. A typical reverse iontophoretic schematic is 















. A current I is created between two Figure 1.5. Reverse iontophoresis schematics
electrodes placed on top of two hydrogel reservoirs inducing a stream of ions through 







































1.3.5.4.3 The GlucoWatch ® Biographer 
Reverse iontophoresis is the principle behind the only non-invasive glucose extraction 
technology to have received FDA approval: the GlucoWatch 
®
 Biographer (Cygnus, CA, 
USA). It combined the reverse iontophoresis extraction principle with electrochemical 
glucose detection. The device received FDA approval in 1999 and was briefly 
commercialised before becoming unavailable in the early 2000s [28, 119]. The advantages of 
the GlucoWatch were in principle multiple: better patient compliance, fewer finger pricks, 
continuous monitoring and hence better diabetes management, better control of 
hypoglycaemia [120], practicality of a wrist worn device, cost effective technology [121]. 
The device also had additional advantages with respect to the glucose biosensing: high 
molecular weight molecules responsible for electrode fouling were filtered by the skin, 
molecular oxygen was not a detection limitation factor, and common glucose sensor 
interferents were extracted towards the other, nonsensing electrode (anode) [107]. 
Unfortunately, the device was not commercially successful because of several limitations 
already listed in section 1.1 [121-123]. The technology developed in this thesis aims to tackle 
some of these limitations to achieve improved transdermal glucose monitoring. This will be 
achieved by designing an improved and miniaturized biosensing platform as well as targeting 
hair follicle glucose extraction pathways. 
 
1.3.5.4.4 Reverse iontophoresis and privileged extraction through hair follicles 
 
1.3.5.4.4.1 Skin structure 
The human skin is formed by a succession of layers ensuring its fundamental role as a barrier, 
namely the hypodermis, dermis and epidermis. Their typical thicknesses are respectively 1 
mm to 5cm, 1 mm [124] and 100 µm [125]. The hypodermis comprises primarily adipocytes 
and reticulated blood vessels and serves a fundamental structural function. It is easily 
distinguished from the fibrous connective tissues of the dermis, which confer the skin’s 
elastic tensile strength and pliability properties. Cell density in the dermis is less than that in 
the epidermis and the extracellular space is therefore larger. The dermal layer shows good 
integration with the skin appendages and supports the vascular and sensory networks. The 
epidermis is the external part of the skin and is mostly composed of keratinocytes. It is 
structured in layers: (1) the stratum basale, (2) the stratum spinousum, (3) the stratum 
granulosum and (4) the stratum corneum.  
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(1) The stratum basale is the deepest and is formed of mitotic and migrant cells. 10% of the 
cells found in the stratum basale are stem cells that have the potential to differentiate, 
multiply and regenerate the epidermal cell content. It has been estimated that it takes a 
keratinocyte 14 days to travel from the stratum basale to the stratum corneum and another 14 
days until desquamation [126].  
(2) Next, the stratum spinousum is named after the polyhedral histological appearance of the 
cells.  
(3) The stratum granulosum is formed of larger and flatter keratinocytes with kerotohyalin 
granules and a high density of desmosomes. Lamellar bodies are also present that release 
lipids into the extracellular space at the base of the outmost epidermal layer, the stratum 
corneum (SC).  
(4) The SC is composed of “dead” terminally differentiated keratinocytes named corneocytes. 
These cells are surrounded by extracellular lipids in a “bricks and mortar” configuration and 
performs a fundamental barrier role (water loss prevention, selective absorption of molecules, 
etc.). Homeostasis of the SC is maintained by desquamation of approximately one layer of 
cells per day [127].  
 
Skin appendages include sweat glands (eccrine and apocrine), sebaceous glands, hair follicles 
and nails. Hair follicles are present all over the body with the exception of the lips, palms and 
soles. They originate in the deep layer of the reticular dermis, and are associated with 
sebaceous glands that secrete sebum (wax esters, squalene, triglycerides, cholesterol and free 
fatty acids).  
Eccrine glands are responsible for sweat production and therefore play a role in 
thermoregulation. Apocrine glands are specialised sweat glands found in specific body sites 
(axillae, groin, etc.) and develop in association with hair follicles, and open into them. Nails 




 (Reproduced from [129]) Figure 1.6: Skin structure
 
1.3.5.4.4.2 Preferential reverse iontophoresis pathway through hair follicles 
During iontophoresis, 3 pathways across the skin may be identified: intercellular (between 
the corneocytes in the epidermis), transcellular (through the cells) and appendageal [130], 










 The principal Figure 1.7. Extraction pathways through the skin during RI.
anticipated pathway for glucose and large ions during reverse iontophoresis is 
appendageal because of its low electrical resistance [131]. 
 
 
Appendageal Transcellular Intercellular 
Corneocytes 
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The dominant role of the appendageal (follicles, sweat glands) iontophoretic route, has been 
demonstrated in a number of studies [132-135] and it is likely that electroosmotic flow will 
also take place via this low resistance pathway: One study introduced for example the 
preferential iontophoretic delivery of calcein (a negatively charged fluorescent compound) 
through hair follicles [136]. In another study the preferential extraction of a neutral molecule, 
hydroquinone, through hair follicles via RI was also successfully confirmed [134]. Hence, it 
would appear reasonable to assume that the uncharged glucose molecules will follow the 
same extraction pathway in majority.  
 
1.3.5.5 Non-invasive glucose sensing: ocular detection  
Although some research is ongoing in ocular glucose sensing, no device have so far been 
commercialized or received accreditation. Google, very recently (July 2014), filed a patent in 
collaboration with Novartis on the development of a smart glucose sensing contact lens [137]. 
This general announcement does not appear to be a real technological or a scientific 
achievement: the technology is described as a contact lens that will collect tear fluid and 
analyse it through biosensing, electrochemical, amperometric or pressure sensor detections 
without distinctions. Furthermore, no clear proportionality has been demonstrated between 
tear and blood good glucose [138, 139]. Research in ocular glucose sensing is ongoing as 
presented in figure 1.8, but just like the transdermal one, no commercial device as yet 
successfully emerged in the market. 
 
1.3.5.6 Summary 
Figure 1.8 attempts to summarise the state of the “new” glucose monitoring art at the present 
time. While continuous monitoring has been proven possible, current use of the available 
technology is limited by its invasive nature. Less invasive approaches have been developed 
but, for one reason or another, have not been able to make any significant impact in terms of 
sustained, practical use. There remains a real opportunity, therefore, for a non-invasive 























Figure 1.8. Alternative glucose sensing technologies to the fingerstick glucose reference sensor 
 











































































































































































































































































1.4.1 Graphene as a nanomaterial of interest for integration in a 
glucose biosensor 
Graphene has recently been isolated in a free standing form by Geim and Novoselov [140] 
and this led to an exponential growth in research and applications. The authors (who received 
the nobel prize of physics in 2010, for “groundbreaking experiments regarding the two-
dimensional material graphene” [141]) characterized the nanomaterial as: “A flat monolayer 
of carbon atoms tightly packed into a two-dimensional (2D) honeycomb lattice and a basic 
building block for graphitic materials of all other dimensionalities [140]”. The authors did not 
discover the nanomaterial per se, graphene having been studied and characterised 
theoretically as early as 67 years ago [142]. But, for many years graphene was described as 
an academic material since scientists did not believe that such a material could exist in the 
free state (being considered as thermodynamically unstable [140]). Atomic monolayers (part 
of a 3D lattice) were deemed impossible to isolate until 2004 when Geim and Novoselov 
characterised free standing graphene (defined as a 2D atomic crystal) that could be obtained 
on top of non-crystalline substrates, in liquid suspension and as suspended membrane [140]. 
Graphene is defined as a 2 dimensional nanomaterial and will approach the 3 dimensional 
aspect past 10 stacking graphene layers. The graphene carbons are arranged in hexagonal 
configurations and are linked with together with sp
2
 bonding (orbital hybridisation) forming 
the typical 2D honeycombe nanomaterial structure (figure 1.9). Other carbon nanomaterial 
have also been studied in the literature (single wall carbon nanotubes, fullerenes) that are 
“folded” sheets of graphene, and have remarkably been introduced into biosensing devices 




Figure 1.9. Schematic depictions of graphene fullerene, and single wall carbon 
. nanotubes
 
These carbon nanomaterials but also other structures such as graphite or glassy carbon 
electrodes (GCE) are commonly used in biosensing. Following is a table comparing some of 
these materials properties to the graphene ones. 
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 Highly flexible: 
“zero bending” 
stiffness 
 “zero gap” 
semiconductor 











(See chapter 2 for 
a more extensive 


















involving the use of 
gas and controlled 
temperature/pressure 
but easy transfer 






 Graphene is 
being studied 
as the “star” 
novel 
nanomaterial  
in other areas 
that could be 
coupled with 
biosensing 












Conductivity Other physical properties Integration in biosensing 
Large scale 
production 



















 Strong material: 
tensile strength up to 
63 GPa 
 Transparent and 
flexible properties like 
graphene 
 Electrochemical, 
optical and electric 
properties function of 
the heterogeneity in 
length, diameters, 
chiralities 
 Extensive literature on 
carbon nanotubes bio-
integration.  
 Large functionalizable area  
Large scale production 
of SWCN is possible 
but it is still 
challenging to obtain 







are available for 
production of carbon 
nanotubes (arc 
discharge, CVD, 
etc.) that present 
more or less 
complexity but 
won’t be developed 
here 
Nanomaterial studied 
for many years in a 

















 Lower tensile strength 
than the previous 
nanomaterials: ~ 10 
MPa 
 Non-toxic and soluble 
in several organic 
solvents 
 Integration on 
transparent electrodes 
 Spherical structure that act 
as carriers for genes and 
drugs for instance 
 Good electronic mediator 
 Functionalization dependent 
mostly on addition of 
functional chemical groups 
The main issue with 
fullerenes production 
is the poor production 
yield obtained: ~ 8-
15% in most 
production facilities 
Similarly to carbon 
nanotubes and 
graphene several 





induced hot carbon 
plasma 
The spherical carbon 
structures can be used 
in other applications 
than biosensing: drug 
carriers, solar cells, 
etc. 
[162-168] 
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Large scale 
production 
















 Low tensile strength: ~ 
11 MPa 
 Very opaque and rigid 
material 
 Extensive literature on 
graphite bio-integration 
 Wide range of 
functionalization 
techniques  
 Considered as an 
interesting an element for 
bio-amperometric 
applications but the 
question remains 
debatable  
(See section 1.4.4) 
Easy to produce in 
large scale 
Graphite can either 
be extracted or 
articficially 
produced. Its’ 








 Tensil strength of 870 
MPa demonstrated 
with thin films glassy 
carbon electrodes, but 
the strength seems to 
be highly dependent 
on the size of the 
electrode 
 Very opaque and rigid 
material 
 Usually used as an 
adjunct to some of the 
carbon nanomaterial 
cited above for 
biosensing 
 Very few interest and 
less biocatalytic activity 
when used on its’ own 
Easy to produce in 
large scale 
Glassy carbon 
electrode have been 
available 
commercially for a 
long time at a cheap 
price and their 




From table 1.3 two conclusions can be drawn. (1) Firstly, on the comparison of graphene with 
other carbon nanomaterials (SWCN, fullerenes) and commonly used electrochemical 
electrodes (GCE, graphite). Each of the materials presents specific interesting qualities: the 
carbon nanomaterial have good bio functionalization and physical properties. GCE and 
graphite have extensively been studied and are easy to produce. However, they also present 
major drawbacks such as uneven and difficult production methods (SWCN and fullerenes) or 
rigidity and opacity (GCE and graphite electrodes). (2) Secondly, graphene as described in 
section 1.4.3, can be produced via different methodologies that give slightly different 
qualities to the nanomaterial. The type of graphene used here is CVD graphene. It is of 
particular interest when compared to other types of graphene because it can be produced in 
big quantities, it is quite cheap and easily transferrable to many substrates (flexible ones for 
instance). It is also one of the purest (less defects or impurity) form of graphene produced 
which means that it will display exquisite conductivity that will be of great interest in 
potentiometric sensors such as field effect transistors (FET) [176] (see chapter 3).  
 
1.4.2 Characterisation and structure 
Graphene has unique mechanical, optical, electrical/conductive and functionalization 
properties.  
 
1.4.2.1 Mechanical properties 
The measured experimental breaking strength of 42 N/m for a single graphene sheet [177] 
corresponds to the theoretical intrinsic strength of a defect free nanomaterial making 
graphene the strongest material ever measured. A 2D graphene membrane has a “zero 
bending” stiffness [177], and demonstrates stable conductive properties at 11% stretching. It 
follows that graphene may be transferred on flexible substrates thereby offering a wide range 
of potential applications (e.g. flexible solar cells [178], flexible biosensors [145] or flexible 
touchscreens [179]). This high flexibility will be of major interest in the developed 
technology, the ultimate aim being the integration on the skin (a highly flexible membrane). 
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1.4.2.2 Optical properties 
Graphene is optically invisible on most wafers [140], however the nanomaterial becomes 
visible when deposited on silicon dioxide (SiO2) with an oxide layer of 300 nm (i.e. substrate 
used in the design of the presented sensor). The visualisation is possible due to the feeble 
interference contrast with light on an empty wafer and is highly dependent on the thickness of 
the oxide. The transparent properties of graphene could be exploited for future development 
of the introduced technology, (i.e. integration on a transparent substrate). 
 
1.4.2.3 Electrical/conductive properties 
Charge carriers (holes and electrons) have an extremely high mobility in a graphene structure 






 [140]. Graphene is described as a zero-gap semiconductor. 
In graphene, the energy bands (conduction and valence bands) are conical and connects at the 
Dirac point (see figure 1.14). As a result, no threshold energy is necessary to move charge 
carriers from the valence band to the conduction band [147].  
 
1.4.2.4 Functionalization properties 
The “high surface to volume” of the nanomaterial provides a very large area for 
biofunctionalization (e.g. with a protein or enzyme) [149]. Across the broad area of graphene 
biosensing research, the following examples can be identified: DNA [150], bacteria/cells 
[151], protein/antibody [180], enzymatic biosensors [181], etc., using amperometric [182], 
potentiometric (FET) [180], and impedance [183] detection.  
1.4.3 Graphene production  
Two graphene production techniques may be differentiated. The first is a “top down” 
approach and includes mechanical exfoliation, solution based exfoliation, chemical oxidation 
(production of graphene oxide), electrochemical exfoliation of graphite, and 
opening/unzipping carbon nanotubes. The second “bottom up” approach involves building up 
graphene from smaller organic entities [184] and includes: chemical synthesis, epitaxial 





Figure 1.10. Graphene production techniques (reproduced from [184  ])
 
1.4.3.1 Top down techniques 
 
1.4.3.1.1 Mechanical exfoliation 
Micro-mechanical cleavage of highly oriented pyrolytic graphite (HOPG) was the first 
technique to be introduced by Geim and novoselov in 2004 [185]. The technique was 
relatively straight forwards since it involved the pealing down of graphite until obtaining 
few-layers or monolayer graphene (the technique is also commonly referred to as the “scotch 
tape technique”). This technique enables to obtain the highest graphene quality of all existing 
techniques and is at the basis of most of the research on the fundamental physical properties 
of the nanomaterial. But the procedure is limited in applications and scaling up: it has low 
reproducibility and it is impossible to implement in a large scale production process [184]. 
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1.4.3.1.2 Solution based exfoliation 
Considering that exfoliated graphene is of high quality and therefore high interest, scientists 
have tried to exfoliate HOPG in solution. Most of the attempts involved the combination of 
organic solvents and ultrasonication. Examples of solvent based exfoliated graphene include: 
ultrasonication of graphite in N,N dimethylformamide [186] or the use of N-
methylpyrrolidone and the same ultrasonicating process [187]. Other solution based 
exfoliation involved the use of surfactants in aqueous solution in combination with 
ultrasonication [188]. The techniques however suffer significant drawbacks: (1) the 
production yield is fairly low, (2) the majority of the produced flakes are multi-layered, (3) 
the ultrasounds have the adverse effect of breaking the graphene sheets in small flakes and 
graphitic impurities, and finally (4) exfoliating agents can intercalate in the produced 
nanomaterial impairing therefore its’ purity and properties [184]. 
 
1.4.3.1.3 Chemical oxidation: production of graphene oxide 
Chemical oxidation of graphite has also been described to produce the well documented 
graphene oxide. Graphene oxide is a graphene like structure onto which oxygen groups have 
been intercalated (see figure 1.11). 
 
 
 The oxygen groups intercalated inside the Figure 1.11 Graphene oxide structure.
graphene structure are represented in blue. 
 
Graphene oxide is produced by using strong oxidising agents in the presence of strong acids 
such as concentrated sulphuric or nitric acids. Several techniques have been developed based 
on the use of potassium chlorate as described by Brodie in 1859 [189] and further improved 
by Staudenmayer in 1898 [190, 191] or the less dangerous (since it doesn’t involve the 
production of ClO2 gas) use of potassium permanganate developed by Hummers and 
Offeman in 1958 [192]. However advantageous the intercalation of oxygen species might be 
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(for biofonctionalisation for example [193]), it also reduces considerably the graphene 
conductive and electronic properties (as well as modifying the optical characteristics [184]). 
The use of such a material loses the original purpose of benefiting from the amazing 
properties of pristine graphene. Further graphene oxide treatments using thermal [194], 
electrochemical [195] or chemical [196] methods have been implemented to reduce the 
amount of intercalated oxygen, none of which displayed total efficiency (presence of residual 
oxygen groups and defects originating from the oxidation of graphite). Other inconvenient of 
graphene oxide includes: (1) the solution based product, (2) the use of strong solvents, acids 
and (3) the limited large scale production. 
 
1.4.3.1.4 Electrochemical exfoliation 
During electrochemical exfoliation, a working electrode of graphite is introduced in a three 
electrode setup with a counter and a reference electrode. The supporting electrolytes solution 
used in the experiments vary (sulphuric acid, poly(styrenesulfonate), perchloric acid etc…). 
By applying a positive potential on the working electrode, the graphite is oxidised which 
induces the intercalation of negatively charged ions between the graphene sheets. The further 
application of a negative potential will complete the exfoliation process. This production 
technique presents the advantage of being a simple procedure that doesn’t necessarily involve 
strong chemicals. It does however have the same drawbacks as graphene oxide since the 
produced graphene have oxygen groups intercalated in its’ lattice. It is also very difficult to 
produce graphene with homogeneous size and few layers. Finally this technique sometimes 
involves the use of surfactants impairing the quality of the final material product [184]. 
 
1.4.3.1.5 Opening carbon nanotubes 
The opening of carbon nanotubes is slightly different from the previously presented 
techniques in the sense that graphite is not the starting point of the production process. This 
technique is associated with carbon nanotube research and produces high aspect ratio 
(length/width higher than 10) entities named graphene nanoribbons (GNR) that presents a 
typical width of <50 nm [197]. The width and length of GNRs is tuneable by controlling the 
carbon nanotubes circumference and length respectively. Different techniques have been used 
to produce GNRs: (1) Firstly, a controlled unzipping of carbon nanotubes was presented 
using the Hummers and Offeman technique [192]. The GNRs were further thermally treated 
at 900°C in argon in order to reduce the amount of oxygen functionalities on the carbon 
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nanomaterial (2) Secondly, carbon nanotubes were half embedded in a bed of poly(methyl 
methacrylate), PMMA, and further treated with oxygen plasma inducing their opening [198]. 
And finally, (3) a zinc treatment was also used to trigger the unzipping of the nanotubes 
entities [199]. The major issue behind opening carbon nanotubes is the induction of structural 
defects during the opening phase either by introducing oxygen functional groups or simply by 
compromising the graphene structure. These techniques will also suffer from carbon 
nanotubes production drawbacks (presence of metallic or carbonaceous impurities [184]). 
 
1.4.3.1.6 Arc discharge/ Laser ablation 
Arc discharge involves applying very high voltages on graphitic electrodes separated by 
small distances. A high electric field will be formed that induces an instantaneous spark in a 
welding process. The falling entities during the discharged will be the graphene flakes. This 
process however demonstrates very poor selectivity (large amount of unwanted products 
formed/ debris) [200]. Laser ablation involves the use of a laser beam to cleave graphite in a 
so called “photoexfoliation” process. The production of fine numbers of graphene layers have 
been demonstrated by changing the laser energy density. This process is still underdeveloped 
and laboratory based [201]. 
Both techniques where presented together because they suffer the same general limitations: 
(1) they require a large amount of graphite source and (2) an important amount of energy is 
necessary to produce the arc discharge or power the laser ablation, rendering large scale 
production impossible [160]. 
 
1.4.3.2 Bottom up techniques 
 
1.4.3.2.1 Organic synthesis 
Graphene is formed of fundamental polycyclic aromatic hydrocarbon units, it should hence 
be possible to create a graphene sheet by organic synthesis (linking these units together). This 
process is however very limited since, when exceeding a few nanometers, graphene sheets 
become highly insoluble in organic solvents. This will reduce further organic growth as well 
as induce unwanted side reactions [184]. This technique, however interesting for the 
production of pristine graphene, is hence dramatically impaired by the production size of the 
graphene sheets and research is ongoing to improve this crucial aspect (recently the organic 
synthesis of GNRs of 500 nm in length was presented [202]). 
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1.4.3.2.2 Epitaxial growth on SiC 
Another way of growing graphene is through the heating treatment of SiC substrates under 
ultrahigh vacuum conditions. During the thermal process, the Si atoms sublimates to leave 
graphene layers which can be tuned to very few layers by controlling the operating conditions 
[203]. The properties of epitaxially grown graphene from SiC however differs from pristine 
graphene because of surface induced corrugation and irregular orientations of graphene 
layers. The expensive aspect of the technique will also be an important limitation which will 
limit the large scale application of the production method [184].  
 
1.4.3.2.3 Chemical vapour deposition 
Chemical vapour deposition (CVD) is by far the “most promising techniques for industrial-
scale fabrication of graphene” [184]. It involves a high temperature decomposition of gaseous 
hydrocarbon precursors (methane, ethane, propane) into carbon radicals that organise in the 
graphene honeycombed configuration on top of a metal sheet (Cu or Ni). During the growth, 
the supporting metal not only acts as a catalyst to lower the activation energy barrier of the 
reaction but also dictates the deposition mechanism that affects the quality of the 
nanomaterial [204]. The CVD process produces large, close to pristine, and mostly 
monolayer graphene sheets in a cost effective and scaled up manner [184]. It has already been 
applied to diverse developments such as electronic transistors, transparent conductive 
electrodes, electrochemical detection, corrosion inhibiting coating, solar cells etc. The 
technique does however suffer some drawbacks: (1) Graphene growth on the metal surfaces 
occurs via the fusion of graphene “islands”, a process that sometimes induces defects and 
impairs therefore the resulting conductive properties. (2) The transfer of the graphene sheet 
onto a substrate is a potential cause of defects and folding.  
1.4.4 Benefit of CVD graphene introduction in a biosensor device 
The benefit of using CVD graphene in biosensing device depends essentially on the detection 
principle. Hence a field effect transistor (FET) devices would benefit from the pristine quality 
of CVD graphene displaying an exquisite conductivity since any change at the surface of the 
semiconductor will induce a change of gating potential (see chapter 3). This lead to the 
development, in recent years, of hybridization sensor (DNA, cell [205]) or enzymatic FET 
(ENFET [145]) CVD graphene sensor. On the other hand the nanomaterial has been deemed 
less interesting in electrochemical applications, the catalytic activity being increased at edges 
 44 
and decreased on the basal plane of the graphene (i.e. table 1.3) [206]. This last observation is 
however the subject of much debate in the scientific community, and CVD graphene is still 
implemented in amperometric biosensors [207] mostly combined with nanoparticles that 
provide an increased electron transfer and catalytic activity (see chapter 3) [208, 209]. The 
developed amperometric device will benefit from the electrochemical deposition of platinum 
nanoparticles on the surface of the graphene acting as “electron wires” for the GOD catalytic 
reaction. As demonstrated in chapter 4, the sensitivity and limit of detection thereby achieved 
will be highly competitive compared to comparable devices found in the literature. Further 
and foremost CVD graphene possesses exceptional qualities compared to other graphene 
types and commonly used electrodes that are listed in table 1.1 that will be fundamental 
attributes of the developed technology (flexibility, large scale production, etc.). Moreover, a 
comparison of the performance of CVD graphene glucose sensor found in the literature to the 
developed sensor is provided in chapter 4, table 4.3. It presents some of the designs for 
amperometric glucose sensing based on the nanomaterial and metallic nanoparticles. The 
literature study was narrowed down to these characteristics but other glucose biosensor based 
on graphene exist such as amperometric biosensors based on CVD graphene (without 
nanoparticles) [207] or else FET CVD graphene glucose biosensors [145, 181].  
1.5 Analytical and microscopic techniques: principles 
A wide range of microscopic and analytical techniques have been used throughout the thesis 
the principles of which are described in this section. 
1.5.1 Microscopic techniques 
1.5.1.1 Laser scanning confocal microscopy 
Laser scanning confocal microscopy (LSCM) is a visualisation technique that measures the 
fluorescence emitted by the sample. A laser beam is directed to and focused on the sample 
via an objective lens. Fluorophores in the sample are then excited and emit fluorescent 
signals. Part of this fluorescence is collected through the lens, filtered by the dichroic mirror 
and focused onto a pinhole in front of the detector (figure 1.12) [210, 211].  
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LSCM enables high resolution (and 3 dimensional) imaging of the sample, with the specific 
attributes that the light source is focused onto a single point in the focal plane, and that the 
pinhole in front of the detector effectively blocks any out of focus fluorescent signal. The 
image is acquired by scanning the laser across the sample in the focal plane, and then layer by 

















 Green and brown arrows indicate Figure 1.12. Schematic diagram of LSCM.
respectively the direction of the incident laser light and the emitted fluorescence, [213]. 
 
1.5.1.2 Atomic Force Microscopy (AFM) 
AFM enables non-destructive imaging under ambient conditions. It can be applied to hard or 
soft, synthetic or natural compounds and surfaces. Unlike electron microscopy, sample 
visualisation by AFM relies on the mechanical approach of the probe to the sample [214]. 
The resolution of an AFM image is on the order of 0.1 nm (height) and 1 nm (lateral). The 
AFM principle is illustrated in figure 1.13. [215].  
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Figure 1.13. Schematic representation of atomic force microscopy 
1.5.2 Potentiometric operations 
1.5.2.1 Field effect transistors (FET) 
A potentiometric device relies on the measure of a potential change with respect to a 
reference electrode. A typical field effect transistor (FET), or voltage control device, 
comprises three electrical conductors (a source, a drain and a gate). The source and the drain 
are separated by a semiconductor. The current flows from the source to the drain. It is 
modulated by the movement of charge carriers (holes or electrons) that are under the 
influence of a magnetic field created by the gate and separated from the system by an 
insulator. figure 1.14-A presents the electrical double layer formed when applying a positive 
potential on the gate with the ions in solution, while figure 1.14-B is a representation of the 
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A change of charge around the semiconductor (graphene), following an enzymatic reaction 
for example, will have for consequence to change the “gating” of the FET. This will cause a 
displacement of the source to drain current characteristics as a function of the gate potential 
(see chapter 3, figure 3.3 to 3.5). 
 
 














 A: The Figure 1.14. Electrical double layer and schematic diagram of the FET.
electrical double layer formed in an ionic solution when a gate voltage VGS is imposed. 
B: Diagrammatic representation of the FET.  
 
1.5.2.2 Graphene electrical properties; “zero-gap semiconductor” 
Recently, graphene has been introduced as an alternative for integration in FET devices. The 
use of graphene in field effect transistors has been widely studied due to the ability to control 
its electrical transport properties with the gate electrode [216]. Graphene is defined as a zero-
gap semiconductor, approaching the properties of semi-metals in that electron passage 
between energy bands is facilitated and even enhanced [147]. In the low energy range, the 
conduction and valence bands form conical shapes and meet at the Dirac point facilitating 
electron mobility in the nanomaterial and enabling small changes at its surface (when 
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Figure 1.15. Representation of the conduction and valence band in graphene. 
1.5.3 Voltammetric operations 
A potentiometric and an amperometric approach were envisaged for the sensor development. 
Promising preliminary results were obtained with a Field Effect Transistor (FET), (see 
chapter 3). A voltammetric detection was however preferred, the transistor suffering from 
drawbacks such as: complicated integration with non-invasive detection techniques and 
limitations associated to buffer strength, storage, stability etc. 
 
The electrochemical procedures described in the thesis rely on the use of electrochemical cell 
setups including three electrodes: a working electrode (WE), a counter electrode (CE) and a 
reference electrode (RE). The application of a potential between the WE and the RE 
(displaying a stable potential) induces the oxidation or reduction of a compound of interest (at 
the WE) in an aqueous solution which translates in a change of current measured between the 
WE and the CE. The role of supporting electrolytes in the aqueous solution will be to reduce 
the Ohmic (or IR) drop in the cell and to eliminate the contribution of migration current from 















1.5.3.1 The Electrochemical cell  
In a typical electrochemical experiment a redox reaction signal is acquired at a working 
electrode (WE), while the other half of the cell is a reference electrode (RE) which will be 
maintained at a constant potential [218]. When a potential is applied between WE and RE a 
voltage drop IR is observed that follows Ohm’s law, equation 1.4.  
V = IR 
This equation describes the Ohmic relationship between the cell potential (V, Volts), current 
passing through the cell (I, Amps) and solution resistance (R, Ohms).  
 
When IR ≤ 1-2 mV, a two electrode system (RE and WE) might be used to detect the redox 
current signal, however, the RE potential need to stay stable while current passes through it 
which isn’t achievable with high IR. Two electrode cells have been used with micro-working 
electrodes and low IR processes but are not commonly applied in electrochemistry. The 
introduction of a third electrode in the system is preferred in order to maintain a stable 
potential at the RE (approaching ideal non-polarisable characteristics). The current is then 
measured between the newly introduced counter electrode (CE) and the working electrode 
(WE). This situation, displayed in figure 1.16 is the most commonly found in typical 
















A: 2 electrodes setup; the potential is Figure 1.16. Electrochemical cell configurations. 
applied and current measured between a RE and a WE. B: 3 electrodes setup; the 
potential is applied between a RE and a WE while current is acquired between WE and 
CE. 
 
The voltage and current between the three electrodes in situation B are controlled and 
measured by a device called a potentiostat. Finally, a fundamental feature of any 
electrochemical cell will be the presence of supporting electrolytes in sufficient concentration 
to support the redox reactions (see section 1.5.3.5). 
 
1.5.3.2. Reference electrodes (RE) 
Several electrodes are commonly used: 
 
1.5.3.2.1 The standard hydrogen electrode (SHE) 
The SHE is the reference electrode that serves as a globally accepted standard for 
electrochemical literature as defined by the International Union of Pure and Applied 
Chemistry (IUPAC) [220]. This electrode should display the noticeable electrode potential 
E0(H
+
/H2) = 0, at any temperature making it a reliable comparative system. A SHE comprises 
of a platinum black electrode which is dipped in a solution of hydrochloric acid. Hydrogen 






















aq: aqueous, g: gas 
 
1.5.3.2.2 The saturated silver/silver chloride electrode 
This electrode (as well as the saturated calomel electrode) is more applicable than the SHE 
which requires a constant flux of hydrogen gas. Results obtained with these two electrodes 






Figure 1.17. Reference electrode potential variations with respect to the standard 
hydrogen electrode. 
 
A saturated Ag/AgCl electrode is formed of a silver wire coated with porous silver chloride, 
itself dipped in a saturated KCl solution. The porosity of the AgCl chloride layer is of high 
importance for the KCl solution to reach the silver wire. The equilibrium involved in this 
reference electrode is: 
 
s: solid, aq: aqueous 
The Ag/AgCl electrode used in chapter 4 and 5 is not saturated (either pseudo Ag metallic 
wire, or micro Ag/AgCl electrode in 0.1 M KCl). This was done intentionally since the 
enzyme glucose oxidase is inhibited by halide (chloride) ions [61, 221].  
 
1.5.3.2.3 The Saturated Calomel electrode (SCE) 
The SCE is the other very frequently used reference electrode and is used in part of the thesis 
electrochemical analysis. It is formed of liquid mercury contacting insoluble di-mercury (I) 
chloride (also called “calomel”). This assembly is in direct contact with a saturated KCl 
solution. The redox equilibrium of a calomel electrode is presented thereof [218]:  
 
s: solid, l: liquid, aq: aqueous 









1.5.3.3 Counter electrode (CE) 
The role of a counter electrode is to act as a current flowing counterpart for the working 
electrode. The active area of the counter electrode should preferably be large (coiled wire) in 
order to avoid influences on the charge flow (small current density). The most noticeable 
structural characteristic of such an electrode, however, is that it must be inert regarding the 
redox reaction happening in the electrochemical cell. Several techniques can be implemented 
in order to avoid reaction at the CE (use of a frit or a side arm to the electrochemical cell to 
separate the electrode from the working solution), but usually, the choice of an inert metal 
such as platinum will be sufficient to reduce considerably undesirable interactions, especially 
when working under normal voltammetric conditions where tiny quantities of material are 
consumed [218]. 
 
1.5.3.4 Working electrode (WE) 
The working electrode is the core component of the system where the electrochemical 
reaction occurs. The oxidation or reduction happening at the WE will cause current to be 
drawn in or out of the CE producing a signal function of the potential imposed with respect to 
the RE. The efficiency of a WE will be dependent on multiple factors; electrode material, 
geometry, liquid/solid interphase etc. Some of the most common materials used for working 
electrodes can be listed as: metallic electrodes (gold, platinum, silver), carbon electrodes 
(glassy carbon, graphite, carbon paste, carbon nanomaterials) and liquid mercury electrodes 
(dropping mercury electrodes, hanging mercury drop electrodes, static mercury drop 
electrodes, mercury thin film electrode). The following characteristics have been defined to 
obtain an optimal WE: “(1) Small noise levels (for high sensitivity) (2) Reproducibility and 
stability of the electrode (3) Good redox active surface and interphase (4) Large working 
potential range and (5) Easy handling of the electrode assembly” [222]. All these criteria are 
considered and improved in the electrode development described in chapter 4. 
 
1.5.3.5 Supporting electrolytes 
Supporting electrolytes have been defined by the IUPAC as: “An electrolyte solution, whose 
constituents are not electroactive in the range of applied potentials being studied, and whose 
ionic strength (and, therefore, contribution to the conductivity) is usually much larger than 
the concentration of an electroactive substance to be dissolved in it [223].” Most buffers 
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satisfy this definition at concentrations between 1 and 0.1 M. Typical electrolytes are 
identified as: chlorides, sulphates, potassium, sodium, phosphate etc. The role of the 
supporting electrolytes will be to reduce the Ohmic (or IR) drop in the cell and to eliminate 
the migration current contribution from the redox species of interest [222]. Without 
supporting electrolyte, no voltammetric operation could occur as there wouldn’t be any ionic 
entity to counter the migration of the redox analyte. The supporting electrolyte solution used 
in the electrochemical experiments is 0.1 M phosphate buffer pH 7.4, which is adequate for 
maintaining an appropriate pH around biological entities (enzyme: GOD) as well as being 
used widely in electrochemistry [224, 225].  
 
1.5.3.6 Cyclic voltammetry (CV) 
The principle of CV operations, as the name implies, involves varying the potential between a 
WE and a RE in a cyclic manner, and measuring the catalytic current. The imposed potential 
therefore has a triangular shape over time, starting at E1, then increasing to a second E2 and 
finally coming back to E1 [218, 226] (figure 1.18). A cyclic voltammogram displays catalytic 











 The slope of the Figure 1.18. Potential sweep over time during cyclic voltammetry.















The chronoamperometric measurement involves stepping the potential from a value at which 
no redox reaction occurs to one where a current relating to a specific redox reaction is 
observed, (figure 1.19). Chronoamperometry curves display, catalytic current = f(time) at a 











Figure 1.19. Stepping the potential in chronoamperometry 
 
The diffusion of reactant to the electrode surface is described by the Cottrell equation [227] 
and is only applicable in the first few seconds of the chronoamperometric step where there is 
a current spike and a decay. 




IP is the analytic current expressed as a function of the number of electrons n, the electrode 
area A, the concentration C’, the diffusion coefficient D and the time t. 
 
The diffusion field is a concentration gradient which extends out perpendicularly from the 
working electrode surface. Close to the working electrode surface, the redox species of 
interest (A) is depleted due to its uptake of either electrons or holes and therefore its 




  B     (1.9) 
This diffusion field is time dependent and at very short time scales, of the order of 
milliseconds, this diffusion field has not had time to establish. Therefore the depletion layer 
E(V) 
t (sec) t = 0 
No reaction 






close to the electrode surface is very small. Conversely, at longer time scales the diffusion 
field has time to establish and a thick diffusion field is created extending out into bulk 
solution (figure 1.20-A). This effect can be seen from the shape of the chronoamperometry 
curve (figure 1.20-B). At short time scales, the current can be seen to initially increase. This 
is because of the high concentration of redox species close to the electrode surface and its 
immediate conversion to another species. After a time, there is a peak in the current. This 
indicates that the diffusion field has now established and the redox species of interest cannot 
reach the working electrode surface fast enough to pick up the electrons or holes. After this 
peak, the current then falls and eventually stabilises as the diffusion field has reached a 
steady-state where it does not continue extending into the solution because of convection as 










 A: Decrease of reactant Figure 1.20. Chronoamperometry is diffusion dependent.
concentration as a function of time and distance from the electrode. B: Current IP 
response as a function of time. 
1.6 Aims and objectives of the project 
This chapter raises concern regarding the rising evolution of diabetes and the fundamental 
need for improved glucose sensing technologies (as opposed to the commonly used 
fingerstick sensor). An emphasis is therefore brought on alternative technologies and more 
specifically on non-invasive technologies that seems to be the future of the glucose 
biosensing industry. However, no such device has managed so far to be a commercial 











Accordingly, the project therefore aims to develop a new non-invasive technology based on 
reverse iontophoresis. It will follow two principal axes: (1) the development of a highly 
sensitive and specific glucose biosensing platform and (2) the integration with reverse 
iontophoresis on a pig skin model and the targeting of hair follicles glucose extraction 
pathways. 
 
(1) Based on the choice of CVD graphene as the transducer electrode, two characteristics will 
be considered in chapter 2 and 3. First, the biofunctionalization of the nanomaterial with 
GOD. This step is fundamental because it will ensure whether or not the enzyme will be 
retained on the sensor and keep its’ catalytic activity intact. Two coatings will be investigated 
a non-covalent coating of graphene via a linker and the entrapment of the enzyme into an 
agarose gel. Then the detection principle will be considered and two sensing operations 
studied: a FET and an amperometric design. This will lead to the design of a specific and 
sensitive amperometric glucose biosensor in chapter 4. This chapter will more precisely 
describe how the results obtained from chapter 2 and 3 managed to create a performant 
biosensor benefiting from improvements such as the miniaturization of the setup or the 
additions of platinum nanoparticles. 
 
(2) Having developed a performant and competitive sensing platform. The following aim will 
be to integrate it with reverse iontophoresis which will be successfully achieved in chapter 5. 
The preferential extraction of glucose through hair follicles and detection on the miniature 
sensor will then be demonstrated. This will be validated by an independent 
1
HqNMR test of 
extracted glucose through the same pathways. Finally a first attempt will be made at 
multiplexing the sensor and cross talking between the different detection units investigated. 
 
The overall objective of the project is therefore to design a miniature highly sensitive and 
specific glucose biosensor based on CVD graphene and integrate it to reverse iontophoresis 
as well as target reverse iontophoresis pathways where the extraction of neutral molecules 
such as glucose is preferential.  
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Chapter 2: Glucose oxidase 
functionalization on chemical vapour 
deposited (CVD) graphene 
2.1 Introduction 
When designing a biosensor two aspects are to be considered: (1) the biological element and 
its’ functionalization on the transducer and (2) the transducer and the detection principle. The 
first point will be detailed in this chapter while the second will be investigated in chapter 3. 
When functionalising an electrode with proteins (i.e., the GOD enzyme in this case) several 
techniques can be identified: (1) electromagnetic coating, (2) covalent functionalization, (3) 
non-covalent coating and (4) entrapment in a polymeric matrix or a hydrogel, (see figure 2.1). 
(1) Covalent coating involves chemical modification of the transducer or reaction via 
functional groups already present thereon (as is the case for graphene oxide, for example). 
This results in strong and organised coupling but can affect the properties of the transducer 
and/or the enzyme [1]. Graphene, must remain chemically unmodified to retain its’ 
conductive properties [2]; equally, linking an enzyme covalently may alter its 
activity/structure and, self-evidently, the linkage must not involve the catalytic site [3]. A 
common way to covalently attach enzymes on an electronic support is to use self-assembly 
monolayers (SAM) involving long chain molecules that associate with the electrode via 
chemisorption or physisorption [4]. The approach provides strong and organised 
functionalization but can sometimes change the physical properties of the transducer and 
reduce the efficiency of electron transfer due to reduced enzyme activity [5]. Covalent 
bonding has also been used with graphene oxide [6], but this strategy has not been 
investigated here due to the frequently impaired physical properties of the nanomaterial as 
well as the difficulty of scaling-up the production of such sensors. (2) The approach based on 
electrostatic interactions, for example between a positively charged polymer and the 
negatively charged GOD [7], is relatively easy to implement and does not require chemical 
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modification of the transducer. The binding is, however, weak and will be subject to any 
changes in pH or ionic strength that are likely in an electrochemical-based biomedical device. 
(3) With the introduction of carbon nanomaterials such as fullerenes, carbon nanotubes and 
graphene, a new type of functionalization has emerged that provides a uniform coating and is 
minimally disruptive to the transducer and to the enzyme: namely, non-covalent binding via 
π-π interactions [8, 9]. The quality of the coating will however rely strongly on the ability to 
obtain a strong non covalent adhesion (via 1-pyrene butanoic succinimidyl ester: 1-PBASE 
here). (4) Finally, polymeric or gel entrapment, enables the largest quantity of proteins to be 
coated without disrupting the properties of the electrode [10]. Polymeric entrapment has been 
described using polypyrrole [11], chitosan [12] or nafion [13] and results in a thin (sometimes 
conductive) layer in which a high enzymatic loading can be achieved. The use of a hydrogel 
is further explored in the next chapter. This approach also eliminates any electrode coating 
issues and problems related to enzyme stability on long-term storage (i.e., it allows the 
enzyme containing gel to be readily removed and replaced while, leaving the transducer 
untouched). This type of functionalization was used in the GlucoWatch 
®
 Biographer device 
[14]. The presented biosensor development focuses on the last two functionalizations for the 
following reasons:  
(i) Non-covalent coating is minimally disruptive, allowing graphene to retain its 
electrical properties [15]. A uniform layer of enzyme can be formed on the 
transducer (see figure 2.12) [16]. And the enzyme can be patterned on the 
graphene sheet, by means of micro-contact printing, for example [8], (see figure 
2.11).  
(ii) Hydrogel entrapment is also minimally disruptive and will be preferred in the 
second part because it doesn’t require any treatment of the graphene, the graphene 
electrodes can be stored at room temperature, and the enzymatic loading (and 
hence catalytic signal) increased (see section 2.3.2). 
 
Laser confocal scanning microscopy and electrochemical measurements (cyclic voltammetry 
and chronoamperometry) will be used to characterise the entrapments. (1) The first 
microscopic technique helped to visualise the non-covalent coating (on the graphene) of a 
GOD-linker complex on which Fluorescein isothiocyanate had been attached. The coverage 
of the entire graphene surface was visualised as well as the patterned deposition of the 
enzyme via microcontact printing. Both these images allowed to assess the quality of the non-
covalent enzymatic coating. The GOD activity was further investigated by coupling an 
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electrochemical experiment with LSCM visualization (figure 2.8). (2) Attention was then 
focused on developing a first generation biosensor relying on O2 during the enzymatic 
catalysis reaction of glucose oxidase in the presence of the substrate β-D glucose [17]. H2O2 
is formed from the reduction of O2 in the FAD active cofactor centre of the enzyme and then 
oxidised against the electrode. This oxygen-based detection was first introduced in 1962 by 
Clark and Lyons [18] and remains the basic principle for many bio-electrochemical sensors 
[19]. Enzyme immobilization in biosensing applications should ensure efficient physical 
attachment of the enzyme without perturbation of structure and activity. It must allow for 
good electron transfer, and easy diffusional access for the substrate [20]. The enzymatic 
catalytic activity is influenced by several factors. (1) The electron transfer between the active 
site of the enzyme and the electrode. This is highly dependent on the distance between them: 
the closer the enzyme’s active site to the transducer, and the more conductive the supporting 
matrix, the better the delivery of the signal. (2) The retention of the enzyme and diffusional 
access for the substrate. The sensor must be designed so that the enzyme is efficiently 
retained on the transducer while allowing the substrate (glucose) and product (H2O2) to 
diffuse efficiently. (3) The signal will be proportional to the quantity of active enzymes on 
the transducer. (4) The enzyme receptacle or functionalized transducer must be kept under 
conditions that are not stringent for the protein (appropriate pH, temperature). 
 
. The four principal methods used to Figure 2.1. Graphene functionalization
functionalize graphene with biomolecules are presented: polymeric or hydrogel 
entrapment (red), cationic coating (green), covalent functionalization and chemical 
modification of the graphene lattice (or use of graphene oxide) (blue), and non-covalent 
functionalization via π-π interaction (orange). Asterisks (*) signify techniques pursued 
in this work. 
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2.2 Materials and experimental methods 
2.2.1 Materials 
Two glucose oxidase were used in this chapter: (1) glucose oxidase type VII, (EC 1.1.3.4), 
lyophilized powder, ≥100,000 units/g solid (without added oxygen) for the microscopic 
experiments and (2) glucose oxidase type X-S, (EC 1.1.3.4), 100,000-250,000 units/g solid 
(without added oxygen) for the electrochemical experiments. The two enzymes are 
structurally the same (the difference in numbers (VII and X-S) was introduced by the 
manufacturer as an internal classification). D-glucose, Na2HPO4, NaH2PO4, NaHCO3, 
Na2CO3, NH4Cl, FeCl3, 1-pyrene butanoic succinimidyl ester (1-PBASE), N,N-
dimethylformamide (DMF), dimethylsulfoxide (DMSO), silicon master 200® fluid, 
fluorescein isothyocyanate (FITC) and rhodamine isothyocyanate were purchased from 
Sigma-Aldrich (Dorset, UK). Agarose was purchased from Fisher Scientific (Loughborough, 
UK). Phosphate buffer 0.1 M pH 7.4 (our standard electrochemical buffer) was prepared from 
Na2HPO4 and NaH2PO4 salts. MiliQ-water was used for all solutions. CVD graphene on 
copper and deposited on a silicon dioxide wafer, or on glass with a wet etching technique, 
was provided by the Univeristy of Bath, UK. Silicon dioxide (300 nm oxide) was acquired 
from IDB technology (Whitley, UK), 495 PMMA A3 (poly(methyl metacrylate)) from 
Microchem (Rugby, UK), Silcoset 151 silicone rubber from Farnell (Leeds, UK), Amicon 
ultracel 10K centrifugal tubes with regenerated cellulose from Merck Millipore (Darmstadt, 
Germany), PD-10 Desalting Columns from GE healthcare (Little Chalfont, UK), conductive 
silver paint from Agar Scientific (Stansted, UK), S-18-13 photoresist from AZ Electronic 
Materials, Merck (Darmstadt, Germany) and curing PDMS (polydimethylsiloxane) curing 
agent (Elastomer Sylgard 184) from Dow Corning (Midland, MI, USA). The confocal laser 
microscope was a LSM 510 from Zeiss (Cambridge, UK) and the AFM, an Asylum Research 
(High Wycombe, UK) MFP-3D microscope. 
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2.2.2 Experimental methods 
2.2.2.1 Graphene wet etching and transfer 
A wet etching technique [21] was used in order to transfer CVD graphene (which had already 
been deposited on copper) onto Si/SiO2 (300 nm thickness). The procedure involved the 
deposition of a 495 PMMA A3 layer on the top of the graphene by spin coating at 301 g for 
30 seconds: a drop of PMMA was used between the back of the graphene sample and a glass 
coverslip and was cured at 115 ˚C for 25 seconds to fix the sample during spin coating. The 
sample was then cured at 120 ˚C for 2 minutes before being placed in a bath of 1 M FeCl3 
and left to etch overnight. The sample was further washed 3 times with milliQ water for 30 
minutes. It was subsequently deposited on Si/SiO2 and left to air-dry for 10 to 15 minutes 
before a 10 µL drop of PMMA was added to relax the pre-existing polymer layer for 20 
minutes. Finally, the sample was washed and incubated in acetone for 1 hour. 
 
2.2.2.2 Non-covalent graphene functionalization by π-π stacking 
Graphene was then treated with 5 mM 1-PBASE in DMF. This molecule binds to graphene 
via π-π interactions, and to the amine groups on glucose oxidase (GOD) via a nucleophilic 
reaction. The resulting product was then washed with DMF and milliQ water before being 
incubated overnight in a 6.25 mg/mL solution of GOD in 0.1 M sodium carbonate/sodium 
bicarbonate buffer (pH 9.0) at 4 °C. The reaction between the succinimidyl ester group of 1-
PBASE and the NH2 of the enzyme is displayed in figure 2.2. Finally, it was rinsed in 
phosphate buffer (pH 7.4) and milliQ water.  
 
 
Figure 2.2. Reaction between the succinimidyl ester group of the linker and the NH 2 
of the enzyme. 
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2.2.2.3 Glucose oxidase fluorescent FITC labelling 
Glucose oxidase was covalently conjugated with FITC following a protocol described in [22]: 
A solution of 4 mg/mL of GOD was prepared in 1 mL of 0.1 M sodium bicarbonate pH 9. In 
parallel, a 1 mg/mL solution of FITC was prepared in anhydrous DMSO. 200 µL of the FITC 
solution was then very gently added to the GOD solution in 5 µL aliquots while stirring. The 
mixture was subsequently incubated in the dark, overnight at 4 ˚C, under constant stirring. 
NH4Cl was then added to a final concentration of 50 mM, incubated for 2 hours at 4 ˚C, and 
supplemented with 5% glycerol. The unbound FITC was further separated from the labelled 
protein with a PD-10 sephadex desalting column. The column was equilibrated with 4 washes 
of 5 mL bicarbonate buffer. 1 mL of the fluorescent mixture was then introduced onto the 
column with another 2.5 mL of buffer. Finally, 3.5 mL of buffer were added to elute the 
protein. The operation was repeated to collect the maximum amount of labelled protein. The 
obtained concentration of FITC/GOD was estimated as 0.57 mg/mL. It was concentrated 
down using membrane filtration/centrifugation: The eluate was introduced in a falcon tube 
with a 10,000 Da exclusion membrane and centrifuged at 4,900 g for 10-15 minutes. The 
total concentration of enzyme was therefore approximated as 6.25 mg/mL (considering a 
100% recovery of proteins). 
 
2.2.2.4 Micro-contact printing 
Micro-contact printing of glucose oxidase on CVD graphene was used to check the integrity 
of the coating. 
 
2.2.2.4.1 Production of a PDMS stamp 
A poly(dimethylsiloxane) (PDMS) stamp was prepared from a predesigned pattern by 
photolithography. A photoresist (S-18-13) was spin coated onto a Si/SiO2 wafer at 8 g for 5 
seconds and at 134 g for 45 seconds. Subsequently, a negative “line shaped” mask was used 
to obtain a positive pattern on the resist which was exposed for 6 seconds at 45 mJ under UV 
light. A Microposit 
TM
 351 developer (Dow electronic material, Berlin, Germany) was 
prepared (10 into 35 mL into water) and the sample was gently stirred in the solution for 30 
seconds until a pattern appeared. It was then placed into deionized water to stop the 
developing reaction. The PDMS polymer stamp was then obtained by adding a curing agent, 
Elastomer Sylgard 184 (Dow Corning, Midland, MI, USA) to a silicone master at a ratio of 
1:7 [23]. The polymeric mix was poured into a mould in contact with the photolithographic 
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pattern, degassed under vacuum for 30 minutes, and incubated at 90 °C overnight. It was then 
gently peeled off, ready to use. 
 
2.2.2.4.2 Micro-contact printing 
CVD graphene sheets were transferred onto Si/SiO2 wafers, incubated with 5 mM of 1-
PBASE in DMF for 2 hours at room temperature and thoroughly washed with DMF and 
milliQ water. In the meantime, PDMS stamps were incubated with FITC-labelled GOD in 
bicarbonate buffer at 4 °C for 1 h - the enzyme was retained on the stamp via hydrophobic 
interactions. The stamp was then pressed against the graphene sheet for a short period of time 








 A PDMS stamp was inked with a protein solution Figure 2.3. Micro-contact printing.
(GOD) and brought to mechanical contact with graphene functionalised with 1-PBASE 
for non-covalent coating. 
 
2.2.2.5 Visualisation of the GOD activity  
GOD was labelled with rhodamine isothiocyanate in the same way as the fluorescein 
functionalization described in section 2.2.2.3, the final enzyme concentration was therefore 
estimated to be similar to the FITC-GOD (i.e. 6.25 mg/ml). Gold and titanium were 
evaporated onto part of a graphene sample to generate a working electrode, which was 
insulated by depositing silicone rubber onto the gold. The rhodamine labelled GOD was then 
micro-contact printed on CVD graphene following the protocol presented in section 2.2.2.4.2. 
A Pt counter electrode and Ag pseudo-reference electrode were then inserted in the small 
drop of buffer containing 20 µM of fluorescein. The setup was mounted in the fluorescence 
microscope and the electrodes connected to a potentiostat (Autolab, Metrohom, Utrecht, The 
Netherland). Cyclic voltammograms were acquired, at 20 mV/sec, between -0.4 and 0.8 V 
against the Ag reference electrode before and after each addition of glucose. The imaging 
was acquired after each cyclic voltammetric operation (corresponding to the addition of 











 The silicone rubber, when dry, provides good insulation while releasing a small quantity of acetic acid. It is 
believed that the acetic acid is removed in the washing step and does not therefore interfere with the sensing. No 
interference has been identified from acetic acid when studying the catalytic activity of the electrode as shown 
in chapter 4, figure 4.15. 
 
2.2.2.6 LSCM parameters 
Two fluorophores were used, rhodamine and fluorescein with excitation/emission 
wavelengths at 543 nm/580 nm and 490 nm/525 nm respectively, with two different lasers: 
argon (which excites fluorescein at 488 nm (green fluorescence)), and HeNe (exciting 
rhodamine at 543 nm (red fluorescence)), in conjunction with the specific filters BP 505-530 
nm for fluorescein emission and LP 560 nm for rhodamine. The objective lens used for 
imaging the protein coating had a magnification of 20×. 
 
2.2.2.7 Electrochemistry: experimental methods 
 
2.2.2.7.1 Electrode design  
The electronic connection between the graphene flake and the potentiostat was achieved via 
thermal evaporation of successively titanium and gold (10 and 60 nm thickness, respectively) 
or by application of silver paint. Both connections were completed with gold wire making a 
gold-gold or silver-gold contact. The graphene squares were insulated from the gold or silver 
contacts via the deposition of ACC silicone rubber (see 
4α
 footnote). The target graphene 
square dimensions were set as 9 mm
2
; those achieved were 9 mm
2
 ± 2.25 mm
2
 (the error 
originating from the metallic contact with the graphene flake). The devices were left dry at 
room temperature in petri dishes before use. 
 
2.2.2.7.2 Gel casting 
The enzymatic coating entrapped GOD was built in a 0.5% agarose gel matrix. 250 µL of a 
clear 1% w/v solution of agarose in 0.1 M phosphate buffer pH 7.4 was created by warming 
above 80 ˚C and then cooling down to 28 ˚C (a temperature low enough to maintain the 
enzyme’s catalytic and structural properties [24] while enabling efficient entrapment in the 
gel, i.e., below the gelling temperature of ~ 36 ˚C). 250 µL of an 8 mg/mL solution of GOD 
in 0.1 M phosphate buffer was then added to the gel and left for 1 hour at 4˚C; the resulting 
mixture therefore comprised 500 µL of 0.5% agarose gel with 4 mg/mL enzyme. A section 
was excised with a glass capillary of 1.5 mm radius which corresponded to 24 µL +/- 2µL in 
volume, and placed on top of the working graphene electrode for analysis. This gel 
entrapment technique will be designated as entrapment 1, as opposed to other improved 
entrapment presented further in the thesis (chapter 3 and 4: entrapment 2 and 3). 
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2.2.2.7.3 Electrochemical set-up 
A potentiostat (Metrohom, autolab, Utrecht, The Netherland) was used for all electrochemical 
analyses. Fine manipulation of the apparatus and better insulation from electromagnetic 
interference was provided by a circuit board built in house (Jules Hammond, Department of 
Electronic & Electrical Engineering, University of Bath, UK). Two platinum wires of 0.5 mm 
diameter, 99.95% pure (Advent, Oxford, UK) were used as a counter electrode and as a 
pseudo-reference electrode. The pseudo platinum reference electrode was used for practical 
reasons in the set-up; to allow easier measurements in the 24 µL volume of gel. 
 
2.2.2.7.4 Substrate glucose solution 
For glucose sensing experiments, stock glucose solutions were prepared in 0.1 M phosphate 
buffer pH 7.4 and left to mutarotate overnight at room temperature. GOD only catalyses the 
reaction with the β cyclic anomer of glucose. A glucose solution comprises about 64% of the 
β form at equilibrium [25]. If not used immediately, the glucose stock solutions and dilutions 
thereof were kept at 4˚C and, in any case, were used within two weeks of their preparation. 
Glucose stability was checked using the colorimetric enzymatic assay described in section 
2.3.2.1. 
2.2.3 Data analysis: glucose calibration curves 
2.2.3.1 Cyclic voltammetry 
For cyclic voltammograms, calibration curves were built for the oxidative signal in order to 
assess the proportionality of the current obtained with additions of glucose: catalytic current 
= f(glucose concentration). The catalytic current was taken at 0.7 V against the reference 
electrodes and subtracted to the control oxidative signal (obtained at 0.7 V with no glucose). 
The calibration curves were fitted with a linear regression and R
2
 calculated with Microsoft 
Excel following the statistic formula for the data points [26]: 




𝑆𝑆𝑇 = 𝑆𝑆𝐸 + 𝑆𝑆𝑅 
Where SSR is the regression sum of square; the variation explained by the linear relationship 




𝑆𝑆𝑅 =  ∑(𝑃𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑌 𝑣𝑎𝑙𝑢𝑒 − 𝑀𝑒𝑎𝑛 𝑌 𝑣𝑎𝑙𝑢𝑒)2 
And SSE is the error sum of squares; the variation associated with other factors besides the 
linear relationship: 
𝑆𝑆𝐸 =  ∑(𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑌 𝑣𝑎𝑙𝑢𝑒 − 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑌 𝑣𝑎𝑙𝑢𝑒)2 
From this point forwards all the calibrations data will be fitted with linear regression and R
2
 
calculated with Microsoft Excel in the same way. 
 
2.2.3.2 Chronoamperometry 
The catalytic current was approximated as the background-corrected current, averaged (over 
10 seconds) determined for each chronoamperometric step (plateau, i.e. equation 2.4). This 
allowed the calibration curves to be derived (catalytic current = f(concentration)) and to be 
fitted with linear regression (and calculated R
2
) as previously explained. 
 
 
2.2.4 Colorimetric enzymatic assay for control of the enzyme 
activity and glucose stability  
Glucose oxidase activity was regularly assessed using a standard colorimetric assay 
involving: horseradish peroxidase (POD). This test was also used to check glucose stability 
over time. The reactions involved are depicted in figure 2.4. 
  






Figure 2.4. Colorimetric enzymatic reaction for the quantitative analysis of glucose 
Glucose oxidase (GOD) and/or assessment of the glucose oxidase enzyme activity. 
reacts with glucose in the presence of oxygen producing H2O2 that then reacts with 
horseradish peroxidase (POD) and reduced o-dianisidine forming oxidised o-
dianisidine. This, in turn produces a more stable oxidised o-dianisidine that displays a 
pink colour in the presence of sulphuric acid which can be monitored 
spectrophotometrically giving a signal proportional to the concentration of glucose in 
solution. 
 
500 units of GOD and 100 units of POD were dissolved in milliQ water to a volume of 39.2 
mL. The o-dianisidine reagent was prepared at 5 mg/mL in milliQ water and added to the 
enzymatic solution forming the reagent mix. A series of glucose solutions were prepared 
from a standard of 1 mg/mL in 0.1% benzoic acid (benzoic acid is used here as a conservator 
for the glucose solution against degradation by microorganisms [27]). Their concentration 
were: 20, 40, 60 and 80 µg/mL plus a blank control. The reaction was started by adding 2 mL 
of the reagent mix to the glucose standards, the “unknown” sample and the blank. The 
reaction was allowed to proceed for 30 min at 37˚C and then stopped by adding 2 mL of 12 N 
H2SO4. The absorbance was read at 540 nm. For enzyme activity and glucose stability tests, 









2.3.1 Microscopy results 
2.3.1.1 LSCM imaging of GOD/micro-contact printed CVD graphene on 
Si/SiO2 
A CVD graphene sample deposited on Si/SiO2 was treated with 1-PBASE and stamped with 
fluorescently (FITC) labelled GOD. The pattern of the stamp comprised five lines (see figure 
2.5) showing good adhesion of the FITC labelled GOD to the 1-PBASE. 
 
. Figure 2.5. Micro-contact printing of FITC functionalized GOD on CVD graphene
The protein was successfully retained on the nanomaterial and the efficiency of the 
microcontact printing technique was demonstrated. The background auto-fluorescence 
acted as a control. 
  
 84 
2.3.1.2 LSCM imaging of FITC labelled GOD-coverage of the entire CVD 
graphene area 
FITC labelled GOD functionalization of a CVD graphene sample deposited on glass was 
imaged and displayed uniform fluorescence of the FITC labelled GOD (see figure 2.6). This 





 A: LSCM Figure 2.6. Functionalization of CVD graphene with FITC labelled GOD.
image of the protein coating (A1: fluorescent signal; A2: white light image; and A3: 
combination of A1+A2). B: Control P-BASE treated CVD graphene (i.e., without GOD). 
 
2.3.1.3 LSCM combined with microcontact printing as a tool for glucose 
sensing 
Fluorescein is fluorescently inactivated in acidic conditions [28]. When in the presence of 
glucose and under specific electrochemical conditions (0.7 V against a Ag pseudo-reference 
electrode), GOD reacts as shown in figure 2.7 leading to the production of 3 protons 




(displayed in red in figure 2.7), acidifying the nearby medium, and causing fluorescein 
fluorescence to decrease.  
 
 
catalytic reaction in the presence of Figure 2.7. Glucose oxidase reaction mechanism: 
β-D-glucose and under specific electrochemical conditions where H2O2 is oxidised at the 
working electrode (i.e., commonly 0.7 V against SCE). The protons produced that 
acidify the medium are depicted in red. 
 
 86 
To distinguish between the GOD enzyme and the pH conditions, GOD was coated with 
rhodamine, another fluorescent molecule which is insensitive to pH conditions, and a 20 µL 
phosphate buffer drop containing 20 µM of fluorescein put on top of the sample. Cyclic 
voltammetry was performed during fluorescent imaging to produce protons and change the 
pH conditions. Figure 2.8 shows rhodamine coated GOD micro-contact printed on CVD 
graphene (in red) and surrounded in fluorescein solution (in green). These results show that 
the rhodamine labelled GOD can be easily distinguished from the surrounding fluorescein 
solution. At high glucose concentrations, the fluorescence of the fluorescein was depleted 
close to where the GOD enzyme is immobilised indicating production of protons and 




Figure 2.8. Real time LSCM glucose sensing via GOD microcontact printing and 
. Glucose concentrations are: A: 0 mM; B: 5 mM; C: 10 mM; and cyclic voltammetry








2.3.2 Electrochemistry results 
2.3.2.1 Assessment of glucose stability in phosphate buffer (stored at 4 °C) 
Glucose solutions were stored for two weeks in phosphate buffer at 4 °C, while operating 
electrochemical experiments for practical reasons. It was therefore of importance to monitor 
the stability of such solutions over time. This was done by measuring a set concentration of 
glucose (0.054 mg/mL) stored at 4 °C after 2, 10 and 41 days with the colorimetric assay 
presented in section 2.2.4 and measuring the solution absorbance at a wavelength of 540 nm. 
Figure 2.9 presents calibration plots of glucose obtained via the colorimetric test with known 
amounts of fresh solutions of glucose (black curves representing 
absorbance=f(concentration)). The absorbance of the studied stored sample was then obtained 
and reported on the calibration curves in order to obtain the concentration for each of the 
analysed times. The results indicate that the sample concentration of glucose increases but 




Figure 2.9. Glucose stability in phosphate buffer pH 7.4 stored at 4 °C, over 41 
 Glucose concentration calibration curves vs absorbance (black curves) obtained days.
through a horseradish peroxidase/glucose oxidase colorimetric assay. The original 
sample concentration was fixed at 0.054 mg/mL and reported on the gradients. A: day 
2, B: day 10 and C: day 41 





























































































2.3.2.2 Response to glucose of CVD graphene electrode coated with GOD 
through an agarose gel 
The study was performed on samples (22 µL +/- 2 µL) of 0.5% agarose gel, to which 10 µL 
of buffer were added at the start of the experiment (the initial gel volume was therefore 
considered to be 32 µL +/- 2 µL and the glucose concentrations calculated accordingly). The 
gel was then placed on the GOD coated CVD graphene electrode. A cyclic voltammogram 
was then acquired before serial additions of glucose were made, after each of which another 
cyclic voltammogram was recorded (see figure 2.10). A more quantitative test was also 
undertaken by fixing the potential at 0.7 V against a Pt pseudo-reference electrode and 
measuring the variation of current with each glucose addition as a function of time, in a 




Figure 2.10. Response of a GOD coated CVD graphene electrode (via 1-PBASE) to 
. Cyclic voltammograms demonstrate a clear serial glucose additions in agarose gel
increase in current with additions of glucose concentration at 0.7 V vs RE. The scan rate 
was 20 mV/sec, and the results were acquired after 3 scans. The insert is a calibration 
graph displaying the oxidative H2O2 current (at 0.7 V vs the platinum pseudo reference 
electrode) produced as a result of the enzymatic reaction, function of glucose 
concentration added in the gel.   


















Potential (V) vs Pt pseudo reference electrode
 






















































Figure 2.11. Chronoamperometric results from a GOD coated CVD graphene 
 Data electrode (via 1-PBASE) to serial glucose additions (arrows) in agarose gel.
were acquired at 0.7 V against a Pt pseudo reference electrode for H2O2 oxidation 
detection. The insert is a calibration graph presenting the catalytic current acquired as 
a function of the glucose concentration added in the gel. The sensor response is linearly 





Figures 2.10 and 2.11 clearly show the current to increase upon addition of glucose to the 
agarose gel. This indicates that the H2O2 produced in the glucose oxidation can be directly 
detected using electrochemical methods and the response is linear with respect to the 
concentration of glucose. 
 
2.3.2.3 Response to glucose of GOD entrapped in an agarose gel 
Figures 2.12 and figure 2.13 show, respectively, the cyclic voltammetry and 
chronoamperometry results obtained with GOD entrapped in agarose by the method 
described as Entrapment 1. The previous experiment showed that GOD immobilised onto the 
surface of the CVD graphene gave a good response to glucose additions. It is hoped that by 









































dispersing the enzyme in the gel, glucose could reach the enzyme active area from all sides 
whereas when it is immobilised on the graphene surface, glucose can only reach the top 
surface of the enzyme. Furthermore, this entrapment technique will allow an important 








Figure 2.12. Cyclic voltammograms obtained in response to serial additions of 
 glucose to GOD (6 mg/mL) entrapped (by method Entrapment 1 . ) in an agarose gel
The scan rate was 20 mV/sec, and the results were acquired after 3 scans. The insert is a 
calibration graph displaying the oxidative H2O2 current (at 0.7 V vs the platinum 
pseudo reference electrode) produced as a result of the enzymatic reaction, function of 
glucose concentration added in the gel. 
  

















Potential (V) vs pt pseudo reference electrode
 


























































Figure 2.13. Chronoamperometry acquired in response to serial additions of glucose 
(orange arrows) to GOD entrapped (Entrapment 1 A: The glucose ) in an agarose gel. 
concentration in the gel ranged from 1.22 to 2.78 mM. B: The glucose concentration in 
the gel ranged from 0.125 to 0.66 mM. Blue arrows indicate additions of (blank) 
phosphate buffer. Data were acquired at 0.7 V against a Pt pseudo reference electrode. 
The inserts are calibration graphs presenting the catalytic current acquired as a 
function of the glucose concentration added in the gel. Again the signal fits linearly to 
the concentrations (especially in B, with an R
2
 of 0.9887 for the linear regression of the 
calibration curve). 






















































































Figures 2.12 and 2.13 show a much better response to glucose additions with the currents 
being larger and less noisy with glucose additions. The entrapment method has clearly proven 
to be a better technique for GOD immobilisation and glucose detection. 
 
2.3.2.4 Correlation of signal intensity with enzyme concentration entrapped 
in the gel 
The intensity of the signal obtained from gels containing 0.21 and 6 mg/mL of enzyme were 
compared. Figure 2.14 demonstrates the direct correlation between the signal intensity 
observed with cyclic voltammetry and the level of enzyme present with the current measured 
increasing 22.2 times from the 0.21 mg/mL to the 6 mg/mL GOD concentraion. 
 
 
Figure 2.14. Correlation between signal intensity and enzyme concentration in the 
A. Cyclic voltammetry obtained with GOD and glucose added on top of 32 µL+/- 2 gel. 
µL piece of gel. B. Cyclic voltammetry obtained with GOD entrapped following 
“entrapment 1” and with glucose additions. The scan rate was 20 mV/sec, and the results 
were acquired after 3 scans. The inserts are calibration graphs displaying the oxidative 
H2O2 current (at 0.7 V vs the platinum pseudo reference electrode) produced as a result 
of the enzymatic reaction, function of glucose concentration added in the gel. 





















Potential (V) vs Pt pseudo reference electrode

















Potential (V) vs pt pseudo reference electrode
Current ̴ ×22.2 
A. GOD concentration: 0.21 mg/mL 
 






















































































































2.3.2.5 Glucose oxidase non-covalently coated on the surface and entrapped 
inside the gel 
Next, serial additions of glucose were made to a GOD/1-PBASE coated graphene sample, 
and with GOD entrapped in the gel as well. Combining the two different immobilisation 
techniques should increase the signal as there is now twice the amount of enzyme; on the 
surface and in the gel. Figure 2.15 presents the chronoamperometric results again acquired at 






Figure 2.15. Chronoamperometry acquired in response to serial additions of glucose 
(orange arrows) to GOD coated on the surface and entrapped in the agarose gel (by 
method Entrapment 1  Blue arrows indicate additions of (blank) phosphate buffer. ).
Data were acquired at 0.7 V against a Pt pseudo reference electrode. The insert is a 
calibration graph presenting the catalytic current acquired as a function of the glucose 
concentration added in the gel. The signal also fits linearly the concentrations here with 
an R
2
 of 0.9787 for the linear regression of the calibration curve. 
 
Figure 2.15 shows the current to increase further compared to only entrapping the enzyme in 
the gel indicating that the increase in the amount of GOD does have a direct effect on the 
currents measured as shown in section 2.3.2.4. 










































2.4.1 LSCM characterisation of the transducer functionalization  
The efficiency of the 1-PBASE functionalization of GOD was demonstrated (figure 2.6-A). 
LSCM revealed homogeneous fluorescence originating from the enzyme deposited on the 
nanomaterial (in contrast to the glass background, figure 2.6-B). Furthermore, the micro-
contact printing of FITC labelled GOD on graphene was also effectively imaged by LSCM: a 
scan of micro-contact printed GOD on graphene that displayed fluorescent lines 
(distinguished from the graphene autofluorescent background) was obtained (figure 2.5). A 
patterned deposition of enzyme was confirmed. Then, a real-time glucose sensing was 
achieved by combining bioelectrochemistry with micro-contact printing and LSCM 
visualisation (figure 2.8). This detection takes advantage of the pH sensitivity of fluorescein 
and the reaction displayed in figures 2.7. During the reaction of glucose and glucose oxidase 
in oxygenated conditions and at an appropriate potential for the oxidation of the produced 
H2O2, 3 protons are produced. These will cause a local acidification of the medium and hence 
a decrease of fluorescence around the enzyme visualised in red in figure 2.8 (labelled with 
rhodamine). This phenomenon is demonstrated in figure 2.8-A and figure 2.8-D. An excess 
of glucose (>2 M) will cause a significant decrease of fluorescence around the rhodamine 
labelled GOD. The catalytic activity of the enzyme was hence visualised with a proof of 
concept technique. Although fluorescein’s pH dependent behaviour had previously been used 
in sensor devices [29], and combined with electrochemistry [28], these results are the first to 
combine micro-contact printing, enzymatic/electrochemical sensing, and LSCM for real time 
imaging and detection of GOD activity on graphene. The experiment however suffered some 
drawbacks: (1) the potential was not fixed at the oxidation voltage of H2O2 but cycled. (2) 
Although a neat decrease of fluorescence was observed when adding an excess of glucose 
(figure 2.8-D), the fluorescence decay obtained in figure 2.8-B and figure 2.8-C were 
inconsistent with the glucose concentration added (5 and 10 mM respectively), the first 
fluorescence decrease being more intense than the second. This inconsistency might be 
explained by the diffusion of fluorescein in the buffer or the poor sensitivity of the detection. 
(3) The results were obtained from a single experiment. The aim of the thesis being the 
development of a non-invasive sensing glucose sensing platform, the direct visualisation and 
sensing of glucose was not studied further.  
 95 
2.4.2 Electrochemical characterisation of the transducer 
functionalization 
Figure 2.9 is a confirmation study of the stability of glucose stored in phosphate buffer pH 
7.4 at 4 °C, over more than a month. This was done previous to chronoamperometric 
experiments in order to confirm the accuracy of the concentrations used and investigated in 
the rest of the experiments. The standard deviation obtained between the three measured 
concentrations was of 0.0025 mg/mL (i.e., 13.9 µM). This value only represents a total 
variation of 4.6% of the original sample concentration. The glucose solutions storage protocol 
is therefore appropriate for the rest of the analysis.  
 
Figures 2.10 and 2.11 are first electrochemical demonstrations of catalytic activity with 
addition of glucose on a graphene electrode non-covalently functionalised with GOD and 1-
PBASE. The additions were done in an agarose gel volume of 32 µL +/- 2 µL. The inserts of 
the respective figures display a linear increase of the catalytic current with additions of 
glucose. However the response current were relatively low (over 10 nA range), the signal was 
relatively noisy at low concentration of glucose and the chronoamperometric steps were not 
well-defined (figure 2.11). This suggested that the non-covalent coating of the electrode 
achieved was not optimal.  
 
In an attempt to improve performance, the protein was entrapped inside the agarose gel. The 
device presented in figure 2.13 displayed an almost doubled catalytic oxidative current at 0.7 
V vs a Pt pseudo reference electrode (1 mM of glucose gave a current of ~ 0.0057 µA in 
figure 2.11 while ~ 0.0123 µA was obtained in figure 2.13-A, providing an increase of ~2.17 
times). Figure 2.13 also display linear calibration curves in two concentration ranges (1.22 to 
2.78 mM in figure 2.13-A and 0.125 to 0.66 mM in figure 2.13-B). The chronoamperometric 
steps obtained in response to the glucose additions were also more defined than in figure 
2.11. Both the stability and increase of the signal made the gel entrapment an appropriate 
design for the development of the sensor.  
 
Figure 2.14 is a study of the effect of the concentration of GOD in the gel on the catalytic 
current with additions of glucose. Although the entrapment was slightly different, the 
outcome was an increase of oxidative current observed at 0.7 V against a Pt pseudo reference 
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electrode of ~ 22.2 between the low and high concentration of enzyme (the respective 
catalytic currents obtained for 1 mM of glucose were ~ 0.0011 µA for the lowest 
concentration of enzymes; figure 2.14-A and ~ 0.0244 µA for the highest concentration; 
figure 2.14-B). This value was in good agreement with the ratio of GOD concentrations: 28.6. 
The signal correlated therefore well with the amount of enzyme present.  
 
Then the combination of both entrapment and electrode coating of the protein (figure 2.15) 
was also shown to improve the oxidative catalytic signal (the current for 0.5 mM of glucose 
was ~ 0.00325 µA and ~ 0.0224 µA for figure 2.13-B and figure 2.15 respectively). The 
GOD gel entrapment technique was hence selected for further analysis providing with a 
strong catalytic signal towards glucose. It is also an appropriate technique for implementation 
in a future non-invasive sensing design because the protocols involved are cheap and simple, 
the electrodes can be stored under ambient conditions and the gel platform will be adapted for 
extraction of glucose from the skin as demonstrated in chapter 5. The addition of the non-
covalent technique to gel entrapment could however be studied in future work in an effort to 
improve the sensor signal. 
 
Finally the use of agarose is justified by its’ cheap price, its’ availability and the simplicity to 
of its’ gelling protocols and enzyme entrapment. It does however suffer some major issues 
that would need addressing in the future: (1) the enzyme is not fixed inside the gel but 
dissolved in the buffer of the hydrogel and will eventually diffuse out of the matrix, (2) being 
an hydrogel the structure is prone to dry under ambient conditions which will be the cause of 
problems in the development of the technology (in chapter 5 especially). Other gels have 
been used in the literature to entrap glucose oxidase in biosensing configurations. Table 2.1 
enumerates some of the gels found in the literature along with their “enzyme entrapment 
properties”. The focus here was however not placed onto the study of different gel 
formulation for the sensor but rather on the research of the best sensing operation (see chapter 
3) and the optimisation of the sensor via miniaturization and addition of platinum 
nanoparticles (see chapter 4) in order to obtain a performant and adequate platform for non-






Table 2.1: Comparison of gel enzyme “entrapment properties” for some glucose 





Silica-dispersed GOD on platinized 
platinum (Pt) 
“Clark type amperometric sensor” 
Silica sol-gel 
 Maintain the enzyme 
stability 
 Reduced barrier to 
glucose diffusion  
[30] 
polypyrrole-polystyrensulfonate (PPy) 
embedded in polyacrylamide (PA) 





 Inclusion of 
polypyrrole to facilitate 
electron transfer 
 Enzymatic activity 
preserved for at least 
nine months 




Platinum/carbon ink electrode 









e and copolymers  
 Water loss from the 
gel: less than 70 % 
over 24 hours 
 Stability of the 
produced H2O2 (loss of 
H2O2 less than 20 % 
over 30 minutes) 




CVD graphene sensor, 
GOD embedded in the gel 
agarose 
 Fast and easy 
production 
 High diffusion 
coefficient of glucose 
in agarose gels (0.5 %) 
∼6 × 10-10 m2/s [33] 
 Conservation of the 
enzyme catalytic 
activity (see kinetic 
enzymatic parameters 
(Km) determined in 





This chapter investigated one of the fundamental attributes of the development of a 
biosensor: the functionalization of the transducer with enzymes. The first presented technique 
involves non-covalent coating on graphene (covalent attachment of the GOD) via a linker: 1-
PBASE. The enzyme coverage of CVD graphene was successfully demonstrated by LSCM 
with the GOD labelled with fluorescein (either on the entire surface of the electrode or in a 
patterned manner with the application of microcontact printing). The catalytic activity of this 
functionalization was assessed using real time sensing/LSCM visualisation and 
electrochemical measurements. This was an initial demonstration of glucose sensing, but due 
to lack of sensitivity at low concentration of glucose and because the design didn’t fit the 
purpose of the project, the analysis wasn’t carried further.  
 
The later electrochemical evaluation of the activity performed via cyclic voltammetry and 
chronoamperometry displayed linear but small catalytic currents. Therefore the non-covalent 
coating that was used in this chapter as well as chapter 3, was replaced by GOD entrapment 
in an agarose gel. This second technique of sensor design demonstrated increased and linear 
oxidative catalytic signal, it was therefore selected as a good platform for the future non-
invasive sensing application. Finally and even though the combination of both techniques 
was beneficial to the chronoamperometric signal, the latter technique was preferred for the 
design of the sensor and non-invasive integration described in chapter 4 and 5. 
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Third generation biosensors (that rely on the direct electron transfer from the enzymatic active catalytic 
centre to the transducer) [1], or enzymeless glucose detection using transducer materials such as nanoporous 
gold [2] or silver oxide nanowalls [3] have been presented in the literature but will not be investigated further. 
Chapter 3: Biosensor design and 
detection principles 
3.1 Introduction 
This chapter investigates the detection principle of two setups: (1) a potentiometric design: 
field effect transistor and (2) an electrochemical (voltammetric/amperometric) design. The 
latter was separated in two categories: a mediated detection using a redox mediator (second 
generation biosensor) and a direct sensing of the enzymatically produced H2O2 (first 
generation biosensor). Two additional sensing principles have been investigated in the 
literature: direct enzymatic oxidation and non-enzymatic sensing. These won’t however be 
the subject of the presented work, (see 3.α footnote). [1] [2] [3] 
3.1.1 BioFET 
A biological field effect transistor (BioFET) is able to detect small induced ionic variations in 
a solution as a result of (for example): (1) a change in gating potential due to a catalytic 
reaction product; (2) surface polarization effects or changes in dipole moment during DNA 
hybridisation or antigen/antibody immunoreaction; or (3) the complicated biochemical 
signals emitted by living cells. Clearly, the first category of BioFET is of most interest in this 
work, the so-called EnFETs (enzyme field effect transistor). EnFETs were first introduced in 
1976 [4] and, included among the many enzymes studied, GOD. Several limitations have 
been noted, however, relative to their implementation: (i) buffer capacity and ionic strength 
of the solution can impact greatly on protonic detection, (ii) the sensors presents slow 
response and recovery times, (iii) the detection limit and linear range of ENFETs are not 
optimal, (iv) stability on storage and repeatability can be problematic and (v) the performance 
is very sensitive to enzyme immobilisation and patterning which are often far from optimal 
on silicon substrates [5]. 
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The introduction of CVD graphene as a zero-gap semiconductor in the EnFET design was 
anticipated to solve at least some of these problems. One example of where graphene field 
effect transistors have been used in glucose detection is shown in [6]: A FET sensor made of 
graphene fonctionalised with a linker molecule (1-pyrenebutaoic acid succinimidyl ester) and 
immobilising GOD onto the surface of graphene was presented. The device could detect 
glucose levels in the range of 3.3-10.9 mM showing that CVD graphene FET devices are 
good biosensors. 
3.1.2 “Bio”electrochemistry 
The other detection platform is electrochemistry based. Several enzyme-based amperometric 
biosensors have been developed in the past 20 to 30 years including, of course, those with 
GOD [7]. GOD reacts with its β-D-glucose substrate producing H2O2 (chapter 2, figure 2.7), 
which is then oxidised at the WE (e.g., platinum [8] or glassy-carbon [9]) to generate an 
analytical current. On a Pt working electrode, H2O2 is oxidised at a potential between 0.5 and 
0.7 V against a saturated calomel electrode [10]. A glucose sensor based on the direct 
electrochemistry of H2O2 at a graphene electrode was described in [11] with a linear glucose 
response up to 14 mM. This “first generation” detection of H2O2 is presented further.  
 
An attempt at the development of a “second generation” sensor involving the use of a redox 
mediator is also investigated. 1,1-Ferrocenedimethanol (FDM) is a commonly used, 
electroactive mediator that facilitates electron transfer. Sensors using a redox mediator 
instead of molecular oxygen have been thoroughly studied and exploited over the past 30 
years. Some of the most common redox mediators found in electrochemical biosensors are: 
ferrocene, ferricyanide, benzoquinones and methyl viologen. Redox mediators can be 
classified as either “inner” or “outer” sphere depending on their electron transfer properties. 
“Outer” sphere electron transfer is the most common in biological systems and is defined by 
electron passage between two non-connected redox entities separated by a few Ångstroms 
[12]. Electron transfer is highly dependent on the distance separating outer sphere redox 
entities as described by equation 3.1, derived from Marcus theory on electron transfer [12]: 
 kET =  k0exp [−β(d − d0)] 
kET is the rate constant for outer sphere electron transfer, k0 is the electron transfer rate at the 
closest distance d0, d-d0 is the distance between the two entities and β the distance decay 
factor, typically in the range of 0.8 to 1.4 Å-1 [12, 13]. β depends on the nature of the 
(3.1) 
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heterogeneous region between donor and acceptor of the electron: Electrons go through some 
materials in an easier way than others which is reflected in β [13].  
In contrast, “inner” sphere electron transfer involves chemical bonding between the mediator 
and the electrochemical active site for the transfer to occur before the bond is cleaved to 
regenerate the mediator and substrate (being either oxidised or reduced) [14]. Typically, 
ferrocene has been described as an outer sphere redox mediator with respect to the catalytic 
activity of glucose oxidase [15], whereas benzoquinones are examples of inner sphere 
mediators [16]. The use of redox-mediators in second generation biosensors has significant 
advantages such as increasing electron transfer, shifting the electrode potential at which the 
redox signal is detected, and removing the oxygen dependence [17]. The latter, however also 
have negative consequences, specifically that involves working in anaerobic conditions to 
avoid oxygen competition with the mediator for the electron transfer [18, 19].  
 
Some mediators are also toxic; for example methyl viologen can be converted into paraquat 
in solution, a compound which can have deleterious effects on the lungs, liver, kidneys and 
other organs [20]. To achieve optimal mediation, it is necessary to entrap the mediator with 
the enzyme, either in a hydrogel matrix [21] or even by covalent attachment to the enzyme 
[22]. Furthermore, an appropriate redox mediator must present the following characteristics: 
(1) a well-defined redox stoichiometry, (2) fast enzyme and electrode kinetics, (3) appropriate 
solvent solubility and redox/light stability, (4) no alteration of enzyme redox potential and (5) 
an adequate redox potential itself [23]. The latter must be such as to avoid other electro-active 
(interfering) species being oxidised or reduced at the electrode. FDM has a near reversible 
redox signal at a potential of 0.20 to 0.24 V versus Ag/AgCl [24]. It is very unlikely that 
common interfering molecules for the physiological detection of glucose such as ascorbic 
acid, uric acid or acetaminophen will be oxidised at this low potential [25]. FDM is water-
soluble, is stable in the reduced form, insensitive to light and pH, with fast and quasi-
reversible electron transfer. It is suitable for combination with enzymatic electrochemistry 
[26]. This redox species was therefore selected as a potentially useful mediator in this study.  
3.1.3 Reduction of the receptacle volume 
A final key objective of this chapter was the demonstration of the scaling down of the volume 
of the reaction reservoir. The rationale is self-evident: to facilitate mass transfer of the analyte 
to the sensor. Attention has therefore been focused on reducing the dimensions of the 
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electrochemical set-up combining a working graphene electrode with a small gel or liquid 
reservoir and wire, micro counter and reference electrodes (the gel design were already 
presented in chapter 2, sections 2.3.2.2 to 2.3.2.5).  
3.2 Materials and experimental methods 
3.2.1 Materials 
Most of the materials are the same as the ones described in chapter 2, section 2.2.1. 
Additional includes: Silver (Ag), platinum (Pt) wires and gold pellets purchased from Advent 
(Oxford, UK). A Keithley 487 picoameter/voltage and a Keithley 230 programmable voltage 
source (Keithley instruments, Cleveland, OH, USA) were used as voltage and current 
controller in the transistor setup. 1,1-Ferrocenedimethanol (FDM), Ferrocene carboxylic acid, 
(2-aminoethoxy) acetic acid were obtained from Sigma-Aldrich (Dorset, UK). A SCE 
reference electrode was acquired from Radiometer Analytical (Lyon, France). The 
potentiostat used in the electrochemical experiments were Autolabs from Metrohom (Utrecht, 
The Netherland) except in figure 3.9 where an Ivium technology, CompactStat instrument 
(Eindhoven, The Netherland) was used. An AFM, Asylum Research (High Wycombe, UK) 
MFP-3D microscope was used for microscopic imaging of transferred CVD graphene. 
3.2.2 Experimental methods 
3.2.2.1 AFM imaging: CVD graphene microscopic visualisation 
Atomic Force Microscopy images were acquired in tapping mode, using AC240TS-10, 
medium soft cantilevers from Olympus (Asylum Research, High Wycombe, UK). The tip 
approach was carefully monitored through a video camera and an optical microscope. The 
acquisition was controlled via the MFP-3D software provided (Asylum Research, High 
Wycombe, UK). The CVD graphene visualised had been transferred following the protocol 
presented in chapter 2, section 2.2.2.1. 
 
3.2.2.2 CVD graphene transfer and GOD functionalization 
See chapter 2, section 2.2.2.1 and section 2.2.2.2. 
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3.2.2.3 FET transistor  
 
3.2.2.3.1 FET design 
Conduction source (S) and drain (D) silver paint connection pads were deposited on graphene 
leaving a semiconductor conductive channel of ~ 1-2 mm (graphene flake dimensions were ~ 
7×7 mm
2
 ). Silicone rubber was deposited on the silver paint contact and formed an 
insulating “well” into which 20 µL of 0.1 M phosphate buffer pH 7.4 was introduced. A 
silver or platinum wire was used as a gate (G). The FET design is shown in chapter 1, figure 
1.13.  
 
3.2.2.3.2 FET results acquisition 
During the acquisition, VSD (Voltage Source to Drain) was set at 0.2 V and VGD (Voltage gate 
to Drain) varied between -0.4 V and 0.8 V with voltage sources mentioned in the material 
section. Data were recorded using a LabView program written by Gavin Jones, Department 
of Physics, University of Bath. The acquisition measured ISD = f(VGD). 
 
3.2.2.4 Electrochemical design 
 
3.2.2.4.1 First generation sensing: detection of H2O2 
The enzymatic coating, electrode design and electrochemical setup were the same for first 
generation and second generation sensing. The only variations are the addition of a mediator 
in the reaction receptacle or ferrocene coating in the second generation sensing experiments 
(see section 3.2.2.4.2). 
 
The electrodes used for first generation sensing were functionalised with GOD as described 
in chapter 2, section 2.2.2.2. The electrochemical cell comprised three electrodes: a SCE or 
Ag pseudo reference electrode acting as a RE, a platinum wire for CE, and a working 
electrode made of CVD graphene (3×3 mm
2
) deposited on silicon dioxide and non-covalently 
functionalized with GOD. Electrical conduction was achieved by evaporating titanium and 
gold (10 nm and 60 nm respectively) onto a part (approximately 1/6
th
) of the graphene flake. 
The active area of functionalized graphene was insulated via a layer of silicone rubber. As 
mechanical stirring was not optimised, the system relied on diffusion to attain equilibrium. 
An SCE electrode was first chosen for large volume electrochemistry, because it was made 
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available in the beginning of the project and adapted to the measurements. However with the 
decrease of the set-up dimensions (40 µL in figure 3.12) it was replaced by a pseudo Ag 
reference electrode which was more appropriate for manipulations. With improvement of the 
set-up this pseudo reference electrode will be replaced by an Ag/AgCl micro reference 
electrode as described in chapter 4. Glucose solutions used to test the sensor were allowed to 
mutarotate overnight at 4 °C before the electrochemical experiment. The electrochemical cell 
volumes were 21 mL for figure 3.7 and 8 mL for figure 3.9 to 3.11 and 40 µL for figure 3.12. 
Glucose calibration curves were obtained as described in chapter 2 section 2.2.3. 
 
3.2.2.4.2 Second generation sensing: use of ferrocene as a redox mediator 
A solution of 50 µM ferrocene dimethanol (FDM) in 0.1 M phosphate buffer pH 7.4 was 
used in figure 3.7 to detect glucose on a graphene electrode non-covalently coated with GOD. 
For the experiment displayed in figure 3.8, one step was added to the electrode treatment 
described in chapter 2, section 2.2.2.2 with the introduction of a ferrocene-amine compound 
synthesized from ferrocene-carboxylic acid and 2.2’-(Ethylenedioxy)bis(ethylamine) 
following the reaction displayed in figure 3.1 (supplied by Sean Goggins, Department of 
Chemistry, University of Bath). The newly synthetized compound was incubated with the 
GOD coated electrode at 0.27 mM for one hour, at room temperature, in a mixture of 1% 
DMSO and phosphate buffer pH 7.4, for coupling with the free 1-PBASE linkers on the 
electrode. The reaction between the succinimidyl ester of the linker and the amine of the 
compound is described in chapter 2, figure 2.2. 
 




3.3.1 AFM imaging of CVD graphene transferred onto Si/SiO2 
Graphene was transferred onto a Si/SiO2 substrate using the wet etching and transfer method 
outlined in chapter 2 section 2.2.2.1. Figure 3.2 shows AFM images taken after this transfer 
process had taken place to look at the surface morphology. It can be seen that there are both 
monolayer and multilayer regions on the graphene flake as well as folding of the flake. Figure 
3.3 shows a height profile of the flake and the expected region of monolayer has a height of 
0.445 nm which is close to the expected height for graphene of 0.34 nm reported in the 
literature [27]. Discrepancies in these values could be due to a water layer between the flake 
and the Si/SiO2 substrate originating from the wet transfer technique used to place the flake 
on the substrate. Residues from the wet transfer technique are also evident from the AFM 
images as white lines appearing across the substrate which could be left over PMMA as well 
as drying circles. 
 
 
 A: original image. B:Figure 3.2. CVD graphene transferred onto Si/SiO2. specific  
patterns observed after the transfer procedure (i.e., folds, monolayer graphene, 
multilayer graphene and drying circles). The blue region presents a height of ~ 0.445 
nm and is expected to be monolayer.  
Monolayer CVD graphene 








 This height profile graph was obtained Figure 3.3. Height profile of CVD graphene.
by analysing the AFM picture with the MFP 3D software (Asylum Research). The 
graphene thickness (presented between + and × on this figure and on figure 3.1) is an 
approximation and not a complete study of the structure of CVD graphene. It gives an 
indication of the representative graphene height. 
3.3.2 Field effect transistor setup 
3.3.2.1 Displacement of CVD graphene Dirac point as a function of solution 
pH 
The graphene transistor coated with GOD was first tested with 0.1 M phosphate buffers at 
different pHs. Figure 3.4 to 3.6 presents ISD = f(VGD). The lowest ISD point on the curve is the 
Dirac point of the semiconductor and is displaced as a function of pH or H
+
 production in the 
enzymatic reaction between GOD and glucose. There is a noticeable hysteresis in figure 3.4, 
in the gate sweeps which is most likely to be caused by defects in the nanocarbon surface. It 
can be seen, in this figure, that the Dirac point shifts to higher gate potentials at lower pH 
phosphate buffer showing this to be a sensitive technique for studying pH changes on the 
surface of graphene. 




















Graphene height between + (on the 
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Figure 3.4: Displacement of the Dirac point of a GOD coated CVD graphene FET as 
. A range of pHs (0.1 M phosphate buffer) was tested on a CVD a function of buffer pH
graphene FET functionalized with GOD and the ISD and was reported as a function of 
VGS. A slight hysteresis was observed between the forward signal (red arrow) and the 
reverse signal (blue arrow). The hysteresis is most likely caused by defects at the 
nanocarbon surface [28]. A noticeable trend was observed between each ISD = f(VGS) pH 
curves, displaying a shift in the Dirac point (lower ISD) towards high VGS. 
 
3.3.2.2 ISD = f(VGD) with CVD graphene non-covalently coated with GOD 
Figure 3.5 displays the differences in the FET signal obtained with GOD functionalization. 
The bare CVD graphene electrode (green line) has a Dirac point of 0.25 V, whereas when the 
GOD enzyme was non-covalently attached to the graphene surface, the Dirac point shifted by 
0.07 V to a higher gate potential. This change in the Dirac point gives a clear indication of 
adsorption onto the surface of graphene changing the electronic properties of graphene.  
 
 






























 This figure presents Figure 3.5. ISD = f(VGD) for graphene coated or not with GOD.
the shift in the Dirac point with non-covalent addition of GOD via 1-PBASE coating. A 
remarkable shift of around 0.07 V was observed between the bare graphene Dirac point 
and the GOD functionalized nanomaterial Dirac point. 20 µL of 0.1 M phosphate buffer 
pH 7.4 was used in this experiment. 
3.3.2.3 GOD functionalized FET signal with glucose additions 
The effect of different glucose concentrations was then studied by adding glucose at two 
different concentrations to the GOD/1-PBASE FET sensor. The Dirac point shifted at higher 
gate potentials with higher concentrations of glucose indicating that the production of 
protons, produced through the glucose oxidation, increases the pH and therefore shifted the 
Dirac point to higher potentials (see figure 3.6). The pH effect was already confirmed in 
figure 3.4 and shows the FET glucose sensor to be very effective at detecting glucose. 
 
A 10 µL drop of Figure 3.6. Glucose additions on a graphene FET coated with GOD. 
0.1 M phosphate buffer pH 7.4 served as the buffer/supporting electrolytes solution and 
was replaced for each glucose concentration. A shift of the Dirac point was observed 
towards higher VGD was proportional to the amount of glucose added to the system.  
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3.3.3 Electrochemical setup 
3.3.3.1 Second generation sensing 
Cyclic voltammetry was performed on the GOD functionalised graphene electrode with 
different amounts of glucose added to the FDM solution (21 mL). The electrochemical 
response to additions of glucose, in the presence of 50 µM FDM in 0.1 M phosphate buffer 
(pH 7.4) is shown in figure 3.7. There is a clear peak at ca. 0.5 V (vs. SCE) which can be 
attributed to the oxidation of ferrocene dimethanol. The peak, however, decreases upon 
addition of glucose indicating that glucose oxidation is inhibiting the oxidation of FDM. 
 
Figure 3.7. Signal detected on a GOD functionalised graphene electrode in response 
  to additions of glucose to a FDM solution. The scan rate was 100 mV/sec.
In order to improve the ferrocene signal, ferrocene-carboxylic acid was reacted with (2-
aminoethoxy) acetic acid according to the equation displayed in figure 3.1. The ferrocene 
mediator presented in figure 3.1 was then coated next to the enzyme to induce more efficient 
electron transfer by covalently bonding with free 1-PBASE linkers (figure 3.8). Tethering the 
redox mediator to the graphene surface means the ferrocene mediator is within close 
proximity to the GOD enzyme and it enables better electron transfer.  
Figure 3.9 demonstrates cyclic voltammogram signals upon addition of glucose to the 
ferrocene-amine coated graphene electrode. The CVs were acquired in 8 mL of 0.1 M 
phosphate buffer drop (pH 7.4) to which glucose was added in varying concentrations. Again 
there is a peak at 0.5 V (vs SCE) corresponding to the ferrocene complex oxidation, however, 
no significant change in the signal is seen for different glucose concentrations. As the 
ferrocene-mediated detection did not display a significant catalytic signal, a simpler first 
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generation glucose biosensor (i.e., one relying on hydrogen peroxide with respect to redox 
detection) was tested in the next section (see figure 3.10). 
 
Figure 3.8. Ferrocene derived mediator (in blue) coated on “free” 1-PBASE linkers 
  (in orange) alongside GOD coated with the same linker.
 
Figure 3.9. Response to glucose on a graphene electrode functionalised with GOD 
and 0.27 mM ferrocene-amine at a scan rate of 20 mV/sec. A small redox signal 
corresponding to ferrocene is observed at 0.5 V and 0.1 V vs SCE for the oxidation 
and reduction respectively. However no significant current change is observed with 
additions of glucose. 
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3.3.3.2 First generation sensing 
 
3.3.3.2.1 “Large volume” electrochemistry 
First generation sensing relies on detection of hydrogen peroxide produced during glucose 
oxidation. Figure 3.10 presents cyclic voltammetric results obtained following successive 20 
µL additions of a concentrated glucose solution (500 mM in phosphate buffer pH 7.4) in 8 
mL. An increase in the catalytic oxidative signal was identified at 0.7 V vs SCE with 
additions of glucose. Although lacking of linearity as displayed in the insert of figure 3.10, 
the increase of current seemed to be caused by the reaction of glucose with GOD producing 
H2O2 oxidised at the electrode. This was confirmed in figure 3.11 where serial additions of 
H2O2 were made on a bare CVD graphene electrode and the oxidative peak profile resembles 









Figure 3.10. Response to glucose on a graphene electrode functionalised with GOD 
 The bulk and detected via the redox properties of the enzymatically produced H2O2.
solution was stirred mechanically. The insert is a calibration curves presenting 
oxidative current = f(glucose concentration) at 0.7 V against SCE. The scan rate was 20 
mV/sec. 
 
Figure 3.11. Cyclic voltammetry on a bare (i.e., no GOD) CVD graphene electrode 
. A characteristic as a function of H2O2 concentration in an 8 mL electrochemical cell
oxidative signal is observed at ~ 0.7 V against a SCE. The scan rate was 20 mV/sec. 
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3.3.3.2.2  “Small volume” electrochemistry 
To facilitate mass transfer of glucose to the electrode, the volume of the electrochemical 
‘cell’ was reduced to 40 µL (0.1 M phosphate buffer pH 7.4). Figure 3.12 illustrates the 
cyclic voltammetric results obtained on a series of 40 µL drops containing increasing 
concentrations of glucose. The graphene flake was non-covalently coated with 1-PBASE and 
GOD. It again shows the characteristic H2O2 oxidation peak at ca. 0.7 V (vs Ag pseudo 
reference) which increases upon addition of glucose to the solution. The inset graph shows a 
clear linear trend of glucose concentration versus current measured indicating that the small 









Figure 3.12. Cyclic voltammetry on a graphene electrode, non-covalently 
functionalised with GOD, as a function of glucose concentration in an 
 The reference electrode was an Ag wire acting as a “electrochemical cell” of 40 µL.
pseudo-reference electrode, the counter electrode was a Pt wire. The scan rate was 20 
mV/sec. (The Ag wire  was not ideal and was replaced by Pt in chapter 2 and 4 and later 
an homemade Ag/AgCl micro reference electrode because GOD is inhibited by metal 
ions (and especially Ag
+
) in solution [29]). 
  


















Potential (V) vs Ag pseudo reference electrode
 



































































3.4 Discussion  
3.4.1 AFM imaging of CVD graphene transferred on Si/SiO2 
Figure 3.2 is a visualisation of a typical graphene sample transferred onto CVD graphene 
following the protocol exposed in chapter 2, section 2.2.2.1 and obtained via Atomic Force 
Microscopy. It displays several features identified as: monolayer graphene, multilayer 
graphene, foldings and drying circles. The blue region on figure 3.2 was estimated to be 
monolayer since its thickness (between this region and the wafer) was measured as 0.445 nm 
(figure 3.3).  
 
The starting point of this thesis is the integration of chemical vapour deposited (CVD) 
graphene into a glucose sensing device. The reason behind the choice of graphene over other 
already studied electrode materials (glassy carbon, platinum, gold and, more recently, carbon 
nanotubes [30]) and other types of graphene (exfoliated graphene, graphene oxide, graphene 
grown on a support [31]) is principally related to the detection techniques to be used as 
presented in chapter 1. The basal plane monolayer visualised in blue in figure 3.2 would 
benefit a FET configuration, while other structures like cracks or folding would be of interest 
in an electrochemical design (the demonstration have been made that “graphitic islands” play 
a dominant role in the electrochemical signal of CVD graphene [32]). A sketch of CVD 
graphene is presented in figure 3.13 and corresponds to the AFM visualisation of a 
representative transferred sample (figure 3.2). It presents different regions of monolayer 
graphene, several layers of graphene and multi-layered graphite islands. From these 
observations it would appear that the nanomaterial could be of interest in both detection 
setups. Furthermore, it will be modified in chapter 4 with nanoparticles which will greatly 
improve the electron transfer to the nanomaterial and hence the catalytic signal (see chapter 4 
section 4.1.1). Finally, several other interesting qualities of CVD graphene described in 





Figure 3.13. Sketch of graphitic/graphene islands formed when CVD graphene is 
  deposited on a substrate.
3.4.2 Field effect transistor 
Graphene presents two fundamental states (see chapter 1, figure 1.15), where either electrons 
(valence band) or holes (conduction band), are in the majority. When considering a ISD = 
f(VGD) representations, two fundamental characteristics regarding the doping of the 




Several layers of 
graphene 
Edge plane  























 A: Representation of the Dirac Figure 3.14. Electronic profile of a graphene FET.
point shift as a function of the N or P doping. Theoretically the Dirac point of intrinsic 
graphene sheet should be observed at VGD = 0 and it would shift towards positive gate 
potential with a P doping (majority of holes) and towards negative gate potential with N 
doping (majority of electrons) [33, 34]. B: Representation of the two areas 
corresponding to a majority of holes or electrons on a ISD = f(VGD) curve [35].  
 
CVD graphene presents a P type doping, with a Dirac point at around 0.3 V [36], (figure 3.5). 
Figure 3.6 introduces a shift in the Dirac point with glucose oxidase catalytic reaction 
(production of 3 H
+
 at each enzymatic entity; chapter 2, figure 2.7). This shift is also 
observed with the same graphene FET tested with phosphate buffers of decreasing pH (figure 
3.4). These experimental observations are in good agreement with the electronic properties 
exposed in figure 3.14: the more positive charges will be produced or present near the 
graphene surface the more it will shift the Dirac point towards high VGD. The developed 
GOD/CVD graphene FET sensor was hence demonstrated to be sensitive to enzymatically 
produced proton.  
A. 
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Another noticeable effect was observed in figure 3.5 which displays a positive shift of around 
0.07 V (VGD) with GOD non-covalently linked to the graphene. GOD naturally bears a 
negative charge in phosphate buffer at pH 7.4 [37]. The Dirac point should therefore shift 
towards low VGD but the opposite effect was observed. A conductance shift has been 
described to be caused by the enzymatic layer formed on top of the nanomaterial that would 





 sensitive transistor platform was therefore demonstrated. This design was however not 
appropriate for the aimed non-invasive application because of: (1) the complexity of 
manipulation and building of such sensors, (2) the internal limitations of any ISFET (buffer 
strength, storage, stability, etc…) and (3) the complicated integration with non-invasive 
detection techniques (top gating, multiplexing, etc…). The development of the FET 
configuration was hence not studied further, it was nevertheless promising (leading the way 
to the future enzymatic sensor development) and could be re-implemented in the final non-
invasive sensor design along with the amperometric sensor as a single Na
+ 
detector for 
calibration of the device (see chapter 5, section 5.1.1 and chapter 6, section 6.2). 
3.4.3 Electrochemical sensor (Second generation/First generation 
detection) 
Figure 3.7 studies the ferrocene-mediated cyclic voltammetric detection of glucose. It was 
ineffective in the system studied: the oxidative signal decreasing with additions of glucose. 
This could be due to the hydrogen peroxide produced during glucose oxidiation inhibiting the 
oxidation of ferrocene and therefore decreasing the signal upon additions of glucose to the 
system. Similarly when the redox mediator was functionalized on the graphene there was no 
significant improvement in the catalytic activity of the glucose sensor (figure 3.9). The aim of 
the latter was to bring the mediator closer to the enzyme while benefiting from the free 1-
PBASE sites (after GOD functionalization). Even though a ferrocene redox signal was 
identified (oxidation: ~ 0.5 V vs SCE and reduction ~ 0.1 V vs SCE) no increase of oxidative 
signal was observed with addition of glucose. This lack of ferrocene electro-activity may 
have been due to: (a) dissolved oxygen competing with the redox mediator for the electron 
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transfer [39], (b) the distance between the mediator and the catalytic redox centre being 
limiting [12]. (c) the synthesized ferrocene-amine being unstable [40].  
 
In contrast, a promising sensing of glucose was obtained with a first-generation design 
involving H2O2 oxidation (production of electrons at the WE detected at 0.7 V vs the RE, see 
figure 3.10). The signal, although not entirely linear, showed great potential in terms of 
catalytic current increase and display a similar cyclic voltammetry behaviour than with 
addition of H2O2 on a bare CVD graphene electrode (figure 3.11). Remarkably, the catalytic 
oxidative signal obtained at 0.7 V vs SCE in figure 3.11 is particularly low compared to 
figure 3.10. This was most likely attributed to the poor quality of the electrode used in the 
experiment but did not impact on the attribute we wanted to study which was the shape of the 
redox signal of H2O2 on a CVD graphene electrode. The peak obtained in figure 3.11 appears 
to look like the redox signal obtained in figure 3.10, hence confirming the detection of H2O2.  
 
It was therefore decided to develop and improve a H2O2 based CVD graphene sensor that will 
in turn be integrated into a reverse iontophoresis set-up for non-invasive transdermal glucose 
monitoring (chapter 5). Some of the preliminary results with different GOD entrapment had 
previously been exposed in chapter 2, section 2.3.2, and the capacity and performance of the 
final sensor design will be explored in chapter 4. 
3.4.4 Miniaturization of the sensor reaction receptacle 
The miniaturization of the volume of buffer for first generation sensing was finally 
demonstrated which led to the introduction of a small gel platform presented in chapter 2, 
section 2.3.2 and the rest of the thesis. First generation sensing was first introduced in a large 
volume reservoir of 21 mL (figure 3.10), however, intuitively this design was not ideal for 
two reasons: (1) it will be unpractical for future application as a non-invasive sensor and (2) 
the oxidation signal is more dependent on diffusion of H2O2 in a large volume 
electrochemical cell than in a miniaturized setup (diffusion is a function of the distance from 
the electrode, see equation 3.1). It was therefore decided to reduce the volume down to a drop 
(40 µL) in figure 3.12. This downscaling of the reaction reservoir provided a more defined 
peak at 0.7 V vs Ag pseudo reference electrode. While the origin of the difference in the 
oxidative shape is uncertain, the catalytic current from figure 3.10 to figure 3.12 was almost 
doubled: 4 mM of glucose gave a catalytic current of ~ 0.132 µA in figure 3.10 and ~ 0.266 
 123 
µA in figure 3.12. However, a liquid receptacle was still inappropriate for skin 
implementation. The consistency of the drop volume itself was therefore changed to a 
hydrogel (see chapter 2, section 2.3.2). The new catalytic signal was promising and the 
detection platform was now appropriate for integration in the non-invasive device, as 
opposed to a liquid based reservoir.   
3.5 Conclusions 
This chapter presented different detection platforms for the design of the glucose biosensor. 
A FET was investigated and presented promising results towards the detection of 
enzymatically produced H
+
. This setup was, however, discarded in the early stages of the 
development process due several drawbacks regarding the future implementation of the 
sensor. An electrochemical detection was instead preferred and again two glucose detection 
methods were compared: First generation and second generation sensing. The latter is a good 
strategy to replace H2O2 detection (and therefore the need for O2) and enable to reduce the 
detection potential which will be beneficial to a specific detection of glucose (the lower the 
oxidation potential against the RE, the fewer oxidations from interferent molecules). The 
introduction of ferrocene in the design, however, failed to provide a catalytic signal, and 
mediated detection was therefore discarded. On the other hand, the first generation platform 
demonstrated promising catalytic activity towards glucose and was hence chosen as the basis 
for the rest of the sensing operations described in the other chapters. In an attempt to find an 
appropriate design for the integration of the sensor in a non-invasive device placed on the 
skin, the dimensions of the reaction receptacle were reduced to a droplet size (40 µL). The 
catalytic signal obtained from this miniature dimension setup was improved and led to the 
design of the agarose gel reservoir described in chapter 2, sections 2.2.2.7.2 and 2.3.2. The 
combination of the findings of chapter 2 on the enzymatic functionalization and chapter 3 on 
the sensor principle of detection provided a strong basis towards the study of the sensor 
performance in chapter 4. 
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Chapter 4: Performance of the sensor 
4.1 Introduction 
This chapter builds on the work of the previous 2 chapters whereby previously it has been 
shown that the most promising way of measuring glucose concentrations with CVD graphene 
and GOD is through first generation sensing of H2O2. Glucose sensing can be improved 
through the use of metallic nanoparticles and this chapter aims to investigate their catalytic 
enhancement of glucose sensing. Chapter 2 also showed preliminary work on glucose sensing 
in a gel and this chapter will use the gel method developed in that chapter to make a sensor 
coupled with platinum nanoparticles.  
4.1.1 Metal nanoparticles 
In first-generation glucose sensors, H2O2 is a product of the enzymatic reaction of GOD with 
glucose. H2O2 is oxidised at an overpotential of 0.5 V to 0.7 V against SCE on a platinum 
electrode [1], and at ~0.7 V against SCE on graphene (Chapter 3, figure 3.10). There are 
three common interfering species associated with glucose biosensing: ascorbic acid (vitamin 
C), uric acid, and acetominophen (paracetamol). These three main interferents, which are 
often present in biological samples, are also oxidised at a similar potential [2]. It is therefore 
an important aim to reduce the potential at which H2O2 is oxidised so as to avoid such 
interferences. The typical use of a mediator to replace oxygen and lower the oxidation 
potential was ruled out early in the device development process, and attention was instead 
focused on the use of metallic nanoparticles. 
 
Metallic nanoparticles combined with carbon nanomaterial electrodes have been shown to 
dramatically enhance electron transfer and electrocatalytic activity in biosensors. It was hence 
of interest to study the combination of nanoparticles with CVD graphene (already considered 
a useful nanomaterial for electron transfer [3]) that would potentially lower the potential for 
glucose detection.  
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An enhancement of electron transfer turnover rate was demonstrated with addition of gold 
nanoparticles alongside a reconstituted apo-glucose oxidase enzyme (from  700 cm-1 to  
5,000 cm
-1
) [4]. This effect is due to excellent electrical conductivity and the quantum size 
effect of the nanoparticles. A quantum size effect is observed when the dimension of the 
nanoparticles is of the order of the de Broglie wavelength of the valence electrons 
(wavelength associated with a particle, function of the mass m and the velocity v of the 
nanoparticle and the Planck constant h), [5]. A noble metal such as platinum also displays 
good electrocatalysis towards H2O2. Several authors have demonstrated the benefit of 
platinum nanoparticles for the study of the oxidation of H2O2 due to the electrochemical 
stability and the biocompatibility of the nanomaterial [6]. The oxidation of hydrogen 
peroxide is displayed in equation 4.1 [7]. 
 
Both the dimensions and electrocatalytic activity of 
the nanoparticles induce a synergetic effect with the enzymatic reaction towards the 
electrochemical detection of the produced H2O2 [8]. 
 
4.1.2 Sensitivity 
Sensitivity is a fundamental attribute of any sensor. It is defined as the slope of the change of 
current with increasing concentrations. This value, however, is only applicable if the sensor 
response is linear. The linear range of a calibration curve is the range at which the sensor 
signal is proportional to a change in concentration. The linear range is different from the 
dynamic range which describes the range at which a change in concentration will lead to any 
sort of noticeable change in signal. The linear range along with the limit of detection (LOD) 
are essential analytical tools to characterise a biosensor [9-11].  
 
Any analytic assay, even extremely precise, cannot measure concentrations in a dynamic 
range down to zero. There is in every sensing device a limit of detection. It is defined by the 
International Conference of Harmonisation (ICH) as: “the lowest amount of analyte in the 
sample, which can be detected but not necessarily quantitated under stated experimental 
conditions”. It is differentiated from the limit of quantitation (LOQ) defined as: “the lowest 
amount of analyte in a sample, which can be quantitatively determined with suitable precision 
and accuracy” [12]. In the following, the interest will be focused on the LOD in order to 
(4.1) 
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assess the lowest signal differentiated from the background noise. It was estimated using the 
linear regression method:  
 
 
where σ is the standard deviation of the noise and S is the slope of the linear plot of the 
concentration curve [12]. 
 
Linear range and LOD are the most famous parameters to characterise the performance of 
any sensor since it introduces the working sensing range and the limit under which no signal 
will be differentiated from the background noise [13].  
 
The following is an investigation of these characteristics for the developed sensor along with 
additional properties such as repeatability and stability. The repeatability refers to the “in-
laboratory” precision with repeated measurements. It is differentiated from reproducibility 
which studies the “between-laboratory” precision. In order to achieve statistical significance 
the number of repeats, n, needs to be at least equal to 3. The stability of a sensor can be 
differentiated into 3 definitions: working stability, storage stability and long-term stability. 
The working stability is measured during a continuous operation. The storage stability relates 
to the stability obtained after storage. Finally, the long term stability describes the stability 
during an experiment in a sample solution that is not necessarily continuous. The stability of 
the sensor described in section 4.3.6 refers to the storage stability. 
 
This chapter will determine the limit of detection and linear range for platinum nanoparticle 
catalysed glucose detection through a gel on CVD graphene to find out the sensitivity of the 
biosensor. 
4.2 Materials and experimental methods 
4.2.1 Materials 
Hydrogen hexachloroplatinate (IV) hydrate, potassium chloride, H2SO4, glucose oxidase type 
X-S, (EC 1.1.3.4), 100,000-250,000 units/g solid (without added oxygen), low gelling 






Aldrich. Agarose was purchased from Fisher. Ag and Pt wires were purchased from Advent. 
Other materials (such as CVD graphene, 495 PMMA A3, etc.) were the same as the ones 
described in chapter 2, section 2.2.1. 
4.2.2 Experimental methods 
4.2.2.1 Preparation of a homemade micro Ag/AgCl electrode 
A micro-Ag/AgCl electrode was used to maintain a relatively stable potential with respect to 
the working electrode. The electrode was prepared by coating a 0.25 mm diameter, 99.95% 
pure, silver wire with AgCl by chronoamperometry in a 3.5 M KCl solution with Pt as 
reference and counter electrodes, for 1 hour at 1 V. The wire was then encased in a 1% w/v 
agarose gel containing 0.1 M KCl in a 100 µL micropipette tip (figure 4.1). The electrode 
was stored in 0.1 M KCl (replaced every month) at 4 ˚C when not in use. The electrode held 
only a low (0.1 M) KCl concentration to limit the amount of glucose oxidase inhibitor present 
(see chapter 1 section 1.3.2). Stability of the electrode was checked every week against a 
solution of 0.1 mM ferrocene dimethanol in 0.1 M phosphate buffer pH 7.4, against a 
standard saturated calomel electrode (SCE) (figure 4.2 and 4.3). The reason behind this 
monitoring was to assess if the electrode, while not being in saturated KCl, kept a stable 
potential which will be appropriate for electrochemical measurements. 
 
 
. A is the micro-Ag/AgCl reference electrode Figure 4.1. The electrochemical setup
(encased in agarose gel), B is the Pt counter electrode, C is the working graphene 
electrode, and D is the GOD/Hydrogel. The setup is mounted with helping hands and 
flat connectors. The connection between the silver paint on the working electrode and 






4.2.2.2 Electrode design  
The sensing electrodes were first prepared as described in chapter 2 section 2.2.2.2 and then 
platinum nanoparticles were electrochemically deposited as followed. 
 
4.2.2.3 Electrochemical deposition of platinum nanoparticles 
Platinum nanoparticles were formed on the graphene electrodes by chronoamperometry for 
1000 seconds in a 10 µL drop of a solution of 1.7 mM hydrogen hexachloroplatinate and 0.1 
M H2SO4 at -0.5 V against a Pt pseudo-reference electrode, or -0.35 V against the Ag/AgCl 
micro reference electrode. Cyclic voltammetry was used to assess the chloride reduction 
potential before chronoamperometry was performed in the same solution and at the 
determined potential. A peak was observed at -0.5 V when using a Pt pseudo-reference 
electrode and at -0.35 V when using an Ag/AgCl micro reference (see figure 4.4-A) electrode 
which explains the difference of deposition potential. The deposition as well as 
characteristics of the nanoparticles are presented in figures 4.4 and 4.5. 
 
4.2.2.4 GOD entrapment 
GOD was incorporated into the gel when cited via the methods identified as Entrapment 2 or 
Entrapment 3. These entrapment techniques were improvement of the previous Entrapment 1 
since the gel was formed directly on top of the electrode: 
Entrapment 2: 12 µL of 1% w/v agarose in phosphate buffer pH 7.4 was heated (above 80 
ºC) until a clear solution was obtained. It was then cooled down and directly casted onto the 
electrode at ~ 28 ˚C. 12 µL of an 8 mg/mL solution of GOD in phosphate buffer was 
immediately added on top of the gel at about 20 ˚C.  
Entrapment 3: 12 µL of an 8 mg/mL solution of GOD was deposited directly on the 
electrode. Then 12 µL of 1 % w/v low gelling temperature agarose (which had been heated 
and cooled down in the same way as entrapment 2) was deposited on top of the enzyme at ~ 
28 ˚C, i.e., a temperature low enough to maintain the enzyme’s catalytic and structural 




4.2.2.5 Determination of the gradient concentration curves 
To assess the sensitivity of the sensor, its performance was determined in a range of glucose 
concentrations prepared from a stock solution of 100 mM glucose in phosphate buffer 0.1 M 
pH 7.4 and left to mutarotate overnight. Glucose calibration curves were acquired as 
described in chapter 2 section 2.3.2.1. The background was averaged over the time period 
displayed in red in figure 4.16, and in figure 4.18. 
 
4.2.2.6 Determination of the sensor LOD 
The limit of detection was calculated using equation 4.2. It involved the determination of the 
sensor sensitivity (or slope of the linear plot) and the standard deviation of the background 
displayed over the period depicted in red in figure 4.16 and figure 4.18. This period was 
purposely chosen as the stabilised amperometric background. 
4.3 Results 
4.3.1 Set-up characteristics and modification of the sensor with 
platinum nanoparticles 
4.3.1.1 Stability of the homemade micro Ag/AgCl reference electrode 
The stability of the newly created Ag/AgCl reference electrode was regularly tested with a 
glassy carbon electrode (WE) in 10 mL of 0.1 mM ferrocene dimethanol (FDM). Figure 4.2 
presents cyclic voltammograms obtained with the same WE and CE (platinum wire) and 
FDM solution but with different RE, respectively a saturated calomel electrode (SCE) and the 
created micro Ag/AgCl reference electrode. The difference of half peak potential ΔE between 
the SCE and the micro Ag/AgCl electrode is then plotted in figure 4.3. 
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Figure 4.2. Comparison between the FDM redox signal (ΔE) measured against a 
traditional saturated calomel electrode (SCE) (red curve), and relative to a micro 
.  Ag/AgCl reference electrode (blue curve)
 
. The ΔE between the Ag/AgCl Figure 4.3. Stability of the micro Ag/AgCl electrode
and a commercial SCE shows little variation over ~ 4 weeks. 
 
The average ΔE was 47.8 mV (standard deviation: 20 mV), a reasonable value given that the 
typical potential variation between SCE electrode and Ag/AgCl electrode is 45 mV [15]. The 
electrode had a quite stable peak signal potential difference (∆E), of only few mV, relative to 
the SCE (figure 4.3) and was therefore suitable for this study. 
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4.3.1.2 Platinum nanoparticle deposition 
Figure 4.4-A shows a cyclic voltammogram obtained in a 10 µL drop of H2SO4 and hydrogen 
hexachloroplatinate. A clear reduction peak was identified at -0.35 V against Ag/AgCl and is 
attributed to platinum nanoparticle formation. Therefore this was the chosen potential for 
nanoparticle formation. The chronoamperometric signal was hence acquired for 1000 seconds 
at this potential (figure 4.4-B). The nanoparticles are formed following the reaction detailed 




. A: cyclic voltammogram acquired Figure 4.4. Deposition of platinum nanoparticles
in 10 µL of 0.1M H2SO4, 1.7 mM hydrogen hexachloroplatinate. There is a typical 
chloride reduction peak at about -0.35V against a micro Ag/AgCl reference electrode 
(red dotted circle). The scan rate was 20 mV/sec. B: Chronoamperometric signal 
corresponding to deposition of platinum at -0.35V against the micro Ag/AgCl electrode. 
The blue stripes, “area under the curve” (i.e. integration), will serve to calculate the 
mass of nanoparticles deposited using Faraday’s law (equation 4.3). 
 
The signal in figure 4.4-B was integrated (blue stripes) and gave a value for the charge Q of 
the deposition of 8.557 mC. This value was inserted in the Faraday’s law (equation 4.3) and a 
mass of 9.086 µg was deduced for the nanoparticles produced. 
















Potential (V) vs micro Ag/AgCl reference electrode





























Faraday’s law with Q the charge expressed in C, F the Faraday’s constant expressed in 
C/mol, M the molar mass expressed in g/mol and Z the number of electrons involved to the 
reaction. The molecular weight of hydrogen hexachloroplatinate is 409.81 g/mol, 4 electrons 
are involved in the deposition reaction and the Faraday constant is 96485.34 C/mol.  
 
Figure 4.5 shows cyclic voltammograms of a graphene electrode in phosphate buffer before 
and after platinum nanoparticle deposition. The bare graphene electrode shows a capacitive 
background response to the changing potential, however, upon deposition of platinum 
nanoparticles there is a clear oxidation peak at ca. 0.4 V (vs. Ag/AgCl) and a reduction peak 
at ca. 0 V (vs. Ag/AgCl). These peaks can be attributed to the formation of platinum oxide 
and reduction of platinum oxide nanoparticles respectively [16]. Scanning electron 
microscopy, figure 4.6, shows the nanoparticles to be of uniform size (ca. 375 nm) with some 
aggregates on the surface of the electrode but fairly uniformly distributed. 
 
Figure 4.5. Cyclic voltammograms before and after platinum nanoparticle 
. A significant increase in current and a characteristic redox signal is deposition
observed at ca. 0 V (reduction of platinum oxide) and ca. 0.4 V (platinum oxide 
formation) vs Ag/AgCl micro reference electrode, with addition of Pt nanoparticles. The 
scan rate was 20 mV/sec. 
  










 Bare graphene (10 L phosphate buffer)
















Figure 4.6. Scanning electron microscopy (SEM) pictures of Pt nanoparticles 
electrochemically deposited on CVD graphene  The red box is a zoom of a .
nanoparticle structure. This figure is not intended as an in depth characterisation of the 




4.3.2 Electrochemical catalytic activity with Graphene/Pt 
nanoparticles 
The activity of the newly created graphene/Pt nanoparticle electrodes was first assessed 
against a series of glucose concentrations in 24 µL of a gel entrapping GOD using 
entrapment method 1 (see chapter 2 section 2.2.2.7.2). Figure 4.7 shows the resulting cyclic 
voltammograms. A 1 µA level of increase in current is identified at ~0.4V against the Pt 
pseudo-reference electrode confirming the catalytic effect of platinum nanoparticles. The 
inset graph in figure 4.7 shows the increase in current with glucose additions to be non-linear 
in the all range of concentration while linear from 5 mM onwards. The reason for this could 








Figure 4.7. Cyclic voltammetry on a graphene/Pt nanoparticles electrode as a 
- Entrapment function of glucose concentration in a gel (24 µL) entrapping GOD 
method 1. Scan speed 20 mV/sec; one scan taken after each concentration step. The 
insert is a calibration graph displaying the oxidative H2O2 current (at 0.4 V vs the 
platinum pseudo reference electrode) produced as a result of the enzymatic reaction, as 
a function of glucose concentration added in the gel. 



















Potential (V) against Pt pseudo reference electrode 
 
































































Chronoamperometric experiments were performed at 0.4 V (vs. Pt pseudo reference) as a 
function of glucose concentration (figures 4.8 and 4.9). First a series of 1 L 0.1 M phosphate 
buffer additions (pH 7.4) were added to the gel to see if there was any effect of the 
mechanical addition of solution to the gel. Figure 4.8 shows the first 3 additions (blue arrows) 
to have no effect on the current indicating the sudden rush of solution into the gel has no 
effect. Next, a series of glucose additions to the gel (orange arrows) shows the current to 
clearly increase with each addition. The inset graph shows the trend to be linear in contrast to 
the cyclic voltammetry experiments (figure 4.7) indicating that chronoamperometry is a more 
reliable method to use. At the end of the experiment, 0.1 M phosphate buffer (pH 7.4) was 
again added to the gel. The current was shown to decrease slightly, possibly due to dilution 








Figure 4.8. Chronoamperometry following successive (1µL) additions of glucose 
(orange arrows) to vary the concentration from 0.107 to 1.054 mM in a gel (24 µL) 
entrapping GOD Entrapment method 1. Additions (1 µL) of phosphate buffer (blue - 
arrows) acted as an appropriate control. Signals were acquired at 0.4 V against a Pt 
pseudo-reference electrode, 250 seconds separated successive additions. The insert is a 
calibration graph presenting the catalytic current acquired as a function of the glucose 
concentration added in the gel. 









































Figure 4.9 shows the chronoamperometry data obtained when a range of glucose 
concentrations are added to the gel. The smaller concentrations (1 M and 10 M) are barely 
visible on the chronoamperometry results. This would indicate that these concentrations are 
beyond the limit of detection. When concentrations of 100 M and higher were added to the 




Figure 4.9. Chronoamperometry following successive additions of solutions of 
glucose at concentrations ranging from 1 µM to 10 mM (orange arrows) in a gel (24 
– Entrapment method 1. Additions of 1 µL of phosphate buffer µL) entrapping GOD 
(blue arrows) acted as an appropriate control. Signals were acquired at 0.4 V against a 
Pt pseudo-reference electrode. The insert is a calibration graph of: catalytic current = 
f(glucose concentration). 






































































4.3.3 Non enzymatic electrochemical detection of glucose 
Because of the improved catalytic signal achieved with nanoparticles on the graphene 
surface, it was important to check for non-enzymatic glucose detection (which had been 
reported elsewhere [17]). The experiments reported in section 4.3.2 were therefore repeated 
using a gel, which did not contain GOD. However the results obtained (figure 4.10) showed 
that although there was an increase in the current with glucose additions, an increase in 
current was also seen for additions of 0.1 M phosphate buffer (pH 7.4). Therefore no 







Figure 4.10. Chronoamperometry following successive (1 µL) additions of glucose 
(orange arrows) to vary the concentration from 0.107 to 1mM in a GOD-free gel (24 
Additions (1 µL) of phosphate buffer (blue arrows) acted as an appropriate µL). 
control. Signals were acquired at 0.4 V against a Pt pseudo-reference electrode. The 
insert is a calibration graph of: catalytic current = f(glucose concentration). 
 















































4.3.4 Specificity of the sensor: the impact of potentially interfering 
compounds 
Ascorbic acid (vitamin C), uric acid, and acetaminophen (paracetamol) are three compounds, 
often present in measurable concentrations in the body, and known to interfere with glucose 
detection. Given the potential of these compounds to oxidise relatively easily, it was 
important to test the new glucose sensor in the presence of these substances and to examine 
their impact (if any) on the glucose detection profiles (figure 4.11 to 4.14). Non-enzymatic 
detection was first tested with additions of ascorbic acid as well as glucose to the gel. As with 
the previous experiment (figure 4.10), the current further increased upon addition of ascorbic 
acid (purple arrows) showing the non-enzymatic sensor to be not specific enough. 
 
 
Figure 4.11. Regular additions of glucose and ascorbic acid on a non-enzymatic 
 A: Glucose (orange arrows) and ascorbic acid graphene Pt nanoparticles setup.
(purple arrows) were added to a 24 +/- 2 µL agarose gel. The current was measured at 
0.4 V against a Pt pseudo reference electrode. Three additions of buffer (blue arrows) 
were made as a control before any additions. B: Calibration plot representing catalytic 
current = f(glucose concentration). The orange points refers to glucose additions and the 
purple points to ascorbic acid. 












































The GOD enzyme was reintroduced to the sensor design using entrapment method 1. This 
has shown to be a good glucose sensor in previous experiments (section 4.3.2) and therefore 
it was a good system to test with potentially interfering compounds. Figure 4.12-A shows a 
series of additions to the gel and its resulting chronoamperometric signal. After the initial 
spike in current, the plateau current was seen to increase with glucose additions. The addition 
of ascorbic acid and uric acid did not significantly increase the plateau current and figure 4.12 
indicates that the current actually decreased when these compounds were added. 
 
 
Figure 4.12. Chronoamperometry in response to glucose in the presence of ascorbic 
- Entrapment method 1. A: acid and uric acid in a gel (24 µL) entrapping GOD 
Additions of glucose (orange arrows), ascorbic acid (purple arrows) and uric acid 
(green arrows). Measurements were acquired at 0.4 V against a Pt reference electrode. 
The blue arrows represent additions of phosphate buffer (control). B: calibration graph 
representing catalytic current = f(concentration) with glucose in orange and red, 
ascorbic acid in purple and uric acid in green. 
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Due to the success of the enzymatic mediated glucose detection method, different methods of 
GOD enzyme entrapment methods were tested to see if they had any effect on the specificity 
of the sensor. Direct gel entrapment on the electrode (Entrapment method 3) was used to 
fabricate the glucose sensor tested in figure 4.13. This was an improvement on entrapment 
method 1 in that the gel was directly formed on top of the electrode after a solution of the 
GOD enzyme had been deposited on top of the graphene. Interference experiments with 
ascorbic acid show the current to decrease, and after the first initial decrease in current, 
successive additions did not show a significant variation of the current (figure 4.13-B). 
 
 
Figure 4.13. Chronoamperometry in response to glucose in the presence of ascorbic 
– Entrapment method 3. A: additions of glucose acid in a gel (24 µL) entrapping GOD 
(orange arrows) and ascorbic acid (purple arrows). Chronoamperometry acquired at 
0.4 V against a micro Ag/AgCl electrode. Blue arrows indicate addition of phosphate 
buffer (control) B: calibration graph representing catalytic current = f(concentration) 
with glucose in orange and ascorbic acid in purple 
 














































The sensor made with enzyme entrapment method 3 was then tested for interference with 
acetaminophen (figure 4.14). Once again additions of the interferent initially showed the 
current to decrease, and the current plateaued after further additions of acetaminophen 
indicating that it is only a minor interferent. 
 
 
Figure 4.14. Chronoamperometry in response to glucose in the presence of 
– Entrapment method 3. A: additions acetaminophen in a gel (24 µL) entrapping GOD 
of glucose (orange arrows) and acetaminophen (magenta arrows). Chronoamperometry 
acquired at 0.4 V against a micro Ag/AgCl electrode. Blue arrows indicate addition of 
phosphate buffer B: calibration graph representing catalytic current = f(concentration) 
with glucose in orange and ascorbic acid in magenta. 
It was mentioned in chapter 2 section 2.2.2.7.1 (footnote, 2.α), that a small amount of acetic 
acid was released from the silicone rubber during the design of the sensor. Although the 
sensor preparation and measurements involved washing steps, it was important to 
demonstrate that no interaction is observed with addition of acetic acid (see figure 4.15). 










































































Addition of acetic acid, did show a decrease in the current upon successive additions but the 
concentrations added are well in excess of what would normally be found in a human body 
(42 µM in the serum [18]). 
  
 
Figure 4.15. Chronoamperometry in response to glucose in the presence of acetic 
– Entrapment method 3. A: additions of glucose acid in a gel (24 µL) entrapping GOD 
(orange arrows) and acetic acid (brown arrows). Chronoamperometry acquired at 0.4 V 
against a micro Ag/AgCl electrode. Blue arrows indicate addition of phosphate buffer 
(control) B: calibration graph representing catalytic current = f(concentration) with 
glucose in orange and ascorbic acid in brown.  
 
  















































4.3.5 Sensitivity, linear range and limit of detection 
It has now been established that the best design so far is to incorporate platinum nanoparticles 
on the surface of the graphene electrode as well as using a direct GOD/gel entrapment 
methods for the GOD integration into the gel (entrapment 2 and 3). Here, a broad range of 
glucose concentrations were added to the developed sensor in order to assess the sensitivity, 
linear range and limit of detection of the device. Figure 4.16 shows a series of glucose 
additions to the sensor over the concentration range of 0.001 mM to 1.89 mM. At the lower 
concentrations, only very small changes in current are observed in the chronoamperometry, 
however, higher concentrations show a clear increase in current. Figure 4.17 demonstrates a 
broad linear response over the concentration range from 1 µM to 1.89 mM. However, 
determination of the limit of detection of the sensor required the concentration range to be 
extended to sub micro molar concentrations (see figure 4.18). 
  
    
Figure 4.16. Chronoamprometry were acquired at 0.4 V against a micro Ag/AgCl 
electrode. Catalytic activity of the sensor over different concentration ranges: (A) 0.001 
to 0.01 mM (purple arrows), (B) 0.016 to 0.081 mM (green arrows), (C) 0.127 to 0.652 
mM (orange arrows), (D) 1.031 to 1.89 mM (red arrows). Blue arrows are glucose-free 
buffer acting as a positive control. The enzyme entrapment used was the entrapment 
method 2. 
 






















































































   
   
 
Figure 4.17. Determination of the linear range and sensitivity of the sensor. A-D: 
Calibration curves (catalytic current = f(glucose concentration)) for each of the glucose 
ranges. (A) 0.001 to 0.01 mM, (B) 0.016 to 0.081 mM, (C) 0.127 to 0.652 mM, (D) 1.031 
to 1.89 mM. E: Measured catalytic current as a function of glucose concentration 
represented on a logarithmic graph. The enzyme entrapment used was the entrapment 
method 2. 
 






















































































































Figure 4.18 shows the chronoamperometry data obtained when sub-micro molar 
concentrations of glucose were added to the developed sensor. At concentrations in the range 
of 0.1 M to 1 M it was very difficult to determine an increase in current because the signal 
was so noisy. It can be seen in figure 4.19 that the concentration dependence is linear with 
respect to the measured current, however, the very low concentrations do not follow this 
linear trend and are out of the range of the sensitivity of the device. 
 
   
 
 
Figure 4.18. Chronoamprometry were acquired at 0.4 V against a micro Ag/AgCl 
electrode. The catalytic activity of the sensor was measured down to Sub-micro 
: (A) 0.1 µM to 1 µM (black arrows), (B) 1 µM to 10 µM (magenta molar concentrations
arrows), (C) 10 µM to 100 µM (green arrows), blue arrows are additions of buffer. 






































































     
 
 
Figure 4.19. Determination of the limit of detection of the sensor. A-B: Calibration  
curves (catalytic current = f(glucose concentration)) for each of the glucose ranges, (A) 1 
µM to 10 µM, (B) 10 µM to 100 µM C: Measured catalytic current as a function of 
glucose concentration represented on a logarithmic graph. The enzyme entrapment 
used was the entrapment method 2. 
 
The performance of the sensor obtained from figures 4.16 and 4.18 are listed in table 4.1. 
Here the limit of detection has been calculated according to equation 4.2 and shows the limit 
to be 4 M and 1 M for each of the concentration ranges. These values are in close 
agreement with each other and discrepancies could be due to error in measurement of the 
current because of noise at the lower concentrations. 
























































































4.17 0.263 0.00028 4 0.12 to 2.83 
4.19 0.797 0.00009 1 0.003 to 0.1 
4.3.6 Repeatability and stability of the sensor 
Thus far, it has been shown that the graphene electrode with platinum nanoparticles 
electrodeposited on top and a gel containing GOD using entrapment method 2 has an 
excellent limit of detection for glucose. To check the repeatability of the sensor, 3 sensors 
were tested with different concentrations of glucose and the current recorded with 
chronoamperometry. Figure 4.20 shows the average current obtained from the 3 sensors with 
error bars showing the standard deviation between the 3 different sensors. The error bars 
indicate a large variation in the current from sensor to sensor which is possibly due to the 
graphene wet transfer technique used to make the graphene electrode. 
 
    
The concentration graph was separated in two Figure 4.20. Repeatability of 3 sensors. 
(A and B) in order to give a clear representation of the current increase over the entire 
concentration scale. A: glucose range going from 0.1 mM to 1 mM, B: glucose range 
going from 5 mM to 10 mM. Error bars correspond to standard deviation. The GOD/gel 
entrapment was entrapment 3. 
 
Sensor stability was then assessed over a two week period by measuring its response as a 
function of glucose concentration (figure 4.21). The electrode was stored dry in a petri dish at 
room temperature when not in use. It can be seen that the data recorded on the first day gave 









































higher currents than data recorded after 5 and 14 days. Data obtained after 5 and 14 days gave 
similar currents indicating that the activity of the sensor had reached a plateau after 5 days. 
This could be due to mechanical damage of the electrode in the process of mounting the setup 
and discarding used gels. 
 
Figure 4.21. Stability of the catalytic current, for a representative electrode over 
This figure represents catalytic current = f(glucose concentration) for a two weeks. 
sensor at 0 (black curve), 5 (red curve) and 14 days (green curve). The GOD/gel 
entrapment was entrapment 3. 
 
4.3.7 Sensor enzyme kinetics  
From the data presented in figure 4.20, a Lineweaver-Burk plot was constructed for the new 
first generation glucose biosensor (figure 4.22). A Lineweaver-Burk plot is a graphical way 
of presenting the Michaelis-Menten equation: 
𝑉 =  
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑚+[𝑆]
      (4.4) 
where V is the reaction velocity, Km is the Michaelis-Menten constant, Vmax is the maximum 
reaction velocity and [S] is the substrate concentration. From this graph, Km and Imax were 
assessed as 3.63 mM and 5.26 µA. The Km value was in good agreement with the literature 
(for both amperometric first or second generation biosensors), see table 4.2. 
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Figure 4.22. Lineweaver-Burk plot obtained from the results in figure 4.20. 
Averaged data from 3 freshly created sensors shown in figure 4.20. Error bars 
correspond to standard deviation. 
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4.4.1 Effect of the addition of platinum nanoparticles 
The Pt nanoparticles clearly improved the glucose detection providing increased current 
ranges at low detection potential compared to results presented in chapters 2 and 3. The 
detection potential was lowered from 0.7 V to 0.4 V against both a Pt pseudo reference 
electrode and a Ag/AgCl micro-reference electrode (see figures 4.7 to 4.9 and figures 4.16 
and 4.18). As a comparison, the catalytic current obtained with 1 mM of glucose added to the 
nanoparticle functionalised electrode is  0.108 µA (see figure 4.8) whereas the current 
previously obtained with addition of the same concentration of glucose on an electrode non-
functionalised with nanoparticles was  0.0123 µA (see chapter 2, figure 2.13-A). The 
current was increased (around 9 times) while the detection potential was decrease of 0.3 V, 
benefiting from the synergetic catalytic effect described in section 4.1.1. Chronoamperometry 
was also preferred to cyclic voltammetry as a detection technique providing with better 
linearity over a broad range of glucose concentrations (see the comparison between figure 4.7 
and figures 4.8 and 4.9). 
Having assessed the benefit of adding platinum nanoparticles to the catalytic detection, it was 
then important to study non enzymatic detection of glucose on the nanoparticle functionalized 
electrode. The non-enzymatic sensing of glucose on platinum nanoparticles has been 
demonstrated following the direct oxidation of the analytes on the nanoparticles presented in 
equation 4.5, [24]. 
 
Based on this observation, direct glucose oxidation on the nanoparticles was investigated at 
0.4 V against a Pt pseudo reference electrode. An increase of the catalytic current was 
observed with additions of glucose that demonstrated a good linear proportionality (see figure 
4.10). However, the chronoamperometric steps observed didn't stabilize and an increase of 
current was observed with additions of buffer. Furthermore a signal was also obtained with 
additions of ascorbic acid (see figure 4.11). Non-enzymatic detection was therefore 
abandoned as not reliable enough and not sufficiently specific for glucose detection. 
4.5 
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4.4.2 Impact of ascorbic acid, uric acid and acetominophen on the 
amperometric signal 
The enzyme functionalized gel design was then tested with ascorbic acid, uric acid and 
acetaminophen along with addition of glucose to assess the impact of these interferents on the 
catalytic signal. A good selectivity towards glucose was demonstrated in figures 4.12 to 4.14. 
More specifically, figure 4.12-A presents the alternated additions of glucose and ascorbic and 
uric acid. Although displaying a current peak increase at each concentration steps (probably 
caused by the mechanical additions), the catalytic signal then stabilised after each initial 
spikes. The stable step signals were then plotted as a function of the concentration and a 
linear proportional increase was observed with glucose concentration whereas a decrease of 
catalytic current was identified with ascorbic and uric acid (see figure 4.12-B).  
 
Figures 4.13 and 4.14 then present additions of ascorbic acid and acetominophen after 
glucose additions. In both cases the catalytic signal is linearly proportional to glucose 
additions whereas the additions of each interferents does not increase the signal up to an 
elevated concentration of  1 mM. On the contrary the current seems to decrease with the 
additions of the interferents (with the exception of “high” 1 mM concentrations). This 
phenomenon is also observed when adding buffer after additions of glucose (as indicated in 
figure 4.12 to 4.17 by the blue arrows). The most likely explanation for both of these 
decrease is the dilution of the glucose already present (following the additions depicted in 
every picture in orange) and hence a decrease of catalysis at the electrode.  
 
The design cannot be claimed to be totally specific towards glucose but it is selective enough 
for the integration into methodologies for glucose extraction/detection through the skin 
(chapter 5). This argument can be supported by several facts: Firstly, ascorbic acid in solution 
is in anionic form (ie, ascorbate bearing a negative charge), it is therefore very unlikely that a 
significant amount of this molecule will be extracted via reverse iontophoresis since the 
extraction is made from anode to cathode which induces a flux of cations (Na
+
) towards the 
sensor (on the cathode), see chapter 1 section 1.3.4.5.2.4. Secondly, the physiological levels 
of ascorbic acid for a healthy human being is below 0.1 mM [25] and the typical plasma 
concentration of acetaminophen for a patient ingesting prescribed doses of the analgesic (1g 
every 6 hours) is 0.1 mM [11]. It is therefore highly unlikely that concentration at which a 
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signal is observed for both these molecules (1 mM) will be found at the surface of the 
epidermis after extraction by reverse iontophoresis. In conclusion, the sensor that is not 
altered by the presence of common interferents, presents a great selectivity towards glucose 
and is hence “highly specific” for the intended non-invasive sensing application. 
4.4.3 Sensitivity, linear range and limit of detection 
The performance characteristics of the sensor have then been evaluated. Figure 4.16 displays 
catalytic current steps obtained with additions of glucose over 4 ranges of glucose going from 
0.001 mM to 2.83 mM. The steps in current appear to be well defined and stable. These were 
then plotted against glucose concentrations on linear and log-log graphs (figure 4.17). It 
demonstrated a broad linear range going from 0.12 to 2.83 mM and a LOD of 4 µM. Smaller 
glucose concentration were then added on a similar sensor configuration and a lower LOD of 
1 μM was identified, with a broad linear range going from 3 to 100 µM as shown in figure 
4.19.  
 
The sensitivity of the sensor was assessed from the slope of the linear regression of figure 




) for the 9 mm
2
 area of the graphene 
flakes. These performance values are then compared with the graphene/metallic nanoparticles 
glucose sensors from the literature (table 4.3) and alternative glucose biosensor devices (to 
the fingerstick meters) in table 4.4. The sensor was determined to be competitive with respect 
to the literature (figures 4.17 and 4.19) and as presented in table 4.3 that compares the LOD 
and linear range of the graphene/Pt nanoparticle electrode developed here with similar 
amperometric designs reported in the literature. The sensitivity value of the sensor was 
slightly lower than those of nanoparticle-functionalized amperometric biosensors found in the 
literature [8, 26], but close to those of graphene sensors [13, 27]. Furthermore, with respect to 
the non-invasive extraction and detection of glucose via reverse iontophoresis through the 
skin, it would appear that the LOD and sensitivity are suitable. This conclusion is based on 
the fact that the gel used in the new sensor design has a volume of only 24 µL (compared to 
the 400 µL of the GlucoWatch 
®
 Biographer [28]) and that the concentration extracted after 3 
minutes of reverse iontophoresis into the large GlucoWatch 
®
 Biographer gel volume was 
very low: 2.5 to 25 µM [29]. Much higher concentrations, and well above the LOD, are 
anticipated in the much smaller (17-fold) volume of the new sensor’s gel.  
 156 














Pt nanoparticles/ graphene 
oxide/ glucose oxidase 
0.6 sub µM to 5 
- 
[8] 
PtPd nanoparticles/ graphene 
oxide/ glucose oxidase 
1 2-12 26 [30] 
Pt nanoparticles/ graphene 
oxide/ glucose oxidase/ 
nafion 
25 3-15 - [31] 
Pt nanoparticles/ 
multilayered graphene petal 
nanosheet/ glucose oxidase 
0.3 0.01-50 - [32] 
Pt nanoparticles/ exfoliated 
graphite nanoplatelet/ 
glucose oxidase/ nafion 
1 1-20 61.5 ± 0.6 [26] 
PdNps/ graphene oxide/ 




range up to 
0.1 




oxidase/ glassy carbon 
electrode 
350 1-12 2.243  [34] 
Pt nanoparticles/ graphene 
oxide/ TiO2 nanotube arrays 
100 0.1-8 0.94 [35] 
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Amperometric/ GOD/ First 











(Abbott Diabetes Care, 
Alameda, CA, USA) 
Invasive needle 
sensor  
Carbon/ osmium wired electrode 
Amperometric/wired GOD / 











Platinum electrode/ Polyurethane 
poly urea polymer 
22 gauge insertion needle 
Amperometric/GOD/ First 






-7 (DexCom Inc., 
San Diego, CA, USA) 
Invasive needle 
sensor 
Platinum electrode/ membrane 
(hydrophobic polyurethane and a 
hydrophilic polyurethane mixture) 
26 gauge insertion needle 
Amperometric/GOD/ First 
generation sensor (detection 
of H2O2)  
2.22-22.2 [15, 39] 
GlucoDay
®





Platinum electrode/ three membranes: 
cellulose acetate, nylon net with 
covalently linked GOD, and a 
polycarbonate protective membrane 
Amperometric/ GOD/ First 
generation sensor (detection 
of H2O2) 
up to 30 [40] 
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4.4.4 Repeatability, stability and kinetic parameters of the sensor 
The repeatability and stability of the sensor were investigated in order to conclude on the 
robustness of the detection. The repeatability was not optimal over the range of 
concentrations possibly due to the process of transferring CVD graphene during sensor 
fabrication (see chapter 2, section 2.2.2.1) which would account for some electrode to 
electrode variability. However, this may be solved in the future by the use of dry transfer, for 
example [41]. While there was a significant drop in catalytic activity of the sensor over a 5-
day period (figure 4.21) the signal then stabilized over the next 10 days. The initial drop of 
catalytic activity was potentially due to the deterioration of the transducer surface, caused by 
repeated washing and mechanical positioning of the enzymatic gel. 
 
Finally, the enzyme kinetic parameters deduced for the sensor indicated that high affinity for 
the substrate was maintained. Km was deduced from a Lineweaver-Burk plot based on a 
Michaelis-Menten kinetic presented in figure 4.22. From this representation it was possible to 
deduce a Km of 3.63 mM which was in the order of the glucose sensor presented in the 
literature (table 4.2). The Km value is defined as the concentration of substrate allowing the 
enzyme to achieve half of the maximal catalytic velocity (Vmax). It follows that the lower the 
Km value, the higher the affinity will be for the substrate [42]. Remarkably, a significant 
variation in Km is observed in table 4.2 which can be attributed to the difference of 
entrapment of the enzyme, transducer, enzyme density, detection principle, etc. 
4.5 Conclusions 
In conclusion, the platinum nanoparticles and the direct GOD/gel entrapment on the graphene 
electrode by method 2 or 3 acted synergistically towards the catalytic sensing of the 
enzymatically produced H2O2. It enabled to lower the detection potential and obtain an 
improved catalytic current with reaction of glucose on the GOD loaded gel electrode. The 
specificity regarding glucose was demonstrated by studying the impact on the signal of 
ascorbic acid, uric acid, acetominophen and acetic acid. The sensor performance (sensitivity, 





, a limit of detection of 1 µM and a linear range of 0.003 mM to 0.1 mM (and 0.1 mM to 3 
mM on a separate experiment) was assessed. These attributes made the sensor competitive 
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with respect to platinum nanoparticles/graphene electrodes from the literature (table 4.3) and 
to alternative glucose monitoring technologies (table 4.4). The results however failed to 
demonstrate good reproducibility presenting high standard deviation error bars (attributed to 
the irregular quality of the transferred graphene). Furthermore, the electrode stability 
overtime showed an initial decrease of activity from day 0 to day 5 again possibly caused by 
the mechanical damages of the electrode during the multiple measurements. Finally a low Km 
of 3.63 mM was obtained for the enzymatic reaction that was relatively low when compared 
to the literature and hence demonstrated good affinity for the substrate.  
 
 159 
1. Chu, P.K. and X. Liu, Biomaterials Fabrication and Processing Handbook. 2008: 
Taylor & Francis. 
2. Alegret, S. and A. Merkoci, Electrochemical Sensor Analysis. 2007: Elsevier Science. 
3. Shao, Y., et al., Graphene Based Electrochemical Sensors and Biosensors: A Review. 
Electroanalysis, 2010. 22(10): p. 1027-1036. 
4. Xiao, Y., et al., "Plugging into Enzymes": Nanowiring of Redox Enzymes by a Gold 
Nanoparticle. Science, 2003. 299(5614): p. 1877-1881. 
5. Daniel, M.-C. and D. Astruc, Gold Nanoparticles:  Assembly, Supramolecular 
Chemistry, Quantum-Size-Related Properties, and Applications toward Biology, 
Catalysis, and Nanotechnology. Chemical Reviews, 2004. 104(1): p. 293-346. 
6. Luhana, C., et al., A novel enzymatic glucose sensor based on Pt nanoparticles-
decorated hollow carbon spheres-modified glassy carbon electrode. Journal of 
Nanoparticle Research, 2012. 14(10): p. 1-9. 
7. Gu, Y. and C.-C. Chen, Eliminating the Interference of Oxygen for Sensing Hydrogen 
Peroxide with the Polyaniline Modified Electrode. Sensors, 2008. 8(12): p. 8237-
8247. 
8. Wu, H., et al., Glucose biosensor based on immobilization of glucose oxidase in 
platinum nanoparticles/graphene/chitosan nanocomposite film. Talanta, 2009. 80(1): 
p. 403-406. 
9. Thévenot, D.R., et al., Electrochemical biosensors: recommended definitions and 
classification. Biosensors and Bioelectronics, 2001. 16(1–2): p. 121-131. 
10. Borgmann, S., et al., Amperometric Biosensors, in Advances in Electrochemical 
Science and Engineering. 2011, Wiley-VCH Verlag GmbH & Co. KGaA. p. 1-83. 
11. Fabry, P. and J. Fouletier, Chemical and Biological Microsensors: Applications in 
Fluid Media. 2013: Wiley. 
12. Shrivastava A.  and Gupta V. B., Methods for the determination of limit of detection 
and limit of quantitation of the analytical methods. Chron Young Sci 2011. 2(1): p. 
21-25. 
13. Alkire, R.C., et al., Bioelectrochemistry: Fundamentals, Applications and Recent 
Developments. 2011: Wiley. 
14. Zoldák, G., et al., Irreversible Thermal Denaturation of Glucose Oxidase from 
Aspergillus niger Is the Transition to the Denatured State with Residual Structure. 
Journal of Biological Chemistry, 2004. 279(46): p. 47601-47609. 
 160 
15. McGarraugh, G., The Chemistry of Commercial Continuous Glucose Monitors. 
Diabetes Technology & Therapeutics, 2009. 11(s1): p. S-17-S-24. 
16. Dai X. and R. G. Compton, Detection of As(III) via oxidation to As(V) using platinum 
nanoparticle modified glassy carbon electrodes: arsenic detection without 
interference from copper Analyst, 2006. 131(4): p. 516-521. 
17. Su, C., et al., Nonenzymatic Electrochemical Glucose Sensor Based on Pt 
Nanoparticles/Mesoporous Carbon Matrix. Electroanalysis, 2010. 22(16): p. 1901-
1905. 
18. Psychogios, N., et al., The Human Serum Metabolome. PLoS ONE, 2011. 6(2): 
e16957 
19. Arslan, F., S. Ustabaş, and H. Arslan, An Amperometric Biosensor for Glucose 
Determination Prepared from Glucose Oxidase Immobilized in Polyaniline-
Polyvinylsulfonate Film. Sensors, 2011. 11(8): p. 8152-8163. 
20. Chen, K.-J., et al., Fabrication and application of amperometric glucose biosensor 
based on a novel PtPd bimetallic nanoparticle decorated multi-walled carbon 
nanotube catalyst. Biosensors and Bioelectronics, 2012. 33(1): p. 75-81. 
21. Yu, J., T. Zhao, and B. Zeng, Mesoporous MnO2 as enzyme immobilization host for 
amperometric glucose biosensor construction. Electrochemistry Communications, 
2008. 10(9): p. 1318-1321. 
22. German, N., et al., Glucose biosensor based on graphite electrodes modified with 
glucose oxidase and colloidal gold nanoparticles. Microchimica Acta, 2010. 168(3-
4): p. 221-229. 
23. Luong, J.H.T., et al., Monitoring the activity of glucose oxidase during the cultivation 
of Aspergillus niger using novel amperometric sensor with 1, 1′-dimethylferricinium 
as a mediator. Biosensors and Bioelectronics, 1994. 9(8): p. 577-584. 
24. Su, C., C. Zhang, G. Lu and C. Ma, Nonenzymatic Electrochemical Glucose Sensor 
Based on Pt Nanoparticles/Mesoporous Carbon Matrix, Electroanalysis, 2010. 
22(16): p. 1901-1905 
25. ICH. Harmonized tripartite guidelines; Validation of analytical procedures: text and 




26. Lu, J., et al., Nanometal-Decorated Exfoliated Graphite Nanoplatelet Based Glucose 
Biosensors with High Sensitivity and Fast Response. ACS Nano, 2008. 2(9): p. 1825-
1832. 
27. Lu, J., et al., Simple Fabrication of a Highly Sensitive Glucose Biosensor Using 
Enzymes Immobilized in Exfoliated Graphite Nanoplatelets Nafion Membrane. 
Chemistry of Materials, 2007. 19(25): p. 6240-6246. 
28. Leboulanger, B., R.H. Guy, and M.B. Delgado-Charro, Reverse iontophoresis for 
non-invasive transdermal monitoring. Physiological Measurement, 2004. 25(3): p. 
R35. 
29 Tierney, M.J. et al., Electroanalysis of glucose for non-invasive transdermal 
monitoring. Physiological Measurement, 2004, 25(3): p. R35 
30. Hossain, M.F. and J.Y. Park, Amperometric Glucose Biosensor Based on Pt-Pd 
Nanoparticles Supported by Reduced Graphene Oxide and Integrated with Glucose 
Oxidase. Electroanalysis, 2014: p. 940-951. 
31. Liu, A. and S. Huang, A glucose biosensor based on direct electrochemistry of 
glucose oxidase immobilized onto platinum nanoparticles modified graphene 
electrode. Science China Physics, Mechanics and Astronomy, 2012. 55(7): p. 1163-
1167. 
32. Claussen, J.C., et al., Nanostructuring Platinum Nanoparticles on Multilayered 
Graphene Petal Nanosheets for Electrochemical Biosensing. Advanced Functional 
Materials, 2012. 22(16): p. 3399-3405. 
33. Cheng, N., et al., Amperometric Glucose Biosensor Based on Integration of Glucose 
Oxidase with Palladium Nanoparticles/Reduced Graphene Oxide Nanocomposite. 
American Journal of Analytical Chemistry, 2012. 3(4): p. 312-319. 
34. Veerappan, M., et al., A Novel Glucose Biosensor at Glucose Oxidase Immobilized 
Graphene and Bismuth Nanocomposite Film Modified Electrode. 
Int.J.Electrochem.Sci, 2015. 10: p. 691-700. 
35. Feng, C., et al., Facile Fabrication of Pt/Graphene/TiO2 NTAs Based Enzyme Sensor 
for Glucose Detection. Journal of The Electrochemical Society, 2014. 161(1): p. B1-
B8. 
36. Chan, M.-S., et al., Materials for Fabricating Biosensors for Transdermal Glucose 
Monitoring. Clinical Chemistry, 1999. 45(9): p. 1689-1690. 
37. Heller, A. and B. Feldman, Electrochemistry in Diabetes Management. Accounts of 
Chemical Research, 2010. 43(7): p. 963-973. 
 162 
38. Diabetes Research in Children Network (DirecNet) Study Group, The Accuracy of the 
Guardian
®
 RT Continuous Glucose Monitor in Children with Type 1 Diabetes. 
Diabetes Technology & Therapeutics, 2008. 10(4): p. 266-272. 
39. Zisser, H.C., et al., Accuracy of the SEVEN continuous glucose monitoring system: 
comparison with frequently sampled venous glucose measurements. J Diabetes Sci 
Technol, 2009. 3(5): p. 1146-54. 
40. Poscia, A., et al., A microdialysis technique for continuous subcutaneous glucose 
monitoring in diabetic patients (part 1). Biosensors and Bioelectronics, 2003. 18(7): 
p. 891-898. 
41. Suk, J.W., et al., Transfer of CVD-Grrown Monolayer Graphene Onto Arbitrary 
Substrates. ACS Nano, 2011. 5(9): p.6916-6924 
42. Koolman, J. and K.H. Röhm, Color Atlas of Biochemistry. 2005: Thieme. 
 
 163 
Chapter 5: Non-invasive glucose 
monitoring 
5.1 Introduction 
The glucose sensor developed so far in this thesis has shown excellent detection of glucose 
by coupling platinum nanoparticles with the GOD enzyme entrapped in a gel on top of a 
graphene flake. Integration of this sensor with in-vitro skin experiments was investigated next 
to study its practical applications to the real world. 
 
Non-invasive sensing has been the subject of much research in the past 10 to 15 years and has 
aimed at the development of a solution that provides much needed physiological and 
biological information and helps avoid complicated or painful procedures. It has been 
demonstrated that in patients with both type 1 and type 2 diabetes, fingerstick glucose 
monitoring is associated with significant stress, pain, apprehension and physical symptoms 
that impair the daily life of an individual [1]. Diabetes mellitus is a metabolic disease 
originating from damaged pancreatic cells or induced insulin resistance that involves 
inefficient metabolic conversion of blood glucose leading to high blood glucose, i.e., 
hyperglycaemia (see chapter 1, section 1.2.1) [2]. The disease, if not managed correctly, can 
lead to problems ranging from minor symptoms to life threatening pathologies [2]. It is 
therefore fundamental for diabetics to be able to assess their blood glucose levels regularly in 
order to control their glucose intake or the requirement for an insulin injection.  
 
The most widespread technique to monitor blood glucose to this date involves the use of a 
fingerstick meter as a self-monitoring blood glucose (SMBG) technology. This requires a 
small sample of blood (as low as 0.3 µL) deposited on an electrochemical sensor [3]. 
Improved monitoring technologies would be required to help patients with their disease 
management. Research in this area has followed two principal directions so far: implantable 
and non-invasive sensing, respectively. Implantable sensors provide continuous monitoring 
through devices surgically placed inside the body, mostly subcutaneously [4]. This research 
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area is however still controversial due to multiple limitations: it requires surgical 
interventions and calibrations while being plagued by short lifetime, lag time, 
biocompatibility issues and expensive costs (see chapter 1, section 1.3.5.1) [5].  
 
An alternative is the promising research area of non-invasive sensing. This has attracted 
much interest in the past and several strategies have been proposed, such as glucose detection 
from tears [6] or transdermally [7] (based on multiple techniques listed in section 1.3.5.4); 
but the most notable and remarkable non-invasive system to have emerged is the 
GlucoWatch
®
 Biographer developed by Cygnus in 2000 [8]. This device is based on a 
transdermal extraction technique, namely, reverse iontophoresis (RI), which involves the 
application of a low intensity current (i.e., 0.3 mA/cm
2
) to the epidermis. The current creates 
a flux of ions in the anode-to-cathode direction. This flux will create a movement of H2O 
molecules which will bring the solubilized glucose molecule to the epidermis level where it 
will be detected via a typical carbon paste/platinum electrochemical glucose sensor (the RI 
extraction principle is described in chapter 1, figure 1.5) [9]. The device was considered as an 
interesting competitor for the traditional fingerstick glucose technology, however, it failed 
commercially because of several drawbacks listed in chapter 1 section 1.1 [10, 11].  
 
The aim of this chapter is to use the same extraction principle as the Cygnus device, but with 
the graphene-based sensor presented in chapter 4, and in a way that will help tackle some of 
the GlucoWatch 
® 
Biographer failures and provide more accurate glucose monitoring. The 
electrodes therefore followed a design that would take advantage of both the CVD graphene 
properties and the principle of reverse-iontophoresis extraction. The latter is performed in the 
small volume of the sensor’s gel receptacle. Essentially, the main attribute of the 
implementation is iontophoretic glucose pathway targeting, meaning that preferential 
transdermal glucose pathways will be accessed using an array of multiplexed 
sensing/extraction devices. Indeed, it has been demonstrated that when applying an 
iontophoretic current across the skin, charged molecules tend to follow preferential pathways, 
namely skin appendages (i.e., hair follicles or sweat ducts) [12, 13]. The skin itself is a 
complex barrier formed by several layers (see chapter 1, section 1.3.5.4.4) [14]. It therefore 
naturally acts as an efficient barrier to molecular extraction. It is however predicted that 
glucose will follow the path of preferential extraction through skin appendages (i.e., hair 
follicles) when applying reverse-iontophoresis extraction [15, 16]. In chapter 4 we 
demonstrated a competitive miniaturised sensor with 9 mm
2
 active area and 24 µL enzyme 
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encased gel. Such miniature sensors could be used in a multiplex array that will target hair 
follicles, and give higher glucose concentrations, closer to the interstitial fluid glucose 
concentration than the GlucoWatch 
® 
Biographer, which extracted glucose into a large 
reservoir (400 µL) [12]. The basic concept of this new technology is displayed in figure 5.1-B 
and compared to the GlucoWatch 
® 
Biographer (figure 5.1-A). In figure 5.1-A the glucose 
extracted from the overall skin area is received in a large volume of gel and therefore diluted 
greatly before being detected by a disk platinum/carbon ink disk electrode. In figure 5.1-B 
even though every hair follicles pathway will not be detected, the multiplexed detections of 
the array ensure that at least several preferential pathways will be reached, while the smaller 
dimensions of the electrode and of the reduced gel volume can enable to obtain higher 





















Figure 5.1. The principle of the “glucose path targeting” multiplexed device, 
®
. Skin depiction adapted from Prausnitz et al. [17]. contrasted with the GlucoWatch
A: RI extraction with the GlucoWatch 
®
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5.1.1 GlucoWatch ® Biographer vs proposed technology 
The main differences between our design and the GlucoWatch 
®
 Biographer is the concept of 
targeting transdermal preferential pathways enabled by the reduction of the size and volume 
of the individual device. Nevertheless, other fundamental structural differences exist: (1) The 
GlucoWatch 
®
 Biographer sensor consists of a screen printed platinum/carbon ink working 
electrode (on an alumina substrate) of relatively large area (i.e., 1.25 cm
2
 [13], which is 
considerably larger than the sensor area, of 0.09 cm
2
). (2) The material used for the electrode, 
as well as the fabrication process are radically different. The proposed technology uses CVD 
graphene leading to increased sensitivity, while the GlucoWatch 
®
 Biographer relies on a 
traditional platinum electrode for its’ electrochemistry [18]. (3) The GlucoWatch ® 
Biographer required an external calibration. In our design the extraction should be enhanced 
through the hair follicles and the dilution dramatically reduced, the concentration extracted 
should therefore be close to or similar to the interstitial glucose concentration, hence 
diminishing the need for an invasive calibration. This question is however debatable and 
dependant on the proportionality between blood glucose and interstitial fluid glucose already 
discussed in chapter 1, section 1.3.5.1.3. Nevertheless, if required, a calibrating sensor for 
Na
+
 could be added to the multiplexed array. This uses the findings of Seig et al. who 
demonstrated that such ions could act as an internal calibration for the RI technique. The 
concentration of Na
+
 is indeed constant in the skin, its’ ratio with the extracted concentration 
would therefore provide the needed calibration for the technique [19]. This Na
+
 could be 
designed as a field effect transistor and benefit from the findings presented in chapter 3 
section 3.3.2. (4) The CVD graphene offers other interesting and important developments: (a) 
Large area of CVD graphene can be relatively easily deposited and patterned into small 
squares (structures) via photolithography and oxygen plasma etching [20], producing the 
intended multiplex array required for the targeting. (b) The nanomaterial is also remarkably 
flexible enabling the realisation of a skin-fitting flexible device which confers a big 
advantage over the GlucoWatch
®
 Biographer designed on a solid, inflexible, substrate [21]. 







, see chapter 1, section 1.4.2.3) compared to traditional electrode materials. On the 
other hand, some similarities exist between the two concepts: both use reverse iontophoresis 
extraction, as well as gel entrapment [22] and are first generation in the detection method 
used. Table 5.1 summarises the differences and similarities between the two technologies: 
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Table 5.1. Attributes of the developed technology vs GlucoWatch
®
 Biographer.  
Sensor aspect GlucoWatch 
®
 Biographer Developed sensor 
Sensor material Platinum on carbon ink [23] 
CVD graphene/ Pt 
nanoparticles 
Sensor construction Screen printed electrodes 




First generation GOD/ 
electrochemical sensor 
First generation GOD/ 
electrochemical sensor 
Enzymatic entrapment Hydrogel Hydrogel 
Reservoir volume 400 µL 24 µL (per sensor) 




 (per sensor) 
Substrate Solid 
Flexible substrate in a 
commercial form 
Requirement for an 
invasive calibration 
Yes 





Extraction principle RI RI 
Transducing material 
Detection using hydrogel 
enzyme entrapment 




No preferential pathway 
targeting 
Hair follicles targeting 
5.1.2 Proton NMR (
1
H qNMR) spectroscopy as a quantitative 
comparative technique for RI extracted glucose 
concentrations 
Several techniques have been used in the literature to assess the concentration of glucose in 
various samples. The most widely used and described involve the detection with GOD and 
horseradish peroxidase (POD) in a colorimetric test as described in chapter 2, section 2.2.4, 
but this technique is unsuitable here as a comparative test for the glucose extracted via RI 




qNMR was thereafter implemented as a promising control technique for the developed 
technology. 
5.1.2.1 1H qNMR principle 
NMR spectroscopy is based on the spin of the atomic nucleus in a molecule and their 
behaviour in a set magnetic field. The most common NMR analysis are based on the spin of 
hydrogen and are referred as 
1
H NMR. It focuses on the effect of the applied magnetic field 
on the spin of the different hydrogens and their emission energy. This last value depends on 
the neighbouring hydrogen atoms in the molecule. It is therefore possible to reconstruct a 
molecule with its’ 1H NMR spectra. In that sense, the technique appears to show very 
interesting qualitative information. This will be very useful in order to select glucose from a 
complex gel enzymatic extraction sample, but the main attribute of the reference technique 
should be the quantitative validation of glucose levels. qNMR or quantitative NMR was 
introduced in 1970 by Turczan et al. [24]. It is based on equation 5.1 describing the 
proportionality between the NMR signal intensity and the number of nuclei involved in a 
particular resonance [25]. 
Ix = Ks × Nx 
NMR intensity signal (Ix) described as a function of the nuclear number (Nx) and the 
spectrometer constant (Ks) which depends on pulse excitation, repetition time and broad band 
decoupling [25]. From this formula, relative or absolute quantification can be obtained. 
Relative quantification relates to equation 5.2. It is a molar ratio between the compound x and 
the other species present in solution. 
 
 
nx/ni represents the molar ratio between the molecule of interest x and the m compounds in 
solution, I is the intensity of the signal and N is the nuclear number. 
 
On the other hand, absolute qNMR relates to the use of a standard of set NMR intensity, 
usually giving a singlet at low ppm. A good NMR standard should be inexpensive, stable, 
available in pure form, not hygroscopic, soluble in NMR solvents and displaying a simple 
singlet signal [26]. Absolute qNMR is used in this chapter, with the internal standard: 3-
(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt (TMSP-d4). It will be used to normalise 












 × 100% 
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effectively quantify the selected NMR peak and cancel the chemical shifts observed between 
measurements [27].  
5.1.2.2 Advantages of 1H qNMR over other quantification techniques 
The main advantages of 
1
H qNMR over other traditional quantitative techniques is the direct 
nuclear signal without interferences or the use of biological intermediates (enzymes). Several 
molecules can also be quantified from the same sample with only one standard. 
1
H qNMR 
displays simple sample preparation, small analysed volumes and fast and easy procedures 
that will be appropriate to future analysis [27]. Finally, 
1
H qNMR analysis was defined as 
“more precise and accurate than the chromatographic methods” [28]. The confidence in the 
choice of this reference technique for the new RI coupled sensor was therefore high. 
 
5.1.2.3 Glucose 1HqNMR 
The singular identifiable resonance of glucose will come from its α or β proton on the 
terminal C-OH group. When studying glucose in a complex mixture, two fundamental 
aspects will direct the analysis to this particular proton. (1) Firstly, the α/β proton is 
connected to oxygen. It is deshielded by the electron withdrawing effect of the 
electronegative oxygen atom. (2) Secondly, the position of the proton (equatorial = β or axial 
= α) will shift the value at which the proton resonates [29]. The β form of the hydrogen 
displays a typical signal of 4.6 ppm while the α one was identified at 5.2 ppm [30]. 
5.1.3 Multiplexing of the graphene sensor 
One of the very interesting properties of CVD graphene is its ability to be transferred in 
relatively “large dimensions” to arbitrary substrates, a useful feature in design development. 
Several techniques have been described to achieve the efficient transfer of large monolayer 
graphene sheets, including: the wet etching [31], roll to roll [32] and soak and peel techniques 
[33]. Multiplexed graphene sensors have been described in the literature, for example in the 
areas of pH sensing [34], cell proliferation study [35], and the detection of chemicals in the 
vapour phase [36]. To-date, however, while no amperometric multiplex CVD graphene 
sensor has been described, the scale-up of the sensor developed here to a multiplex array 
appeared realistic. In the final section of this chapter, a single large scale, unpattern CVD 
graphene sample is therefore examined to assess whether it may be used to sense glucose 
simultaneously in separated compartments without any “cross-talk” between the sensors. 
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5.2 Materials and experimental methods 
5.2.1 Materials 
NaCl, KCl, Na2HPO4, NaH2PO4, KH2PO4, ethylenediaminetetraacetic acid, BIS-TRIS 
hydrochloride, EDTA, NaOH, AgCl, glucose oxidase, D-glucose, low gelling temperature 
agarose, hydrogen hexachloroplatinate (IV) hydrate, H2SO4, FeCl3, were purchased from 
Sigma Aldrich (Dorset, UK). Milli-Q water was used for all the solutions. CVD graphene 
was provided by the Univeristy of Bath, UK on copper, and transferred on a silicon dioxide 
substrate according to the procedure described in chapter 2, section 2.2.2.1. Abdominal pig 
skin was collected from a local abattoir, dermatomed (Zimmer
®
, Ohio, USA) to a nominal 
thickness of 750 µm, frozen within 24 hours of slaughter and thawed before use. β-agarase 
was purchased from Thermo Scientific (Loughborough, UK), TMSP-d4 from Goss Scientific 
(Shavington, UK) and Silcoset 151 ACC silicone rubber from Farnell (Leeds, UK). 
5.2.2 Experimental methods 
5.2.2.1 Electrode design  
The sensing electrodes were first prepared as described in chapter 2 section 2.2.2.2, platinum 
nanoparticles were electrochemically deposited as presented in chapter 4 section 4.3.1.2 and a 
GOD entrapped gel was casted on top of the electrode following entrapment method 3. 
 
5.2.2.2 Demonstration of dual function: reverse iontophoresis (RI) coupled 
with electrochemical sensing  
10 and 100 mM glucose solutions were prepared in PBS and left to mutarotate overnight for 
use as the subdermal solutions for the RI experiment. The amount of chloride in the 
glucose/PBS solution was more than sufficient to supply the electrochemical demands (i.e. 
chloride requirement with Ag at the anode to create AgCl and one e
-
). Indeed, the required 
amount was calculated as 0.9 mM which is well in the range of PBS. When starting a RI 
experiment, a piece of skin was placed on a 7.5 mL Franz cell, with the epidermis up. The 
cell was then filled with 7.5 mL PBS/glucose, placed on a magnetic stirrer and stirred for 1 
hour before the operation. Ag/AgCl electrodes were prepared for the experiment by 
depositing molten AgCl on a silver wire. These would serve as cathodes placed on top of the 
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GOD/gel reservoir touching the epidermis. Some other electrodes were electrochemically 
treated in a solution of saturated KCl overnight to induce the formation of silver that will act 
as anodes placed inside the subdermal compartment. It is important to note at this point that 
the experiments presented were not done in a completely non-invasive situation, where both 
electrodes would need to be on top of the skin, but the reverse iontophoresis was executed 
with one electrode in the subdermal compartment and the other electrode touching the 
skin/gel reservoir. However, this was of minor importance considering that any change in the 
skin membrane resistance at a constant iontophoretic current is correlated with a change in 
the voltage across the resistor (decrease). So at constant current the amount of ions involved 
in the RI process will remain unchanged (only the voltage across the skin will double) and the 
amount of glucose extracted should be similar [37]. The model appears therefore appropriate 
for correlation with non-invasive analysis. Figure 5.3 displays the RI setup involving one 












 The anode is placed in the subdermal Figure 5.3. Reverse iontophoresis setup.
compartment and the cathode in contact with the GOD/gel reservoir on top of the skin. 
During the RI process, oxidation occurs at the silver anode to form AgCl and one 
electron. Inversely, the cathode displays a reduction of AgCl to Ag + Cl
-
. The red arrow 
symbolises the RI flow of glucose molecules G.  
RI was performed by passing 0.2 mA (equivalent to 2.2 mA/cm
2
) between the anode and 
cathode from a generator (Kepco power supply, MB electronic). Each RI extraction 
experiment lasted 1 hour. Chronoamperometry was obtained before and after each RI. 
Chronoamperometry was first performed before the RI experiment with a CVD graphene/ Pt 
nanoparticles electrode and 24 µL of gel containing 4 mg/mL GOD as described in chapter 4 
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The initial volume of gel used for the glucose gradients was 27 µL (GOD concentration: 3.56 mg/mL), while 
the volume of gel during the RI process was 24 µL (GOD concentration: 4 mg/mL). The obtained ΔI results 
were hence corrected for volume before being plotted on the glucose gradients (by multiplying by a 27/24 
factor). 
 
The experiment was performed at 0.4 V against an Ag/AgCl micro-reference electrode (with 
a Pt counter electrode) for 700 seconds. The gel was then excised and RI was applied, as 
previously described. After the RI extraction was completed, the gel was placed on the 
electrode again and the chronoamperometry was repeated as before. Current results were 
averaged over 600 seconds (from 100 seconds to 700 seconds, except for the point displayed 
in red in figure 5.5: averaged from 100 to 240 seconds) and subtracted from the 
chronoamperometry current values obtained before the RI. This provided a ΔI current which 
was then plotted on a glucose gradient concentration curve (see section 5.2.2.3.2).  
5.2.2.3 Data analysis 
5.2.2.3.1 “Gradient concentration curves” 
The glucose “gradient concentration curves”; catalytic current = f(concentration), were 
obtained by previously testing the sensor with several glucose concentrations. They are 
represented as dotted black curves. The increase of catalytic current with addition of glucose 
were analysed similarly to the calibration curves for sensitivity analysis presented in chapter 
4 (method described in chapter 2 section 2.2.3.2). The current was then plotted as a function 
of the concentrations of glucose and fitted with linear regressions. For both sections 5.3.1 and 
5.3.2 (see figures 5.7, 5.8 and 5.10) the “gradient concentration curves” were separated 
between the “low concentration ranges” and the entire range, because most of the calibration 
curves didn’t fitted the linear regressions in the “low concentration range”. When plotting a 
low ΔI, it therefore appeared more accurate to use this “low concentration range” in order to 
get the most realistic value of the extracted concentration. 
5.2.2.3.2 chronoamperometric signal: “∆I” 
The chronoamperometric signal obtained before and after reverse iontophoresis for both 
experiments (see figure 5.6) presented different slopes. These differences relied on the 
experimental conditions: the drying of the gel (and therefore the diffusion of glucose) was not 
constant between experiments. The proposed solution was to take the average of the catalytic 
signal and hence account for each of the decays over 600 seconds (140 seconds for the red 
points in figure 5.8). The first 100 seconds were not analysed in order to cancel the initial 
decay of any chronoamperometric operation. This decay is described by the Cottrell equation 
(see chapter 2, section 2.1.2.7). The subtraction of the signal after and before reverse 
iontophoresis is designated as ∆I. The ΔI values were corrected for volumes of gel (footnote 
5.α) and reported on the glucose gradient giving corresponding glucose concentrations.  
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5.2.2.4 Control experiment 
A control experiment is presented in figure 5.8 in which the same experimental protocol is 
applied but without any glucose in the subdermal compartment during the RI.  
 
5.2.2.5 Hair follicles targeting  
In a second instance, abdominal porcine pieces of skin were classified into “less hairy” (LH) 
and “hairy” (H) samples. Typically the difference in hair frequency ranged from 2 to 6 times 
(LH samples were defined as presenting ≤ 22 hairs/cm2 while H samples had a hair density ≥ 
34 hairs/cm
2
). The positioning of the gel was of utmost importance and was achieved using a 
binocular microscope. Gels were specifically positioned on top of a single or multiple hairs of 
the H samples whereas effort was made to avoid any hairs on the LH samples. Figure 5.4 
shows the RI setup with the gels strategically placed for targeting the hair follicles (H 
sample) or avoiding them (LH sample). Depending on the hair follicle density, it was possible 
to achieve a comparison between hair/no-hair extraction (see table 5.2).  
 
 
              
 Photography of the hair Figure 5.4. H and LH samples for reverse iontophoresis.
targeting setup on porcine skin: the yellow GOD-loaded gel is placed on top of a hair 
using the H sample, or in between hairs using the LH sample. In these pictures, the hair 
density was estimated to be 17 hairs/cm
2





GOD/ gel 24 µL 
LH H 
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The experiment followed three steps: First, two chronoamperometry were acquired at 0.4 V 
against an Ag/AgCl micro-reference electrode (with a Pt counter electrode) before reverse 
iontophoresis. The same electrode but two different GOD-loaded gel pieces were used that 
will then be placed on H and LH samples (see figure 5.4). Then, RI was performed for 1 hour 
with a 100 mM glucose subdermal concentration for both LH and H skin samples, in a 
similar set-up as figure 5.3. Finally, two chronoamperometry were again acquired at 0.4 V 
against an Ag/AgCl micro-reference electrode (with a Pt counter electrode), on the sensing 
electrode after RI. The increase of current ΔI between the chronoamperometry acquired 
before and after the RI were then reported on “glucose gradient concentration curves”, see 
section 5.2.2.3.1, (the concentration curves were obtained by previously testing the sensing 
electrode with glucose). The concentrations corresponding to the ΔI fitted on the “glucose 
gradient concentration curves” will be the extracted concentrations. 
 
5.2.2.6 1H qNMR spectroscopy 
 
5.2.2.6.1 RI and sample preparation 
Reverse iontophoresis was performed for 1 hour using the same setup as in figure 5.3, on H 
and LH skin samples (of 23 hairs/cm
2
 and 8 hairs/cm
2
 respectively), and with the subdermal 
glucose concentration set at 100 mM. The gels into which glucose was extracted (which did 
not contain GOD) were then diluted (1:5, vol/vol) in Bis-Tris/EDTA (10 mM/1 mM) buffer 
at pH 6.5. The mixture was warmed at 65 °C for 10 minutes, and subsequently cooled to 
42°C before being incubated with one unit/100 µL of β-agarase for 1 hour at 42 °C. The β-
agarase is an enzyme that is used to dissolve the low gelling temperature (LGT) agarose gel 
in order to obtain a liquid sample for 
1
H qNMR analysis.  
 
In parallel, a calibration curve displaying the NMR signal as a function of the glucose 
concentration was constructed with 24 µL samples of gel (without GOD) containing known 
concentrations of glucose : 250 µM, 1 mM and 19 mM respectively, (i.e., not obtained 
through RI) and dissolved in the same way (dotted black line in figure 5.11). Finally, the 
reverse iontophoresis values were reported on the calibration curve in order to assess the 
extracted glucose concentrations. 
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5.2.2.6.2 1H qNMR 
120 µL of dissolved gel samples were inserted into a NMR analysis tube with TMSP-d4 (as 
the internal standard). The NMR solvent was deuterium oxide (D2O). Spectra were recorded 
on a Bruker Advance III NMR spectrometer operating at 500.13 mHz. Results were analysed 
with Topspin 2.1 software. 
 
5.2.2.7 Multiplexing of the sensor 
 
5.2.2.7.1 CVD graphene transfer  
A Large piece of graphene of 36 mm
2
 (figure 5.14) was transferred onto Si/SiO2. The transfer 
via wet etching was obtained using the method described in chapter 2, section 2.2.2.1. 
 
5.2.2.7.2 Pt nanoparticles treatment  
The graphene sheet was then treated electrochemically for Pt nanoparticles deposition, with 
50 µL of 1.7 mM hydrogen hexachloroplatinate and 0.1 M H2SO4, as described in chapter 4 
section 4.2.2.3. Once transferred, the sample was patterned into 4 wells of 3×3 mm, using 
Silcoset 151, ACC silicone, Farnell (Leeds, UK). 
 
5.2.2.7.3 Enzymatic gels  
Glucose oxidase and then LGT agarose were cast on the graphene compartments up to a 
volume of 24 µL using entrapment method 3. 
 
5.2.2.7.4 “Cross-talking” investigation 
Sensor “cross talk” was assessed on a 2×2 multiplex. Unfortunately two of the four sensors 
did not display any conduction (probably due to problems on the graphene structure that 
occurred during the wet etching transfer). Attention was therefore focused on the two 
remaining functional sensors onto both of which were placed 24 µL of GOD-loaded gel. 
Chronoamperometry was performed on the first sensor (A) at 0.4 V against a micro Ag/AgCl 
electrode for 500 seconds. This was repeated on the other functional sensor (B) with the same 
conditions except that it was exposed to a series of increased glucose concentrations so that 
the characteristic step-like catalytic activity could be observed. Finally, the 
chronoamperometry experiment was repeated on sensor (A) to assess if any signal was 
detected due to the glucose additions to sensor (B).  
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5.3 Results  
5.3.1 Demonstration of dual function: reverse iontophoresis 
coupled with electrochemical sensing  
This section demonstrates that one individual sensor can perform both glucose extraction 
through reverse iontophoresis and electrochemical sensing of glucose. The device consisted 
of CVD graphene with the GOD entrapped gel and platinum nanoparticles placed on top 
(entrapment method 3). No specific targeting of skin appendages is undertaken at this stage. 
 
5.3.1.1 Cyclic voltammograms before and after RI 
Cyclic voltammograms of the gel were acquired before and after RI with 10 mM and 100 
mM subdermal glucose used in the RI step. Figure 5.5 shows the data obtained for the 
different concentrations of glucose. A clear difference in the extraction was identified 
between the two different subdermal concentrations. It can be seen that in figure 5.5-A that 
the lower concentration (10 mM) shows almost no difference in the signal between the cyclic 
voltammetry before and after RI whereas at 100 mM (figure 5.4-B) there is a very clear 
difference in the cyclic voltammograms. Figure 5.4-B shows a peak at 0.4 V (vs. Ag/AgCl) 





Figure 5.5. Cyclic voltammograms before and after reverse iontophoresis with 10 
 A: RI applied with 10 mM subdermal and 100 mM glucose subdermal concentration.
glucose concentration. B: RI applied with 100 mM subdermal glucose concentration, 
scan rate 20 mV/sec. 
 
Chronoamperometry was also carried out on the gel at a constant potential of 0.4 V (vs. 
Ag/AgCl) before and after RI. Differences ∆I were obtained by subtracting the 
chronoamperometric currents (before and after RI), figure 5.6 A and B (see section 5.2.2.3.2). 
This method of glucose detection seems to be more sensitive as even the 10 mM subdermal 
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A. 10 mM subdermal glucose 
B. 100 mM subdermal glucose 
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glucose concentration shows an increase in current after reverse iontophoresis. ∆I values 
were then reported on a glucose concentration gradient. From there glucose extracted values 





Figure 5.6. Chronoamperometric signal before and after reverse iontophoresis with 
10 and 100 mM glucose subdermal concentration. A: RI applied with 10 mM  
subdermal glucose concentration. B: RI applied with 100 mM subdermal glucose 
concentration. Fixed potential vs micro Ag/AgCl reference electrode: 0.4 V. 
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Figure 5.7. Chronoamperometric detection of extracted glucose via reverse 
 The dotted iontophoresis with 10 and 100 mM subdermal glucose concentrations.
black curves are gradient of glucose obtained with the sensor previous to the 
iontophoresis operation. The ΔI currents obtained from (A) and (B) in figure 5.6 were 
reported (in blue) on the sensor glucose gradient curve (black curves) and hence gave 
corresponding RI extracted glucose concentration values. A: plotting of the RI value 
obtained for 100 mM subdermal glucose on the entire glucose gradient curve (i.e. 0.05 
mM to 50 mM). B: plotting of the RI value for 10 mM subdermal glucose for a small 
concentration range going from 0.05 mM to 0.5 mM. The * is a correction of the 
concentration following the dilution of the gel. 
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5.3.1.2 Repeatability of reverse iontophoresis detection 
RI experiments were repeated under the same conditions as section 5.3.1.1, with different 
electrodes and different pieces of abdominal skin, from the same pig (see figures 5.8-A and 
5.8-B). Even though the experimental conditions were variable the aim of this experiment 
was not to measure a repeatability on similar tissue models but rather assess if the extraction 





Figure 5.8. Repeatability of the reverse iontophoretic detection with 10 and 100 mM 
 The blue curves are the glucose gradients subdermal glucose concentrations.
presented in figure 5.7 with reported RI extraction current obtained from 10 and 100 
mM subdermal glucose concentration. A. The red curve is the glucose gradient obtained 
with a second electrode with reported RI extraction current obtained from 100 mM 
subdermal glucose. B. The brown curve is the glucose gradient obtained with a third 
electrode with reported RI extraction current obtained from 10 mM subdermal glucose. 
These glucose gradients only present small concentration ranges going from 0.05 to 1 
mM. The * is a correction of the concentration following the dilution of the gel. 
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5.3.1.3 Selectivity of the detection towards extracted glucose 
Reverse iontophoresis was then undertaken in conditions similar to those described but 
without any glucose in the subdermal compartment to act as a control experiment. The GOD-
loaded gel sensor (entrapment method 3) was tested, in figure 5.9, via chronoamperometry at 
0.4 V (vs. Ag/AgCl) before and after the 1 hour of RI experiment. The control was positive 
since no significant increase in catalytic current was observed after the RI (blue curve). 
 
 The chronoamperometric current was Figure 5.9. Selectivity of the RI extraction.
obtained before and after RI without any glucose in the subdermal compartment. The 
RI and chronoamperometric experiments were acquired under the same conditions as 
used in figure 5.6. The spikes observed on the blue curve are most likely due to noise 
coming from the experimental setup. 
 
5.3.2 Hair follicles targeting 
The RI flux is not uniform over areas of the skin and appendages such as sweat, sebaceous 
glands or hair follicles appear to have a dominant role in the process. The structure of the skin 
as well as the preferential reverse iontophoresis extraction through hair follicles is presented 
in chapter 1 section 1.3.5.4.4.2. The following section focuses on hair follicle targeted 
extraction into micro-gels and glucose detection with the developed graphene sensing device. 
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5.3.2.1 Targeted RI 
Chronoamperometry was performed on gel samples both before and after RI. The RI was 
operated on skin samples with lots of hairs (H) and less hairy samples (LH). A net increase in 
the current signal was observed, in figure 5.10, from sample H (i.e. hairy extraction; depicted 
in pink) as compared to sample LH (i.e. less hairy extraction; depicted in blue). 
 
 
Figure 5.10. Extracted glucose concentrations from H and LH skin samples in a 
 A: Chronoamperometric measurements acquired targeted hair/no-hair experiment.
before and after RI from LH and H skin samples, of 6 and 34 hairs/cm
2
 respectively. 
The signal was acquired at 0.4 V vs a micro Ag/AgCl reference electrode. B: Glucose 
concentration gradient curve (black dotted curve) obtained for the same sensing 
electrode used in (A). The extracted glucose concentrations ∆I for the H sample is 
indicated and plotted in magenta on the gradient curve. The glucose gradient curve 
displayed the all range of concentration tested (i.e. 0.01 mM to 1 mM). C: Glucose 
gradient curve displayed over a low concentration range (i.e. 0.01 mM to 0.1 mM). The 
extracted glucose concentrations ∆I for the LH sample is indicated and plotted in blue 
on the gradient curve. 








 After RI (H sample)
 After RI (LH sample)
 Before RI (H sample)



















 Glucose gradient concentration curve











I = 0.152 A 
0.310 mM
Glucose concentration (mM)







 Glucose gradient concentration curve
0.037 mM
I = 0.0146 A 
















5.3.2.2 Repeatability of targeted RI extraction 
The same experiment was repeated with different LH and H samples and the same electrode. 
Extracted concentrations are displayed in Table 5.2 along with their average and standard 
deviation values. The hair density for each samples are also reported. The extracted 
concentrations didn’t correlate with the densities of follicles (with high hair follicle density 
presenting low extracted concentrations). However, the concentration and hair density ratios 
showed similarity (i.e., average concentration ratio of the order of average hair density ratio). 
Moreover, even though the LH and H glucose extraction didn’t show statistical difference 
(P(t.test)>0.05), H samples recurrently displayed increased concentrations (see Table 5.2).  
 
Table 5.2. Comparison of extracted concentrations for LH and H samples. In addition 
with the concentration and hair density values the table also presents the student 
P(t.test) value used to assess the statistical difference between the two sets of 












LH H LH H 
0.017 0.031 1.824 22 46 2.091 
0.082 0.108 1.317 17 39 2.294 











P(t.test) applied to the extracted concentrations 







H qNMR spectroscopy confirmation test 
Reverse iontophoresis was then applied to H and LH samples in a similar way as section 
5.3.2 but the samples (obtained in gel without enzymes) were analysed via 
1
H qNMR which 
acted as an independent confirmation technique for the glucose extracted. The NMR results 
of these samples are shown in figure 5.11. They were then reported on a glucose calibration 
curve displaying normalised number of protons = f(glucose concentration) in figure 5.12 
(black dotted curve). The measured doublet peak for glucose was observed at ~5.1 ppm (after 
TMSP normalization). The signal corresponds to the α-D-glucose [30]. -D-glucose was then 
estimated from the proportionality between the two forms in solution at equilibrium: 64% β-
D-glucose, 36% α-D-glucose [38] (the β glucose wasn’t directly quantified due to the lack of 
specificity of the NMR signal in the gel mixture around 4.6 ppm). Table 5.3 displays the 
comparison between the 
1
H qNMR β-D-glucose calculated extracted values and the ones 










 Visualization of the α-D-Figure 5.11. 1H qNMR spectra from H and LH samples.
glucose proton NMR signal at ~ 5.1 ppm and normalised for TMSP-d4. The signals 
were acquired after reverse iontophoresis (100 mM glucose subdermal concentration) 
on A: H samples and B: LH samples.  
 
A. H sample 






Figure 5.12. Extracted glucose concentrations from H and LH samples determined 
 The proton NMR signals of glucose extracted from H (blue) and LH (green) by NMR.
skin samples are converted to concentrations using the glucose calibration curve (black 
symbols). The glucose calibration curve was previously obtained by testing different 
concentration of glucose in the gels as described in section 5.2.2.6.1. 
 
Different sets of skin samples (i.e., H and LH) have been used for the electrochemical (see 
figure 5.10) and 
1
H qNMR evaluation of glucose extracted by RI. Again here even though 
different skin samples were used it didn’t influence the problematic, which was to assess 
whether the extraction was preferential using both techniques or not. The concentration ratios 
are compared in table 5.3:  
Table 5.3. Comparison between glucose analysis by electrochemical sensing and 
1
H 
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17 31 1.824 2.091 
82 108 1.317 2.294 
37 310 8.378 5.667 




































The extracted glucose concentration ratios were then plotted as a function of their respective 
hair density ratios for both detection techniques (figure 5.13). The concentration ratios 
obtained via 
1
H qNMR seems to fit on the same linear regression than the ones obtained 
electrochemically. A good proportionality between the two techniques was hence 
demonstrated. 
 
Figure 5.13. Extracted glucose concentration ratio = f(hair density ratio) obtained 
1
H   with electrochemical and  qNMR detections.
 
5.3.4 “Cross-talk” experiment applied to a multiplex sensor 
configuration 
The next step in the development of the non-invasive technology was the multiplexing of the 
sensor (on the same graphene sheet). Figure 5.14 depicts the chronoamperometric signal 
obtained in two sensors in which a GOD functional gel had been casted. Glucose was added 
in sensor (B) but no addition of glucose was made in sensor (A). A signal was acquired in (A) 
before and after additions in (B). The chronoamperometric signal difference ∆I at sensor (A) 
provoked by glucose exposure up to 1 mM in sensor (B) was about 0.13 µA. Based on the 
calibration curve (obtained in sensor (B), (see figure 5.14-B), the signal was only equivalent 
to 0.029 mM glucose (i.e., less than 3% of the total amount of glucose added to sensor B) and 
suggests very little cross talk between the sensors.  
  



















































A: Green Figure 5.14. “Cross-talk” assessment between sensors on CVD graphene. 
and magenta lines are the chronoamperometric signals obtained on sensor (A) before 
and after, glucose additions in the sensor (B). The black line is the chronoamperometric 
signal observed in sensor (B) with additions of glucose concentration (the orange arrows 
are additions of glucose and the blue arrows are additions of buffer acting as a positive 
control in the experiment). B: The ΔI value from sensor (A) was reported on the glucose 
calibration (black dotted curves) obtained with sensor (B) and a “cross talking” 
concentration of 0.030 mM was found.  
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5.4.1 Demonstration of dual function: reverse iontophoresis 
coupled with electrochemical sensing  
From the first RI results described (Figures 5.5, 5.6 and 5.7) it was possible to validate two 
attributes of the technique: (1) the extraction of glucose through the skin, (2) the selective 
detection of glucose with the miniature sized sensor developed in chapter 4. Two subdermal 
concentrations differing by a factor of 10 were chosen for the initial test that provided a clear 
difference in the detection. The effectiveness of the extraction was demonstrated. The 
extracted concentration values (figure 5.7) were then converted into iontophoretic flux, 
respectively calculated as 39.2 nmol/h/mA and 3.13 μmol/h/mA for 10 and 100 mM 
subdermal concentrations. The ratio between the two fluxes was ~ 79.8. This value is 
significantly higher than the subdermal concentration ratio of 10. It could be explained by the 
drying of the gel not being controlled in the experimental protocol. This led to the re-dilution 
of the gel reservoir after reverse iontophoresis, but also and as presented in the next section to 
the overall overestimation of the extracted concentrations values of this section. The results 
nevertheless display a neat enhancement of extracted concentrations of glucose following the 
increase in subdermal concentration. Moreover, figure 5.8 indicated that a reproducible 
extraction of glucose was detected by different sensors that was within the sensitivity range. 
Noticeably, the 3 concentration gradients for electrode 1, 2 and 3 presented different slopes. 
This could be explained by the variability of signal from electrode to electrode itself 
influenced by many factors such as the quality of the deposited graphene, mechanical damage 
caused to the electrode while placing the gel, etc. Nevertheless, close concentration values 
were repeatedly obtained for extracted glucose: 93 μM and 327 μM for 10 mM subdermal 
concentration and 11.601 mM and 26.112 mM for 100 mM subdermal concentration. The 
selectivity of the sensor for glucose was finally demonstrated in figure 5.9 which didn’t show 
any signal derived from RI samples treated without glucose. It was therefore possible to 
describe the glucose extraction and detection as highly selective (no interference coming 
from the skin itself). This section hence demonstrated the efficiency of the RI glucose 
extraction in small 24 µL volumes of GOD-loaded gel and the successful, coupled detection 
with the newly-developed sensor. However, thus far, no attempt to specifically target the hair 
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follicles had been made, the gels having been placed randomly onto the skin samples used. 
The next step, was therefore to investigate targeting of the hair follicles. 
5.4.2 Hair follicles targeting 
Hair follicle targeted extraction was then accomplished by placing the gels on top of hair 
follicles on H samples. Comparatively attention was placed to avoid any hair follicles on LH 
samples in order to compare the two collections of glucose (see figures 5.4 and 5.10). For 
both reverse iontophoresis experiments the subdermal glucose concentration was 100 mM. 
The respective extraction flux for H and LH extractions were then calculated as 37.2 
nmol/h/mA and 4.4 nmol/h/mA. Following, are two aspects to be considered in the 
interpretation of the results: (1) The difference of order of magnitude between the values 
obtained here and in the previous section and (2) The preferential extraction through the hair 
follicles. 
 
(1) The flux values obtained in this section are small when compared to the one obtained for 
100 mM subdermal concentration in the previous section (i.e. 3.13 μmol/h/mA). Sieg et al. 
indicated in the literature that a glucose flux of 54.3 nmol/h/mA was obtained from a 10 mM 
subdermal glucose concentration [39]. In this study an iontophoretic current of 0.5 mA/cm
2
 is 
passed through a skin area of 0.78 cm
2
 for 6×1 h. The average hair density of a human subject 
in the thorax is 22 hairs/cm
2
 [40]. Considering the area covered in the study, the average 
amount of hair involved in the extraction would be ~ 17. In our targeting experiment the 
hairy extraction flux is 37.2 nmol/h/mA for 100 mM subdermal concentration of glucose, it 
would therefore correspond to 3.72 nmol/h/mA for 10 mM subdermal. If this value is 
multiplied by the 17 hairs covered by Sieg et al., considering that the targeting only applies to 
a single hair, the resulting flux is 63.24 nmol/h//mA. This last result is close to the 54.3 
nmol/h/mA obtained from the literature. It therefore appears that the results from the first 
section were over-estimated. The most logical explanation for these higher values is the 
drying of the gel during the experiment. As indicated by the * in Figures 5.7 and 5.8, the gel 
tended to dry during the experimental procedure (following mechanical pressure or longer 
time between experiments). This could have led to a significant increase in the glucose 
concentration of the sample from part one (however still proportional to the subdermal 
concentration of glucose). 
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(2) In a second instance, the results from figure 5.10 confirms the preferential extraction of 
glucose via the hair follicles pathways since a neat increase in extracted glucose 
concentration is observed for the hair targeting (H) when compared to no hair targeting (LH). 
The ratio between the obtained concentrations was ~ 8.4 which was in accordance with the 
hair density ratio between the two samples of ~ 5.7. In the same way, table 5.2 presents 
extracted glucose concentrations for H and LH samples obtained with different pieces of skin 
and hence different hair densities. The procedure did not allow for similar samples or hair 
densities between experiments. However, table 5.2 displays a resemblance between the 
average glucose extracted concentration ratio: 3.84 and the average hair density ratio: 3.351. 
These repeatability results were not, however, entirely consistent with the expected 
conclusion of preferential extraction of glucose through follicles since: (1) the H and LH 
extracted concentrations were not statistically different P(t.test)>0.05 and (2) the hair density 
of H samples didn’t correlate with the extraction of glucose. This was likely due to the 
variability in the experimental protocol (positioning or drying of the gel) and related to the 
use of different abdominal pieces of skin acquired from the same pig. Nevertheless these 
experiments are a first demonstration of an already established theory of preferential 
extraction of neutral molecules (i.e. glucose) through follicles [16]: the extraction fluxes 
observed in figure 5.10 are indicative of this phenomenon. 
5.4.3 
1
H qNMR spectroscopy confirmation test 
An independent 
1
H qNMR test was then developed for the quantitation of the glucose 
amounts extracted by a non-enzymatic method. The technique enabled the accurate 
quantification of the α glucose enantiomer concentration in RI samples. figure 5.11 displays 
the number of protons (normalised for TMSP-d4) for the α-D-glucose extracted by reverse 
iontophoresis with an H and LH sample. These values were then reported on a glucose 
concentration gradient and provided with the corresponding extracted concentrations values 
for α-D-glucose of 172 µM and 50 µM (figure 5.12). The respective β-D-glucose 
concentrations were then calculated from the proportion of enantiomers at equilibrium (see 
section 5.3.3) as 306 µM and 89 µM for H and LH samples respectively. The corresponding 
concentration ratio was 3.438 which resembled the skin samples hair density ratio of 2.875 
(see Table 5.3). Moreover, when plotting the concentration ratios as a function of the hair 
density ratios, these fitted the same linear regression plot than the one obtained 
electrochemically with the sensor (see figure 5.13). A good agreement is therefore 
 191 
demonstrated between the amounts of extracted glucose following different pathways 
measured with both detection techniques (electrochemical vs 
1
H qNMR). Two conclusions 
could therefore be drawn: (1) 
1
H qNMR spectroscopy is a good control technique for the 
developed technology and (2) the enhanced follicular extraction was confirmed by 
1
H qNMR. 
This confirmation experiment however presented limitations: (1) the limited number of 
measurements in the glucose gradient curve (three; see figure 5.12) and (2) the lack of 
repeatability (single experiment). Hence, these results are not a statistically relevant 
demonstration of glucose sensing with 
1
H qNMR, rather a promising step towards the 
implementation of a confirmation protocol for the developed sensor. To date, however, the 
combination of RI with 
1
H qNMR detection for glucose detection has not yet been 
investigated in the literature, the procedure is therefore an original, state of the art technique. 
It is also a sensitive, specific and quantitative sensing of glucose in a mixture of enzymes and 
buffers (with discrimination of the α and β enantiomers of the molecule), it does not require 
complicated sample preparation and small volumes can be analysed. 
5.4.4 “Cross-talk” experiment applied to a multiplex sensor 
configuration 
Figure 5.14 presents an attempt at building a multiplexed sensing device. Unfortunately half 
of the sensors failed probably due to an inefficient graphene transfer leading to the formation 
of defects and consequent conduction problems. However, several other graphene transfer 
techniques, as described before, could be investigated for further development [32, 33]. The 
figure studies the cross talking signal obtained in the compartment (A) when adding glucose 
in the compartment (B) (both being functional sensors). The chronoamperometric signal (ΔI: 
difference between the signal in (A) before and after glucose additions in (B)) is 3% of the 
total amount of glucose added in (B). It can therefore safely be concluded that the detections 
are well separated and independent from each other, even without patterning the graphene 
sheet (no physical separation/etching of the nanomaterial). Considering that a hair follicles 
extraction pathway glucose detection has already been demonstrated on one sensor, this 
multiplexing experiment will lead the way to an integrated RI-based targeting device. 
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5.5 Conclusions  
The in-vitro application of the sensor from chapter 4 to transdermal glucose monitoring via 
RI was successfully demonstrated. The proportionality of the extracted detected glucose 
concentration in the micro-sized gels with the subdermal concentrations was first confirmed. 
The extracted results however overestimated (most likely due to drying) followed the 
increase in subdermal glucose concentrations. A hair targeting experiment was then 
implemented involving the positioning of the GOD containing gel on top of hair follicles or 
not. It was not however possible in the experimental procedure to be as precise as required to 
get the extraction from one hair only or no hair. The notion of hairy (H) samples and less-
hairy (LH) samples was hence introduced in order to relate the hair density to the glucose 
extracted concentrations. Remarkably the glucose concentrations extracted from H samples 
were always higher than the ones extracted from LH samples. Furthermore, the ratio between 
the extracted concentrations (H/LH) were noticeably alike the hair density ratio (H/LH). 
Some discrepancies were however observed in between the results, principally in the 
concordance between the H samples hair density and the corresponding extracted 
concentrations. The extracted concentration for H and LH samples were also not significantly 
different (P(t.test) value > 0.05). Nevertheless, these results are a confirmation that the 
glucose is preferentially extracted through hair follicles and can successfully be detected with 
the miniature gel/sensor setup. Following this observation an independent confirmation test 
was necessary for the extracted concentration of glucose from H and LH samples that will act 
as a positive control towards the results obtained previously (i.e. section 5.3.2).  
 
1
H qNMR was used following reverse iontophoresis with enzymeless gels on H and LH 
samples. The extracted concentration ratio (H/LH) detected with this technique fitted the 
linear regression of the extracted concentration ration (H/LH) obtained electrochemically. 
The control was hence positive and the conclusion obtained previously on the preferential 
extraction of glucose through hair follicles confirmed. The 
1
H qNMR results were however 
obtained from a single experiment, attention will therefore be placed in the future work on 
repeating this control in order to attain satisfactory statistical significance. Finally, an attempt 
to multiplex the sensor was done that wasn’t entirely successful: half of the four sensors 
failed to provide a signal. An important attribute was however studied that would be of major 
importance in a future multiple sensor configuration: the cross-talking between sensors 
signal. The last results of the chapter indicated that no such phenomenon is happening 
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significantly since only 3% of the signal was communicated from one sensor to the other on a 
continuous graphene sheet. 
 
To summarize, the objective of demonstrating non-invasive targeted extraction coupled with 
the sensor technology was achieved and confirmed via an independent analytical tool. A 
multiplex sensor platform was also introduced that will provide an improved targeting of hair 
follicles and therefore high accuracy in the glucose detection. 
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Chapter 6: General conclusions and 
future work 
6.1 General conclusions 
This work presents a highly innovative method for non-invasive, transdermal glucose 
monitoring. The principle at its core is to target privileged reverse iontophoresis extraction 
pathways existing in the skin (such as hair follicles), through which glucose can be extracted 
directly from the interstitial fluid, and then detected by a coupled miniature, electrochemical 
glucose biosensor. Reverse iontophoresis enables even neutral molecules, such as glucose, to 
be extracted across the skin. The embodiment of multiple such sensors in a multiplexed array 
would provide a way to randomly reach such individual pathways by individual detectors in a 
future patch-like technology.  
 
The main achievements of this work are:  
(1) The realization of a miniaturized, highly specific and sensitive first generation 
glucose biosensor based on glucose oxidase. The sensor benefited from the incorporation of 
CVD graphene as a nanomaterial platform (advantageous for final implementations as patch-
like technology due its mechanical resilience and flexibility), decorated with platinum 
nanoparticles to boost the electrochemical signal. The method of GOD enzyme entrapment 
into the gel put on top of the CVD graphene was found to be important in glucose detection 
and a suitable technique consisting of depositing a solution of the enzyme on top of the 
graphene and the gel dropped on top was found to be the best method. The miniature device 
displayed exquisite detection performance towards glucose and was later successfully 
multiplexed in a small-size array.  
 
(2) Successful integration of the electrochemical sensor with glucose extraction, via 
reverse iontophoresis, and demonstration of enhanced extraction via hair follicle 
targeting. Proportionality between the source, sub-dermal concentration and the 
concentration of glucose extracted across the skin was demonstrated, with the extracted 
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glucose being detected electrochemically (by chrono-amperometry) by the coupled enzymatic 
sensor. The preferential hair follicle extraction was then confirmed with an experiment 
targeting the pathways and even though the results presented some discrepancies they tended 
to agree with the initial hypothesis of privileged extraction (as anticipated from the literature 
[1]). These results were further confirmed by correlation with measurements of extracted 
glucose concentrations via an independent 
1
H qNMR technique. This confirmation 
experiment was not statistically significant (single experiment) but would lead the way to the 
implementation of an appropriate control for the developed technology. 
 
Finally, some initial results were obtained on the multiplexed device based on the presented 
design. Although half of the sensor on the multiplex platform failed to give a signal, 
significant information was obtained: no cross linking was observed between two 
neighbouring sensor compartments on the same graphene sheet. These results are proof-of-
concept of a future non-invasive, path-selective, highly sensitive and highly specific 
transdermal technology for glucose monitoring. 
6.2 Future work 
Future work is directed towards taking this proof-of-concept further and developing it into a 
complete technology, to be applied in real-life. This involves moving away from the current 
embodiment, which involved hard supporting substrates and macroscopic wiring, towards a 
patch-like technology, that requires flexible substrates and fully patterned, substrate-
supported microelectrodes for both glucose extraction and detection. 
 
Full size arrays of many (e.g. a 8×8 matrix) dual extraction/detection devices will need to be 
implemented to ensure that at least one hair follicle is reached by a sensor of the array in all 
cases of average density of hair follicles representative for human skin [2], as well as to 
provide some redundancy. Reaching this goal requires good uniformity in performance of all 
the sensors of the array, which is foreseen to be greatly influenced by the quality and 
uniformity of the supporting graphene layer. To this end, good control over the techniques for 
large area graphene transfer onto the desired, flexible substrates is highly important (this 
issue should be tractable in the same way as for other graphene-based flexible electronics, 
array-based applications that are being currently developed). 
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Some effort will also be made to further improve the sensor itself. Specifically further 
microscopic characterisation and optimization of the platinum nanoparticles deposition will 
be made. Some specific attributes will also be investigated or improved such as the speed of 
detection and the stability overtime respectively. 
 
Another issue to be solved relates to the reproducibility of the characteristics of the enzyme-
encasing gel; this requires higher control over the undesired process of gel drying that occurs 
during longer extraction times. This effect can be minimised by decreasing the glucose 
extraction time, which is a parameter linked to both the geometry of the sensor and the 
reverse iontophoresis process itself. It should also be solved by the integration of the sensor 
directly on top of the reverse-iontophoresis setup. This would also provide more control on 
the extraction and detection procedure since the gel receptacle will not have to be moved. 
 
The preferential extraction through hair follicles and subsequent detection with the sensor 
although demonstrating promising results will have to be further repeated and the focus 
should be placed on the hair targeting with the gel (using microscopy for example). Similarly, 
1
HqNMR was demonstrated to be an appropriate control test. However the results were only 
obtained from a single experiment. This control should hence be repeated to provide more 
robust comparison results. 
 
A field effect transistor device for the detection of Na
+
 will also be developed (benefiting 
from the work presented in chapter 3 and the demonstration of Na
+ 
as an internal standard for 
the reverse iontophoresis technique by Sieg et al. [3]) that will act as a calibration sensor for 
the technology (see chapter 5 section 5.1.1). 
 
Finally, the developed multiplexed array monitor will need to be tested in-vivo, on human 
subjects, and several factors will need to be investigated such as the correlation between 
blood glucose and that extracted through the hair follicles by reverse iontophoresis, as well as 
variations between different skin areas or inter-individual variations. 
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